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S U M M A R Y
A subpopulation of lymphocytes was detected using a novel assay 
utilising calf erythrocytes sensitised with the Facb fragment of 
rabbit immunoglobulin G (IgG). This subpopulation was detected in 
raised percentage numbers in the peripheral blood of rheumatoid patients 
and was also present in rheumatoid synovial fluid. A cross-sectional 
study showed that these increased numbers did not map disease activity 
and were not related to the expression of HLA-DR4. Although normal 
percentage numbers were present in the peripheral blood of patients 
with osteoarthritis and ankylosing spondylitis, the elevation is not 
specific to rheumatoid arthritis since occasionally healthy volunteers 
showed raised percentages, and percentage numbers also increased 
transiently following skin testing of sensitised individuals and 
during viral infection.
The receptor for Facb sensitised erythrocytes (Facb receptor) 
appears to be a high avidity Fc receptor which is specific for the 
C^2 region of IgG and is trypsin and neuraminidase resistant. Phos- 
pholipase C also did not diminish Facb receptor expression. The 
Facb receptor was detected on a small percentage of polymorphonuclear 
leucocytes and monocytes as well as on lymphocyte surfaces.
Lymphocytes bearing Facb receptors displayed neither T nor B 
ceil markers using conventional techniques. Functional assays showed 
these cells to be noncytotoxic. A possible role for these cells in 
immunoregulation is discussed.
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c H A P T F R 1
INTRODUCTION
S E C T I O N  I 
L Y M P H O C  Y T E  S
This section will be divided into four parts. The first part 
will be a brief general introduction to the major lymphocyte 
populations, their origin and role in immune responses. The re­
maining three parts will describe each of the major lymphocyte 
populations with particular emphasis on their subpopulations 
characterised by membrane markers and functional assays.
(i) General Introduction
Lymphocyte Morphology, Origin and Participation in Immune Responses
"The lymphocyte, once considered an end stage cell devoid of 
known functions, stands at the forefront of new and exciting 
developments pervading the entire field of biology". So wrote 
Ritzmann and colleagues in 1973 and continued "it has emerged 
uncontested as the healthy person's chief guardian against myriads 
of invading micro organisms, as well as against the enemy that 
bears from within, the mutant cell with neoplastic potential".
The lymphocyte is indeed a remarkable cell, its functional 
capacity being masked by its apparent quiescence and uninteresting 
morphology. Ultimately all lymphocytes derive from pluripotential 
haematopoietic stem cells. In human peripheral blood, lymphocytes 
comprise 20-40% of the differential leucocyte count and range in 
diameter from 6-25ywJn, The majority of these cells are small
lymphocytes (6-9yw.m) while a few may be intermediate (9-llyw.m) 
or large ( 1 2 - 2 5 m ) ; their life span varies from a few days to 
several months for recirculating small cells. All three size 
types have a dense nucleus surrounded by a basoohilic cytoplasm, 
due to the ribosomes present, and few organelles. The larger cells 
have more cytoplasm and may have a nuclear cleft.
Since Gowans (1962) first showed that small lymphocytes were 
involved in graft versus host reactions and gave rise to large 
pyroninophilic cells which can divide, evidence for lymphocyte 
recirculation and their participation and co-operation in immune 
responses has expanded (Sell and Gell, 1965; Roitt et al, 1969;
Greaves, Torrigiani and Roitt, 1969; Parrott and De Sousa, 1971;
Sprent, 1977; Howie, 1978). The immune response appears to be 
macrophage dependent (Askonas and Roelants, 1974; Dupont Guerry et 
al, 1978; De Vries et al, 1979; Nathan, Murray and Cohn, 1980;
Rosenthal, 1980; Martinez-Alonso, Bernabe and Diaz-Espada, 1980) 
and genetically restricted (Winchester, Wernet, Dupont and Kunkel,
1975; Barnstable and Jones, 1977; Burakoff et a l , 1980; Rich et 
al, 1980). It is generally accepted that there are two major arms 
of the immune response (Roitt et a l , 1969);-
(a) humoral immune responses generated by B lymphocytes 
which can synthesise antibody
(b) cell-mediated immunity dependent on T lymphocytes
T or thymus-derived lymphocytes are of two types, being 
either cortical or medullary thymus-derived lymphocytes. In the 
mouse, the former have been characterised as small cortisone sensitive 
lymphocytes with a raoid turnover having a high content of Thy-1 antigen
and a low content of H2 antigen, while the latter have a slower 
turnover, more H2 antigen and are cortisone resistant. It has been 
demonstrated that neonatally thymectomised mice cannot evoke graft 
versus host reactions, do not express delayed-type hypersensitivity 
and show minimal responses to certain (T-dependent) antigens 
(Loor and Roelants, 1977).
B lymphocytes were so named after the avian Bursa of Fabricius, 
a cloacal lymphoid organ. Bursectomised chickens were found to 
have reduced levels of serum immunoglobulin, few plasma cells and 
depleted populations of surface immunoglobulin bearing small lympho­
cytes (Loor and Roelants, 1977). The bursal equivalent in mammals 
is a highly contentious element; bone marrow or gut-associated 
lymnhoid tissue is favoured by most investigators. It is likely 
that both are involved. The thymus and Bursa of Fabricius are 
primary lymphoid organs in which lymphopoiesis is intense, in­
dependent of antigenic stimulation and prominent before birth.
Bone marrow may also fall into this category.
The secondary lymphoid organs contain a mixture of T and B 
cells and lymphopoiesis is relatively slow; the lymphocytes are 
not sessile but migrate continuously via the blood stream and 
lymph. The spleen, lymph nodes and certain regions of the alimentary 
tract (tonsil; Peyer’s patches of the ileum; appendix) are all 
examples of secondary lymphoid organs.
Lymphocyte Separation and Identification
The most commonly employed method of lymphocyte separation is
by density flotation on ficoll/diatrizoate (B^yim, 1968). More 
recently polyvinylpyrrolidine-coated silica (PVP-Silica; Percoll) 
has been shown to be a useful separation medium for lymphocytes 
(Kurnick and co-workers, 1979).
T and B cell identification and separation is of prime im­
portance for any functional definition of lymphocyte subpopulations. 
Morphologically B and T cells are identical when viewed by conventional 
light microscopy. However using the scanning electron microscope, 
Polliack and colleagues (1973) showed that B cells have surface 
projections ("hairy cells") whereas T cells present a bland flat 
surface. Further work by Polliack and co-workers (1974) demonstrated 
that "hairy cells" resulted from cell activation. This work is now 
thought to be artefactual and more conventional methods of detection 
are employed. A number of surface markers have been accepted to 
differentiate between T and B lymphocytes (WHO/IARC, 1974). It is 
necessary to test for as many markers as possible on a given cell 
since it is increasingly evident that within the T/B groups there 
are many subclasses.
A wide variety of surface markers are available and these will 
be presented in detail in the next sections. The application of 
these techniques has resulted in the identification of a third 
population of null lymphocytes (Fr^land and Natvig, 1973). Null 
lymphocytes lack conventional T and B lymphocyte surface markers 
but bear high avidity Fc receptors; These cells will be discussed 
in detail in Chapter 1, Section I (iv). Lymphocytes may also be 
classified by their functional characteristics (Jondal, Wigzell and 
Aiuti, 1973). Thus K and NK lymphocytes have been described which
mediate specific cytotoxic reactions (Chapter 1, Section I (ii) and
(iv)).
(ii) Thymus-Derived (T) Lymphocytes
This section will consist of a short introduction, listing T 
cell immune responses, and a brief report of mouse T cell identifi­
cation and functional characterisation. Human T lymphocyte sub­
populations, defined by surface markers, and the functions ascribed 
to such subpopulations will be described in detail.
Introduction
As previously stated, T lymnhocytes are mediators of cellular 
immune responses (Roitt et al, 1969). T lymphocytes are known to 
produce soluble non-specific factors following interaction with 
antigen; these non-immunoglobulin factors have been termed lympho- 
kines (Dumonde et a l , 1969). Soluble factors have also been 
demonstrated following interaction with mitogens (Maini et al, 1969). 
Delayed type hypersensitivity has been attributed to a T cell sub­
class (Huber et al, 1976) and, more recently, T lymphocytes have 
been implicated in the response of B cells to certain mitogens 
and to antigenic stimulation. T lymphocytes which augment B cell 
responses are termed helper T cells and those which diminish B cell 
responses are T suppressor cells (Moretta et al, 1976; 1977; Lipsky, 
Ginsberg, Finkelman and Ziff, 1978; Moretta, Mingari, Moretta and 
Cooper, 1979; Johnsen and Madsen, 1979c; Dillner-Centerlind et al 
1980). Cytotoxic T cells have been described and are generated 
during mixed lymphocyte reactions (Webb, Mason and Williams, 1979;
Palacios et al, 1980). Mitogen-induced, antibody dependent and 
spontaneous cellular cytotoxicity have been attributed to T lympho­
cytes by some workers. These will be described in detail later 
in this section.
Identification and Functional Characterisation of Murine T Cells
The expression of the Thy-1 (theta; 0) antigen, first recognised 
by Reif and Allen (1964) is the most characteristic feature dis­
tinguishing T cells in mice. Functional studies have been facili­
tated by the use of antisera to certain lymnhocyte antigens. The 
Ly (lymphocyte) subclasses were defined by Shiku and colleagues
(1975) and a Ly 1 negative (Ly 1-), Ly 2,3 positive (Ly 2,3+) 
cytotoxic cell was characterised. Cantor and Boyse (1975 (a);
1975 (b)) showed differential expression of Ly 1, Ly 2 and Ly 3 
on peripheral blood Thy 1 positive mouse cells, about 50% having 
all three Ly antigens (Ly 1, 2, 3+), 33% Ly 1+ and 7% Ly 2,3+.
Helper T cells were shown to be Ly 1+ while Ly 2,3+ cells generated 
cytotoxic activity. Vadas and co-workers (1976), investigating 
phenotypes of T cells involved in delayed type hypersensitivity 
(DTH) and suppression, confirmed that T cells responsible for DTH 
and helper function were Ly 1+2- while cytotoxic and suppressor 
T cells were Ly 1-2+. The same workers showed that immune- 
associated (la) antigens produced by the I region of the mouse 
major histocompatibility complex (H2) were present on suppressor cells 
while DTH responsive cells were la negative. The presence of these 
differentiation antigens has made it possible to investigate more 
easily cell-mediated immunity in the mouse (Leclerc and Cantor,
1980 (a); 1980 (b)).
\\
Identification of Human T Cells and T Cell Subpopulations
Human T cell identification has proved more difficult than 
murine systems. A number of surface markers have been described 
which can be used for human T cell identification.
E Rosettes
Jondal, Holm and Wigzell (1972) described a population of 
human lymphocytes forming spontaneous rosettes with sheep ery­
throcytes (SRBC). They showed that rosette formation occurred 
only with living cells and was temperature and cation dependent; 
inhibition of rosette formation occurred when the reaction mixture 
was warmed to 37°C and when sodium iodoacetate (which blocks 
glycolysis) or ethylene diamine tetra acetic acid (EDTA) was added. 
Trypsinised lymphocytes did not form SRBC rosettes but this ability 
was restored after culture. Lymphocytes forming these spontaneous 
'non-immune* E rosettes were later confirmed to be thymus-derived 
(Wybran, Carr and Fudenberg, 1972; Wybran and Fudenberg, 1973;
Jondal, 1976).
Yu (1975) characterised two populations of T lymphocytes by 
their ability to bind SRBC, defining them as early or active rosette- 
forming cells (RFC) and late or inactive RFC. Early rosettes are 
formed immediately after sedimentation while late rosettes require 
incubation at 4^C for optimal formation. Chisholm and Tubergen
(1976) using varying SRBC/lymphocyte ratios were unable to identify 
discrete populations of T cells. Further modifications of the 
original method have appeared; prior treatment of the erythrocytes
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with the sulphydryl reagent 2-aminoethylisothiouronium bromide 
(AET), or with neuraminidase enhances binding resulting in increased 
numbers of more stable rosettes (Kaplan and Clark, 1974).
The SRBC receptor is still the most widely used T cell marker 
although attempts at characterisation of the receptor have, until 
very recently, been minimal (Pyke, Rawlings and Gelfand, 1975).
Kamoun and co-workers (1981), using a murine monoclonal antibody, 
have identified a protein on human T lymphocytes which is associated 
with the E rosette receptor. Suomalainen, Goldsby, Osborne and 
Schrader (1980) using mouse/human hybrid T cells have shown that 
expression of the SRBC receptor is genetically coded by the human 
chromosome 6. A human homologue of Thy-1 has also been characterised 
(Ades, Zwerner, Acton and Balch, 1980).
Helix Pomatia (HP) Receptors
Hammarstr^m and co-workers (1973) described another useful 
marker for T lymphocytes. Neuraminidase treated lymphocytes express 
a receptor for Helix pomatia (vineyard snail) A haemagglutinin. 
Affinity chromatography can be used to isolate enriched T cell 
populations (Hellstr^m et al, 1976). The Helix pomatia receptor 
positive (HP+) cells are mainly T cells although a small population 
("^10%) do not form E rosettes.
Fc Receptors
In 1975, Hasten and associates showed the presence of a receptor 
for the Fc portion of immunoglobulin G (IgG) on a subpopulation of
\
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murine T cells and concluded that IgG Fc receptor (FcR) bearing 
T cells represent a subpopulation of cells within the thymus and 
the secondary lymphoid tissue. In m a n , two distinct T cell sub­
populations have been defined on the basis of IgM or IgG Fc
receptor expression. Thus E rosette positive cells bearing receptors
for IgG are termed Ty (T gamma) cells (Ferrarini et al, 1975) and 
those T cells with IgM Fc receptors are (T mu; Moretta et al,
1975). A small population of T cells exist having neither receptor.
la Antigens
la antigens were first recognised on murine B lymphocytes 
and subsequently demonstrated on human lymphocytes (Lunney, Mann 
and Sachs, 1979). Fu and co-workers (1978) and Metzgar and
associates (1979) Identified la antigens on activated T cells in man.
Antisera
Antisera have been raised against human T lymphocytes in an 
attempt to recognise an equivalent to the murine Ly series. Various 
approaches have been m a d e . Heteroantisera have been produced 
against T lymphoblastoid cell lines (McMahon Pratt, Schlossman 
and Strominger, 1980; Niaudet and Greaves, 1980), human la-like 
antigens of the HLA-D region of chromosome 6 (Broder, Mann and 
Waldmanp, 1980) and T lymphocyte Fc receptors (Cunningham-Rundles 
et al, 1980). Early work, using rabbit antisera raised against 
human lymphocytes and rendered specific for T cells by adsorption, 
characterised two populations of T lymphocytes, the THl and 
TH2 subsets (Evans et a l , 1977; 1978).
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Monoclonal Antibodies
A recent step forward in the characterisation of human T 
lymphocytes has been the production of monoclonal antibodies 
directed against cell surface antigens. Kbhler and Milstein (1975) 
first successfully cloned hybrid cells producing a specific mono­
clonal antibody, and since then many T cell specific monoclonal 
antibodies have been prepared (Reinherz and Schlossman, 1980).
Thus OKTl and 0KT3 are spe cific for all peripheral blood T cells 
while 0KT4 recognises T helper cells and 0KT5 reacts with suppressor/ 
cytotoxic cells (Reinherz, Kung, Goldstein and Schlossman, 1980). 
la positive cells react specifically with the monoclonal anti­
body O K U .  A list of monoclonal antibody specificities is given 
in Table 1.1.
Functional Characterisation of Human T Cell Subpopulations
Functional characterisation of human T cell subsets has been 
attempted using methods involving skin testing, antigenic or mito­
genic stimulation and measurement of the cytotoxic capacity of 
various subpopulations.
Delayed Type Hypersensitivity (DTH)
The active E rosette test has been adapted by many workers; 
Felsburg and Edelman (1977) reported elevated levels of active 
E rosette forming cells 24-72 hours after intradermal skin testing 
of sensitised individuals. Skin-test negative individuals showed 
no change in the level of active E rosette forming cells. Thus
Table 1.1
MONOCLONAL ANTIBODIES EMPLOYED IN THE CHARACTERISATION




OKT 1 Peripheral blood total T population
OKT 3 Peripheral blood total T population
OKT 4 Peripheral blood helper/inducer T population
OKT 5 Peripheral blood cytotoxic/suppressor T population
OKT 6 Thymocytes
OKT 8 Peripheral blood cytotoxic/suppressor T population
OKT 9 Thymocytes
OKT 10 Thymocytes
OKI 1 la antigen positive populations
OKM 1 Monocyte/myeloid population
1 3
the assay is specific and appears to correlate with delayed type 
hypersensitivity. A group of Japanese workers (Nagaoki et a l , 1978) 
demonstrated a transient increase of Ty cells in tuberculin sensitive 
individuals following skin testing with a purified protein deriva­
tive of tuberculin (PPD); this increase was observed 36-48 hours 
following inoculation. No significant change was noted in skin 
test negative individuals. Yu and colleagues (1980), using tetanus 
toxoid, showed increased levels of la positive T cells in sensitised 
individuals within two days of immunisation. As previously stated, 
la expression is associated with T cell activation (Fu et al, 1978; 
Metzgar et al, 1979).
In Vitro T Lymphocyte Activation by Mitogens and Antigens and in Mixed 
Lymphocyte Cultures
Functional characterisation of active E resetting cells, des­
cribed by Hokland and Heron (1979), compared their in vitro response 
to antigen and mitogens. Active E rosette forming cells (RFCs) 
responded significantly better to PPD and allogeneic cells than did 
late non-active RFCs. The converse was true with phytohaemagglutinin 
(PHA), concanavalin A (Con A) and pokeweed mitogen (PWM), when the 
non-active (low-avidity receptor) T cells gave higher responses 
and were better stimulators in a mixed lymphocyte reaction. Mono­
cyte dependence was shared by both subsets. The finding that early 
T cells are sensitive to PPD stimulation and are better responders 
in mixed lymphocyte culture (MLC) provides further support that 
this subpopulation is involved in cell mediated immunity. Charac­
terisation of subsets of T cells, in terms of SRBC affinity, was
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attempted by Sasaki and co-workers (1975), using two different 
buffering systems. They found an increased PHA responsiveness 
in one subset but their results cannot be directly correlated with 
the early and late rosettes described by Yu (1975).
Using rosette techniques, Moretta and colleagues (1976) isolated
Ty , T yy^ and Ty depleted (i.e. enriched) subpopulations of lympho­
cytes and ccanpared these with a total T cell population. They 
demonstrated similar Con A dose response curves in all the popu­
lations tested while the PHA dose response curves showed a signifi­
cant reduction in the response of Ty cells relative to total T cells.
Ty depleted ponulations showed the greatest variability in individual 
patterns of PHA responsiveness. It was thus concluded that a normal 
PHA response requires synergism between the two T cell subsets.
Moretta, Webb, Grossi, Lydyard and Cooper (1977), using PWM, 
reported that helper activity was confined to the ' 1 ^ nopulation while 
the Ty population, after interaction with IgG immune complexes 
(termed modulation) during isolation, suppressed the generation of 
plasma cells when added to helper T cells and B cells together with 
PWM. No such suppression was seen using depleted (i.e. Ty enriched) 
populations where no interaction with immune complexes had occurred. 
Dependence on modulation for expression of suppressor activity was 
confirmed using T lymphocyte clones (Canonica et al, 1980).
Functional characterisation has been attempted using the 
THl and TH2 subsets previously described. Thus Evans and colleagues
(1977) showed that THl positive T cells comprised 50-60% of all 
T cells, proliferated in the MLC and generated lymphokine but did 
not proliferate in response to certain soluble antigens (mumps.
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PPD, tetanus toxoid). Conversely, the THl negative subset neither 
responded in the MLC nor produced lymphokine but mounted a good 
proliferative response to the specific antigens. The TH2 positive 
subset, which is inactive in MLC, mediates cytotoxic and suppressor 
functions (Evans et al, 1978; Reinherz and Schlossman, 1979).
T Cell Mediated Cytotoxicity
A wealth of literature is available on the cytotoxic potential 
of human lymphocytes. Thus, E rosette positive lymphocytes have 
been implicated in mitogen-induced (PHA) cellular cytotoxicity 
(MICC), antibody-dependent cellular cytotoxicity (ADCC) and natural 
or spontaneous cell mediated cytotoxicity (SCMC). Much controversy 
has arisen concerning the identification of killer (K) cells, which 
mediate ADCC, and natural killer (NK) cells, responsible for SCMC. 
Some workers have ascribed K and NK cells to the same population 
(De Landazuri et a l , 1979) while others have successfully separated 
the two populations (Neville, 1980).
Waller, Campbell and MacLennan (1976), using columns coated
with albumin or immune complexes (IgG - anti IgG), demonstrated
that two populations of lymphocytes are involved in MICC, one
dependent and the other independent of Fc receptors. A large
proportion of Ty cells were retained on the IgG-anti IgG column
(approx. 20%) and these were presumed to be responsible for the
observed drop in MICC ( —  activity removed). Both ADCC and SCMC3
were completely abolished by removal of FcR positive cells. 
Perlmann, Perlmann, Pape and Hallden (1976) observed similar 
effects using ovalbumin-anti ovalbumin affinity columns ; the E
1 6
rosette positive fraction showed scane depletion of Fc receptor 
positive T cells after passage over the immune complex column and 
the unbound population had very low K cell activity.
Direct measurements of MICC confirmed the dependence on two 
different subpopulations bearing Fc receptors (Cordier, Samarut 
and Revillard, 1978). Both populations were C3 receptor negative 
but only one carried a T cell marker (E rosette positive); the 
other was non-T in nature. Other investigators have demonstrated 
the release of a factor by PHA stimulated lymphocytes which augments 
E and EA rosette formation (Agbata and Kirkpatrick, 1979; Kubota,
Yoshida, Shinomiya and Mikawa, 1980). This may provide indirect 
evidence for Ty mediation of MICC and the soluble factor may be 
important in the mediation of other cellular immune responses.
In 1976, Nelson and co-workers attempted to differentiate the 
effector cells in MICC and ADCC in terms of their target specificity. 
Using chicken erythrocytes (CRBC) and Chang liver cells, they con­
cluded that MICC was directed against both target cells by a non- 
FcR bearing T cell whilst T lymphocytes did not mediate ADCC against 
either CRBC or Chang cell targets.
Initial direct evidence for T cell co-operation in ADCC was 
supplied by West, Boozer and Herberman (1978) who showed that ADCC 
activity was confined to the non-active E (low avidity SRBC receptor) 
rosette population. Jonsdottir and co-workers (1979) demonstrated 
K cell activity in both active and non-active E rosette forming 
cells. In parallel with these observations, Moretta, Mingari and 
Romanzi (1978) showed a loss of IgG FcRs from Ty cells modulated
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with immune complexes and reported that Ty depleted subpopulations 
and isolated cultured Ty cells (i.e. immune complex modulated) no 
longer carried out ADCC. Pichler, Lum and Broder (1978) also 
observed a transition of receptor expression demonstrating that 
Ty cells can express Fc receptors for IgM after immune complex 
modulation; no functional Étudiés were performed. Extending this 
work, Pape, Moretta, Troye and PerImann (1979) confirmed the loss 
of ADCC activity after immune complex modulation, but reported 
that a significant part of the NK activity was retained. Similar 
experiments by Shen, Lydyard, Penfold and Roitt (1979) demonstrated 
Ty mediation of ADCC and reported that this activity could not be 
ascribed to contamination by monocytes or neutrophils. However, 
Hammarstr^ (1979) showed that cultured human monocytes could be 
induced to kill E562 target cells when activated by supernatants 
of autologous lymphocytes stimulated with bacteria (lymphokines).
Using Helix pomatia Sepharose, Pape, Troye and PerImann, (1979) 
demonstrated NK activity in both HP+ and HP- subpopulations. The 
HP+ lymphocytes were thought to be T cells. Experiments using 
whole lymphocyte populations showed that NK activity can be 
further subdivided since some of the activity is lost after adding 
Fab fragments of rabbit anti human IgG. The authors suggest that 
antibody dependent natural cytotoxicity may occur (Pape, Troye,
Axelssdn and Perlmann, 1979). However if virus-infected target 
cells were used in the assay, no immunoglobulin specific NK activity 
was observed (Hàrfast, Andersson and Perlmann, 1978). It was con­
cluded that the elevated cytotoxicity observed was probably spon­
taneous, virus-dependent and mediated, not through antibodies, but 
by some non-immunological agent, perhaps interferon; interferon is
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known to boost NK activity in vitro (Ortaldo et al, 1980). Fc- 
receptor modulation had no effect on virus-dependent cytotoxicity 
indicating that a functionally intact FcR is not required for 
cytolysis in this system (Hàrfast, Andersson, Alsheikhly and 
Perlmann, 1980). The recent production of a cloned line of natural 
killer cells may help to unravel some of the questions concerning 
the role of these cells in immunity (Dennert, 1980).
T Lymphocyte Characterisation by Surface Markers and Functional 
Assays - Technical Difficulties
It must be stressed at this point that many of the isolation 
procedures used to obtain "pure" T cell subsets may result in 
alteration or elimination of functional capacity. Modulation with 
immune complexes has been described previously; this causes an in­
crease in suppressor activity and elimination of ADCC (Moretta,
Webb, Grossi, Lydyard and Cooper, 1977; Moretta, Mingari and Romanzi, 
1978). Neuraminidase treatment, employed prior to affinity chroma­
tography on Helix pomatia Sepharose, has been shown either to stimulate 
NK and K cell activity (Kay et al, 1977) or to have no significant 
effect (Schulof, Fernandes, Good and Gupta, 1980). Ammonium chloride 
treatment, used in the isolation of Ty cells, has been shown to 
depress the cytotoxic response when measured using a 4 hour assay 
but this capacity was restored after incubation for 24 hours (Kay 
et al, 1977). Thus ammonium chloride is only detrimental in the 
short term.
Probably the most exciting recent development in the analysis 
of lymphocyte subpopulations has been the introduction of monoclonal
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antibodies to specific surface antigens. Inevitably, comparisons 
must be made between cells separated using these antibodies and 
cells characterised by previously accepted markers. Reinherz and 
co-workers (1980) compared T lymphocyte subpopulations defined by 
Fc receptors and monoclonal antibodies; the results obtained were 
interesting but disappointing in that, other than a slight enrich­
ment of Tyuk cells within the 0KT4 subset, there was little correlation 
between T cell subsets defined by the two techniques. A large 
number of cells in the Ty population were la negative and reacted 
with O K M l , suggesting that many so named Ty cells are of monocyte/ 
myeloid origin. This may again be due to preparative procedures 
since neuraminidase enhances binding of sheep erythrocytes but may 
reduce snecificity. Both Ty and 0KT5+ cells can be induced to 
suppress following activation by Con A; however Ty cells effect 
SCMC and ADCC which is not a property of unactivated 0KT5+ cells.
The authors infer that the Ty/OKMl subset may be natural killer cells.
It is apparent that even after twenty years of research, the 
role of T lymphocyte subsets in immune responses remains unclear.
However, much progress has been made and the present techniques 
available will, without doubt, facilitate definition of these sub­
sets.
Table 1.2 summarises the work presented in this section concer­
ning functional aspects of human T cell subpopulations with respect 
to surface markers.
(iii) Bursa Derived (B) Lymphocytes
This section will essentially follow the same pattern as the
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Table 1.2
SURFACE MARKERS DETECTED ON FUNCTIONAL
HUMAN T LYMPHOCYTE SUBPOPULATIONS
S U R F A C E M A R K E R
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* For abbreviations see text
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T lymphocyte section in that it will consist of a short introduction 
followed by a report of B cell surface markers and their interactions. 
Finally attempts to characterise B cell subpopulations will be 
accounted.
Introduction
The primary role of B lymphocytes in immune responses is the 
synthesis of specific antibody. Surface immunoglobulin (sig) forms 
an integral part of the B cell membrane and this can act as an 
antigen binding receptor although triggering probably involves 
more signals than this single interaction. Four cells have been 
implicated in the initiation and regulation of antibody synthesis 
(Fagraeus, 1981). A simplified scheme of events may be as follows. 
The macrophage takes up antigen and presents it to the T helper 
cell which receives both the antigen and products of the immune 
response genes of the major histocompatibility ccanplex. The T 
helper cell then passes these same or similar products to the B cell 
which is triggered following antigen recognition. The B cell 
produces antibody with the same specificity as the surface immuno­
globulin recognition molecules and differentiates into a plasma 
cell. Receptor immunoglobulin recognition molecules are lost during 
differentiation (Abdou, Alavi and Abdou, 1976). The fourth cell, 
the suppressor cell, triggered by macrophage produced factors, acts 
on the T helper cell and perhaps the B cell to regulate antibody 
synthesis. T suppressor cells have been described previously 
(Chapter 1, Section I (ii)). B suppressor (Zubler et al, 1980) and 
macrophage suppressor cells (Denman, 1979) have also been reported. 
The presentation of antigen by macrophages may be more complex. It
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has been postulated that a genetically restricted factor (GRF) 
released by the macrophage acts on an early T cell (Ly phenotype 
1, 2, 3) which in turn enlists the T helper cell (Ly 1) by the 
release of soluble factors (Howie, 1978).
B cells can be induced to lose sIg by incubation with anti­
immunoglobulin sera and thus their antigen recognition site is lost 
(Raff et al, 1975). Antigen recognition is important to avoid the 
production of autoantibodies. Nossal and Pike (1975) proposed 
that during development B lymphocytes contact self antigens and 
thus achieve immunological unresponsiveness or tolerance to self. 
Auto-immune disease (e.g. rheumatoid arthritis) presents a disturbance 
of the self/non-self discriminating mechanism.:
Non-T Lymphocyte Surface Markers
Much of the early work on B cell characterisation was performed 
on non-T cells. Mouse non-T cells specifically express the allo- 
antigen Ly 4.2 (McKenzie and Snell, 1975).
Surface Immunoglobulin (sig)
The presence of surface immunoglobulin (sig) is probably the 
most widely accepted B cell marker. Raff, Sternberg and Taylor 
(1970) demonstrated sig on mouse lymphocytes; these cells were sub­
sequently shown to be non-T cells (Rabellino, Colon, Grey and Unanue, 
1971). Papamichail, Brown and Holborow (1971) confirmed the presence 
of sig on human lymphocytes and Fr^land and Natvig (1972 a) described 
a lack of sig positive lymphocytes in hypogammaglobulinaemia, implying
23
that these lymphocytes were of B cell lineage. Further work by 
Fr^land and Natvig (1972 b) showed class, subclass and allelic 
exclusion of sig on human non-T lymphocytes, the dominant class 
being IgM and the dominant subclass of IgG being IgG2. Taylor 
and co-workers (1971), using mouse non-T lymphocytes, demonstrated 
that antibody interaction caused redistribution of sig to one pole 
of the cell (capping) and subsequent pinocytosis of immunoglobulin 
molecules. These authors suggested that cap formation and pinocytosis 
may trigger lymphocyte transformation (biastogenesis) or tolerance 
induction.
Complement Receptors
Non-T cells were shown to possess a receptor for the third com­
ponent of complement, C3 (Bianco, Patrick and Nussenweig, 1970).
Ross, Polley, Rabellino and Grey (1973) characterised two different 
complement receptors on human lymphocytes, the C3b or immune ad­
herence receptor and the C3d receptor. They are antigenically 
distinct, cap independently and have specificities for different 
regions of C4 or C3 molecules (Ross and Polley, 1975; 1976).
Fc Receptors
Binding of both heat aggregated human IgG, agg.G (Dickler 
and Kunkel, 1972; Dickler, 1976 a) and antigen complexed IgG (Basten. 
Miller, Surent and Pye, 1972) was demonstrated by non-T cells.
Binding was dependent on an intact Fc portion of the immunoglobulin 
and thus the term Fc receptor (FcR) was applied. Soluble molecular 
antigen-antibody complexes (immune complexes) or cellular antigen-
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antibody complexes (EA rosettes) have been used extensively in 
the study of B lymphocyte Fc receptors (Brown and Greaves, 1974; 
Johnsen and Madsen, 1979 a). Dickler (1974) demonstrated binding 
of both immune complexes and aggG by the same re centor on human 
B cells.
B Lymphocyte Identification - Technical Problems and the Presence 
of a Third Lymphocyte Population
In 1973, Ross, Rabellino, Polley and Grey reported that not all 
C3 receptor positive lymphocytes were sig positive and that almost 
all sig negative cells were E rosette positive. Fr^land, Natvig 
and Michaelsen (1974) suggested that binding of immunoglobulin 
by B lymphocytes may be independent of Fc receptors. It soon became 
evident that not all non-T lymphocytes were bursa-derived but that 
a population of non-T, non-B lymphocytes existed (Fr^land, Wisl^ff 
and Michaelsen, 1974; Kurnick and Grey, 1975; Natvig and Fr^land, 
1976) and also lymphocytes expressing B and T cell markers (Van 
Boxel and Rosenstreich, 1974; Dickler, Adkinson and Terry, 1974).
The Fc and C3 receptors could not be regarded as specific B cell 
markers.
Methods of B lymphocyte separation and detection have been 
intensively studied and technical problems were discovered (Win­
chester, Fu, Hoffman and Kunkel, 1975). Thus, two populations of 
sig positive human lymphocytes were described (Lobo, Westervelt and 
Horwitz, 1975). The non-T population was shown to contain lympho­
cytes with cold reactive FcRs for cytophilic immunoglobulin 
(Horwitz and Lobo, 1975) and therefore non-T lymphocytes were
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described as having membrane incorporated (B cells) or membrane
labile (null cells) immunoglobulin (Lobo and Horwitz, 1976),
Kumagai and co-workers (1975) investigated the membrane incorporated
sig on non-T cells. They demonstrated that incubation at 37°C or
acid treatment of lymphocytes resulted in the loss of surface IgG
and IgA but had no effect on IgM. This was confirmed by Pettersson,
Meldstedt and Holm (1978) who showed that incubation and washing of 
olymphocytes at 37 C decreased the total sig and surface IgG measured 
but had no effect on surface IgM or IgD. Ross, Winchester, Rabellino 
and Hoffman (1978) showed that all sIgM positive lymnhocytes were 
FcR positive and expressed both C3b and C3d complement receotors. 
Alexander and Henkart (1978) concluded that most human peripheral 
B lymphocytes do not have easily detectable Fc receptors and most 
FcR bearing cells do not have B cell markers.
B Lymphocyte Surface Markers
Surface immunoglobulin, C3 and Fc Receptors
Human B lymphocytes bear surface membrane incorporated IgM 
and C3 and Fc receptors (see above). B cell FcyRs are sometimes 
difficult to detect (Alexander and Henkart, 1978; see also Chapter 
1, Section III).
The demonstration of F c ^  receptors on T lymphocytes (reported 
in the previous section) promoted work using B lymphocytes. Human 
peripheral blood F c y * ^ positive B cells (sIgM positive) were found 
only occasionally but 30% of tonsil B lymphocytes expressed F c ^  
receptors (Pichler and Knapp, 1978). Pichler and Broder (1978), 
using B cell (sig and C3 positive) enriched human peripheral blood
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lymphocytes demonstrated F<y-. receptors on all B lymphocytes following 
oincubation at 37 C. Preud*homme and colleagues (1979) investigated 
culture conditions and found that these had some effect on Fc/*. 
receptor detection; a second culture in a different medium was 
often needed to detect F ^  receptors on lymphoblastoid cell lines.
la Antigens
The immune-associated (la) antigens are products of the I region 
of the murine major histocompatibility complex (H2). Mouse allo- 
antisera have been prepared and shown to cross react with human 
lymphocytes (Lunney, Mann and Sachs, 1979). Thus human la-like 
antigens were shown to exist. Human B lymphocyte alloantigens have 
been studied (Johnson, Ward and Amos, 1977) and HLA-D locus related 
(HLA-DR) antigens have been shown to be analagous in tissue dis­
tribution and structure to murine la antigens (Snary et al, 1977).
Virus Receptors
Receptors for Epstein Barr virus (EBV), a member of the herpes 
virus group, have been detected on B lymphocytes (Jondal and Klein,
1973) and this marker is specific for B lymphocytes (Greaves, 1976).
The response to EBV was shown to be T independent (Kirchner et al,
1979) although other workers (Biberfeld et al, 1980) have shown 
that PPD and PWM (T dependent activators) induce viral antibody 
production by B cells.
Other Surface Markers
Other methods of B cell identification include rosette
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formation using mouse erythrocytes (Bertoglio, Laldjim and Dore, 1979) 
and the use of hybridoma antibodies (Beckman et al, 1980; Nadler 
et al, 1931).
Surface Marker Interactions
Two groups of workers suggested that la antigens and Fc receptors 
on mouse B lymphocytes were either identical or closely related 
(Dickler and Sachs, 1974; Basten, Miller and Abraham, 1975). In­
hibition of mouse B lymphocyte Fc receptors has been attempted 
using IgG and F(ab’)^ fragments of anti-la (Dickler,Arbeit and 
Sachs, 1975), and antisera to H-2D and H-2K (non la producing 
loci of the mouse H-2 comnlex), Ly 4.2, mouse immunoglobulin 
(Halloran and Schirrmacher, 1977), B^ microglobulin (Grey, Anderson, 
Huesser and Kurnick, 1975) and Thy-I (Schirrmacher, Halloran and 
David, 1975), Both IgG and FXab')^ antibodies to la antigens 
inhibited EA rosettes but antibody against irrelevant H2 antigens 
or against T cell antigens failed to inhibit EA rosette formation.
This strengthens the view of Dickler and Sachs (1974) and Basten, 
Miller and Abraham (1975). Other workers have shown that FcRs and 
la antigens are independent entities on the B cell membrane 
(Schirrmacher and Halloran, 1975). In man FcRs and DRw antigens 
have also been demonstrated to be independent of each other 
(Soulillou and Peyrat, 1979). Interaction may be dependent on 
a ligand-binding mechanism (Riéber and Wernet, 1977). An inter­
action between la antigens and C3 receptors has also been described 
(Schirrmacher et al, 1976).
Associations between sig and FcRs have been investigated.
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Under normal circumstances these receptors are independent 
(Ramasamy and Lawson, 1975) but under certain conditions (e.g. 
anti-Ig-induced redistribution) capping of sig results in co-capping 
of FcRs suggesting that some interaction takes place (Fo m i  and 
Pernis, 1975). This observation was confirmed by Unanue and 
Abbas (1975) but the reverse phenomenon (i.e. co-capping of sig 
by fluoresceinated antibody bound to FcRs) was not observed and 
capping of sig with concomitant capping of FcR did not produce 
alterations in la distribution. This latter observation opposes 
the view of Dickler and Sachs (1974). In contrast, Scribner, Weiner 
and Moorhead (1977) have shown that activated cells cannot co-cap. 
Recently Dickler and Kubicek (1981) have demonstrated a specific 
interaction between ligand-bound surface IgM and ligand-bound 
Fc Rs on B lymphocytes; their results also suggest that whenever 
Ig?i is involved in the response to an immunological stimulus, 
the FcyR is also involved.
Most workers agree that sig, C3 and Fc receptors and la antigens 
are independent entities on the B cell membrane but may interact 
following antigen binding (Parish and Hayward, 1974; Unanue and 
Abbas, 1975).
B Cell Subpopulations
Subsets of B cells have proved difficult to isolate. Several 
workers have attempted to subdivide B cells in terms of their res­
ponse to mitogen. Some B cell mitogens do not only induce DNA 
synthesis and mitosis but may activate the cells to synthesise 
immunoglobulin. Thus B cell mitogens are more correctly termed
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polyclonal activators (PCA). Ringden and Miller (1976) have des­
cribed three types of B cell in terms of response to PCA; these 
are non-responders, B cells which respond by proliferation but 
not immunoglobulin production and th.ose which proliferate and 
beccmie high rate antibody synthesising cells. The same workers 
showed that rabbit antibodies to microglobulin were mitogenic 
but antibody synthesis occurred only with spleen and tonsil cells 
and not peripheral blood lymphocytes, suggesting different subsets. 
The response was found to depend on the stage of ontogenesis.
The protein microglobulin (mol.wt.^^ 12,000) was known to 
display a partial hcxnology with the constant domains of IgGl 
heavy chains and to be associated with HLA antigens on the B cell 
membrane (Neauport-Sautes, Bismuth, Kourilsky and Manuel (1974).
It is now known t h a t m i c r o g l o b u l i n  forms an integral part of 
the HLA-A and HLA-B antigens.
Beverley (1977) has described murine B^ cells, present in 
spleen and bone marrow, and B^ cells, found mainly in spleen. B^ 
cells require T cell help in their response to antigen while B^ 
cells are T cell independent. However, it has recently been demon­
strated that T cells can influence the class and subclass of anti­
body produced by B cells after contact with 'T-independent' antigens 
(Mongini, Stein and Paul, 1981).
B lymphocyte subpopulations have been characterised by their 
differential expression of IgM and IgD. Ault and Towle (1981) 
demonstrated that the small number of sIgG bearing B cells 
are responsible for the PWM response.
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Owing to the difficulties encountered in B cell identification, 
the characterisation of B lymphocyte subpopulations remains in­
complete. Much of the published work relates to murine B cells. 
However, the recent production of a human B lymphocyte hybridoma 
antibody may help to clarify the picture. At present, the only 
specific B lymphocyte markers are considered to be surface (membrane 
incorporated) IgM and EBV receptors.
(iv) Null Lymphocytes
This section will consist of an introduction to the various 
methods for isolation of null cell populations followed by a report 
of cell characterisation and functional studies.
Introduction
A population of human peripheral blood lymphocytes lacking 
conventional T and B cell markers has been described as "null" 
lymphoid cells (Kalden et al, 1977; Niandet, Greaves and Horwitz, 
1979), non-T, non-B third population cells (Fr^land, Wisl^ff and 
Michaelsen, 1974), L lymphocytes with membrane labile IgG (Horwitz 
and Lobo, 1975) and undefined lymphocyte like (UL) cells (Dickler, 
1976 b ) . These terms are not synonymous but the populations over­
lap and all appear to contain cells with high avidity Fc receptors,
Third Population Lymphocytes
EA rosette formation is commonly used for the detection of
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Fc receptor (FcR) positive lymphocytes (WHO/IARC, 1974). Fr^land,
Wisl^ff and Michaelsen (1974) demonstrated that human group 0 
erythrocytes sensitised with Ripley anti CD antiserum were selectively 
bound by human peripheral blood non-T, non-B lymphocytes. Several 
EA resetting systems were compared; Natvig and Fr^land (1976) 
achieved similar results using other anti-rhesus isoantibodies with 
anti-CD specificity. Pang and Wilson (1978) confirmed the ob­
servations of Fr^land and co-workers (1974). Using sensitised ox 
erythrocytes (EA^^^ and human erythrocytes coated with anti-CD IgG 
(EA^^), they showed that both B and null FcR positive cells formed 
rosettes with EA^^ whereas B cells did not form EA^^ rosettes.
Also, B cells required high concentrations of sensitising antibody 
for rosette formation whereas null cells formed rosettes at low 
concentrations of antibody. More recently, it has been suggested 
that cell populations detected by EA^^ and EA^^ are identical (Dunne, 
Spiegelberg and Vaughan, 1981). Other workers have demonstrated 
binding of Ripley sensitised erythrocytes by cells other than null 
cells (Shaw, Levy and Lobuglio, 1979; Dobloug et al, 1979; Andersson 
and Svennevig, 1980).
UL Lymphocytes
UL cells have been shown to have high avidity Fc receptors in 
that soluble antigen-antibody complexes were bound even when present 
at very low concentrations (Arbeit, Henkart and Dickler, 1977).
This agrees with the observations of Pang and Wilson (1978). In 




L lymphocytes are the C3 receptor (C3R) - negative subset of 
non-T, non-B cells with high avidity, trypsin resistant, cold reactive 
Fc receptors which comprise about 95% of all null cells. L 
lymphocyte populations are prepared by the removal of E rosette 
and C3R positive cells from whole lymphocyte populations (Lobo, 
Westervelt and Horwitz, 1975; Lobo and Horwitz, 1976; Horwitz, 1977).
L cells were found to be divided into two subsets of C3R negative 
lymphocytes; about 60% of L cells were shown to be la positive 
while approximately 60% reacted with F(ab')^ fragments of an anti- 
myeloid IgG. A small number (10-15%) of la positive, myeloid 
positive L cells were detected and these showed some morphological 
features of monocytes (Horwitz, Niaudet, Greaves, Dorling and 
Deteix, 1978).
Null Cells
Null cell populations contain L lymphocytes and a small 
population of C3R positive non-T, non-B cells. However the term 
"null" is often applied to all the populations described here.
Niaudet, Greaves and Horwitz (1979) demonstrated a slightly in­
creased percentage of la positive cells in null compared with L 
cell preparations. This was probably due to the presence of la 
positive, FcyR positive, C3R positive cells. Null cells are usually 
obtained by negative selection.
Null Cell Characterisation
Since the majority of bone marrow cells lack surface markers
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(Abdou, Alavi and Abdou, 1976; Yang et al, 1978), many investigators 
believed that null cells were immature cells. This question remains 
unanswered. It has been shown that some null cells are immature 
B cells. Chess, Levine, MacDermott and Schlossman (1975) demon­
strated sig on cultured null cells and compared Ig content and Ig 
secretion of cultured B and T cells with cultured null cells; the 
values obtained with B and null cells were similar while T cells 
showed no Ig synthesis and no measureable Ig content. In contrast 
to the findings of Chess and co-workers (1975), Horwitz and 
Garrett (1977) concluded that L lymphocytes were not a subset of 
B cells since L cells did not spontaneously develop sig in culture 
and PW?i did not induce transformation and Ig production.
Mixed antiglobulin rosetting reactions were developed (Haegart 
and Coombs, 1976) and Haegart (1979) demonstrated integral surface 
immunoglobulin on L lymphocytes. Haegart, Hurd and Coombs (1978) 
showed that less than 1% of all peripheral blood lymphocytes were 
null cells and less than 5% had B and T cell markers. This finding 
strengthened the argument that null cells are a population of B 
cells (Haegart and Coombs, 1979; Haegart, 1980).
Horwitz and co-workers (1978), using direct immunofluorescence 
and mouse erythrocyte rosette formation found only 8% positive cells 
in the L population and supposed these to be contaminating B cells. 
The same workers (Horwitz et al, 1978) defined 11% of the L popul­
ation as "contaminating T cells" since they reacted with anti 
human T lymnhocyte antiserum and with sheep erythrocytes. The L 
cell population was esterase arid peroxidase negative. Niaudet, 
Greaves and Horwitz (1979) and Horwitz and colleagues (1978) showed
3 4
high reactivity of null populations with anti la and anti myeloid 
sera. More recently, Kay and Horwitz (1980), using hybridoma anti­
bodies, showed reactivity of null cells with 0K*(1 but confirmed 
their non-phagocytic,oc-naphthyl esterase negative properties.
Functional Characterisation of Null Cells
Lymphocyte Stimulation
As previously stated, Horwitz and Garrett (1977) showed that
PWM did not induce L lymphocyte transformation. Protein A is also
non mitogenic to L lymphocytes (Sakane and Green, 1978). Horwitz
and Garrett (1977) found L lymphocytes to be ineffective stimulators
of autologous and allogeneic mixed lymphocyte cultures depleted of 
monocytes and L cells could not replace monocytes in helping T cells 
respond to Con A and PWM; however, the addition of L lymphocytes to 
B cell depleted T lymphocyte preparations containing monocytes 
greatly enhanced the response of T lymphocytes to mitogens and 
soluble antigens. The observed enhancement of blastogenesis was 
studied in detail (Carvalho, Davis and Horwitz, 1980). Peripheral 
blood mononuclear cells from individuals sensitised to Keyhole limpet 
haemocyanin (KLH) and healthy controls were stimulated in vitro 
with KLH and KLH-anti KLH immune complexes. Only sensitised 
individuals responded and immune complexes produced a higher response 
than antigen alone. Enhancement was greatest after 3-5 days in cul­
ture and was dependent on an intact Fc region since immune complexes 
prepared with the F (a b ')^ portion of antibody and Fc receptor 
negative lymphocyte populations did not produce enhancement. T 
cell-L cell combinations were studied using mitomycin treatment to 
block cell division. Thus T but not L cells participated in the
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blastogénie response and L cells amplified T cell reactivity.
This work led to the assumption that L cells are accessory cells 
derived from myeloid stem cells (Carvalho, Davis and Horwitz,
1980; Horwitz and Carvalho, 1980).
Cell Mediated Cytotoxicity
The cytotoxic B cell was described by MacLennan (1972) and 
defined as a non-T lymphocyte. Wisl^ff, Fr^land and Michaelsen 
(1973) ascribed cytotoxic potential to their third population 
lymphocytes. Other workers confirmed that antibody dependent cellular 
cytotoxicity (ADCC) was independent of B cells and required lympho­
cytes with high avidity FcRs (Wisl^ff and Fr^land, 1973; Revillard 
et al, 1975; Papamichail and Temple, 1975; Perlmann et al 1975;
Brier, Chess and Schlossman, 1975; Perlmann, Perlmann, Pape and 
Hallden, 1976; Horwitz and Garrett, 1977; Ziegler et al 1977;
Pape, Troye and Perlmann, 1977). The effector cells have been 
termed killer (K) cells. ADCC activity has been found in many Fc 
receptor positive cell populations; thus T^ lymphocytes (described 
in the previous section), B lymnhocytes (Brier, Oiess and Schlossman, 
1975), monocytes (Papamichail and Temple, 1975; Hammarstr^m, 1979; 
Norris et al, 1979), polymorphonuclear leucocytes (Shaw, Levy and 
Lobuglio 1979) and null lymphocytes all mediate ADCC.
The K effector cell has been described as a villous cell 
(Perlmann et al, 1975) which bears a receptor for C3 (Perlmann 
et al, 1976). Others workers find no requirement for C3 receptors 
(Horwitz and Garrett, 1977; Johnsen and Madsen, 1979 b ) . Using 
Helix pomatia lectin (HP) affinity column chromatography, Hellstr^m
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and colleagues (1976) found enhanced K cell activity in the HP 
negative population over the HP positive population. The HP 
positive lymphocytes were also sig positive but this was probably 
externally absorbed IgG and thus this fraction is probably a T^ 
cell fraction. K cells were shown to be la negative (Nelson,
Sachs and Dickler, 1977).
Null cells have also been implicated in spontaneous cell 
mediated cytotoxicity (SCMC). In murine systems these have been 
extensively studied. Kiessling and colleagues (1976) showed that 
murine NK cells lacked C3 receptors but K cells formed EAC 
rosettes, that heat aggregated IgG inhibited ADCC but not SCMC and 
that NK cell activity was sensitive to trypsin treatment while K 
cell activity was resistant to trypsin. A cell surface antigen was 
identified which was selectively expressed by natural killer (NK) 
cells (Ly 5); these cells did not express Thy-1, Ly 2 or Ig 
surface markers (Glimcher, Shen and Cantor, 1977). Nude mice 
(congenitally athymic) have high NK activity, thus indicating a 
non-T nature for these cells.
In man, NK activity hws been demonstrated in null Fc receptor 
positive cell populations, although the Fc receptor does not seem 
to be necessary for activity (Muchmore, Decker and Blaese, 1977). 
Using HP affinity chromatography, NK activity was found in HP 
positive and HP negative populations; the SCMC activity of the HP 
negative cells was always higher than the unfractionated cells 
(Pape, Troye and Perlmann, 1979). Spontaneous cytotoxicity by 
lymphocytes from healthy donors shows considerable variability 
both between donors and in the same donor over several months 
(Santoli et al, 1978).
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Comparisons of ADCC and SCMC are often made since isolated 
null cells contain both activities. Both human K and NK cells 
are inhibited by protein A (Kay et al, 1977) and null effector 
cells have been shown to lack 'la-like' antigens, (Ozer et al, 1979).
The separation of K and NK cells has proved difficult. Kalden 
and co-workers (1977) showed that sig negative lymphocytes depleted 
of high avidity FcR bearing cells were still capable of killing 
and SCTîC was enhanced. Recently, Neville (1980) successfully 
separated K and NK lymphocytes using different glutaraldehyde 
treated cell lines and NK cells were shown to have less avid 
Fc receptors.
The null lymphocyte subset is thus very diverse containing 
cytotoxic cells and accessory cells. A suppressor function has 
also been postulated (Fr^land and Abrahamsen, 1979). Null cell 
populations are usually obtained by negative selection but the 
recent production of a hybridoma antibody may facilitate future 
separation and characterisation (Beckman et al, 1980).
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S E C T I O N  I I  
THE imUNOPATHOGENIC ROLE OF LYMPHOCYTES IN RHEUMATIC DISEASE
Rheumatoid arthritis (RA) is a connective tissue disease of 
unknown aetiology which manifests itself both locally and systemi- 
cally but is characterised chiefly by an inflammatory erosive 
polyarthritis.
In this section, the pathological changes occurring in RA will 
be outlined and a possible aetiology briefly discussed. The 
majority of the section will be restricted to an account of lympho­
cyte populations in RA with respect to their surface markers and 
functions and differences between healthy and rheumatoid lympho­
cytes will be reported. Lymphocyte abnormalities in other rheumatic 
diseases relevant to work in this thesis will be summarised.
RHEUMATOID ARTHRITIS (RA)
(i) General Introduction
Anatomy, Pathology and Pathogenesis
Glynn (1972) described the three outstanding anatomical 
features of RA to be "inflammation with progressive deformity of 
joints, subcutaneous nodules, ... and vascular lesions ..."
A normal diarthrodial synovial joint consists of two bone ends 
canped with articular cartilage and joined by a fibrous capsule 
which is contiguous with the periosteum of the bones. The synovial
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membrane or synovium lines the capsule and is composed of a thin 
layer of cells (Swinson and Swinburn, 1980). The lining layer of 
the synovium, the intima, is 1-3 cells in thickness and rests on 
a very vascular subintimal tissue which may be adipose, fibrous or 
areolar. Synovial cells or synoviocytes are responsible for the 
secretion of hyaluronic acid into the synovial fluid, the removal 
of solid particles from the joint cavity and the activation of 
fibrinogen which is thought to prevent the accumulation of fibrin 
in the joint (Fell, 1978). The intimai cells have been shown to be 
of two types, A cells which are phagocytic and resemble macrophages 
and B cells which are characterised by abundant, well-developed, 
rough-surfaced endoplasmic reticulum and are fibroblastic in 
apoearance. The A cells are the predominant cell type. It is 
uncertain which types are responsible for specific functions 
(Zvaifler, 1973; Fell, 1978).
In health, synovial fluid is thick, clear and viscous and 
contains hyaluronic acid. Normal synovial fluid does not clot; 
fibrinogen is absent in normal fluid but all the components of the 
fibrinolytic system necessary to produce free plasmin are present. 
PIasmin is the enzyme normally involved in fibrin removal. Normal 
joints contain small volumes ( <  2 ml) of synovial fluid (Zvaifler, 
1973; Swinson and Swinburn, 1980)i
Early RA is characterised by swollen joints and proliferative 
synovitis. Within the joint, excess connective tissue or "pannus" 
is produced by the proliferation of synovial lining cells with 
extensive vascularisation and infiltration of lymphocytes, plasma 
cells, Dolymorphonuclear leucocytes and macrophages (Harvey, 1978);
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the lining cells increase to a depth of 6-10 cells (Zvaifler, 1973) 
and the pannus protrudes into the joint space. Harris (1976) 
suggested that irreversible joint destruction may begin with the 
degradation of articular cartilage which is mediated by the en­
croaching pannus. Chayen and Bitensky (1971) have demonstrated a 
high lysosome content in rheumatoid synovial lining cells and the 
presence of lysosomal enzymes in rheumatoid joints; these may con­
tribute to the inflammation.‘
The rheumatoid synovial membrane has been studied using electron 
microscopy. Kobayashi and Ziff (1973) identified perivascular 
accumulations rich in lymphocytes or plasma cells or both cell types. 
Gaucher and colleagues (1976) characterised cells of varying sizes 
connected by intercellular bridges and thus rheumatoid synovial 
membrane presented a villous surface in comparison to the smooth flat 
surface of normal synovial membrane. Hyperplasia and hypertrophy 
is a characteristic feature of rheumatoid joints.
Rheumatoid synovial fluid varies considerably from normal 
fluid. Perhaps the most striking differences are the total volume 
of the fluid (as much as 200-400 ml in active RA) and the ability 
of rheumatoid synovial fluid to clot (Zvaifler, 1973). Rheumatoid 
synovial fluid protein and lipid levels are grossly elevated while 
the haemolytic complement activity is significantly depressed; in 
contrast, serum complement levels in rheumatoid patients are either 
normal or slightly increased.
It is obvious that cells infiltrate the joint from the sur­
rounding tissues or blood vessels. Zvaifler (1973) has described
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the Dredominant cell in rheumatoid synovial fluids as a mature 
polymorphonuclear granulocyte accounting for 75-90% of all nucleated 
cells. The remaining cells consist of 5-10% lymphocytes with some 
monocytes, macrophages and synovial lining cells; all may be 
involved in the pathogenesis of R A . Direct evidence for the detri­
mental effects of lymphocytes in RA was provided by Paulus and 
co-workers (1977). Thoracic duct drainage produced a clinical im­
provement in rheumatoid patients and reinfusion of the cells induced 
exacerbation of disease activity.
Humoral Immunity
The presence of antibodies against the Fc region of autologous 
IgG (Rheumatoid factors; RFs) in the serum of approximately 80% 
of patients with RA has been known for many years (Waaler, 1940; 
Rose, Ragan, Pearce and Lipman, 1948) and has been extensively 
reviewed (Zvaifler, 1973; Johnson and Faulk, 1976; Ziff, 1980). 
Classical IgM rheumatoid factor (IgMRF) led to the definition of 
seroDositive or seronegative RA. No correlation was found between 
IgMRF and raised immunoglobulin levels in rheumatoid patients 
(Barden, Mullinax and Waller, 1967). More recently IgG rheumatoid 
factor has been demonstrated in both seropositive and seronegative 
rheumatoid patients but not in other seronegative rheumatic diseases 
(Allen et al, 1981). High levels are associated with rheumatoid 
vasculitis. IgA rheumatoid factors have also been described 
(Johnson and Faulk, 1976; March et al, 1981).
Rheumatoid factors consequently lead to the production of 
circulating antigen-antibody complexes and thus RA is-often termed
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an immune complex disease. Complexes can interfere with Fc receptor 
mediated functions and, once deposited in the tissues, may have 
pathological effects. Glomerulonephritis may be immune complex 
induced (Wiggins and Cochrane, 1981) although this is rare in PA.
The rheumatoid synovial membrane is known to synthesise immuno­
globulin of mainly IgG class (Smiley et al, 1968); IgG-IgG complexes 
can be synthesised intracellularly and secreted. Approximately 
50% of the plasma cells are synthesising IgG (Natvig and Munthe,
1975). Immune complexes containing Ig*f, IgG and complement have 
been detected in synovial fluids (Zvaifler, 1973). Britton and 
Schur (1971) described intracytoplasmic inclusions of immunoglobulins 
and complement in synovial fluid leucocytes and suggested that 
immune complexes form in the synovial fluid, fix complement and 
through activation of C3 are phagocytosed by synovial fluid leuco­
cytes. This may provide an explanation for low complement levels 
in the joint.
Other autoantibodies have also been documented. Anti nuclear 
antibodies (ANAs) have been described and many reviews are available 
(Holborow, 1979). These antibodies are mainly found in patients with 
systemic lupus erythematosus (SLE) although they are sometimes found 
in rheumatoid patients. Grennan, Sloane, Behan and Dick (1977) 
showed that rheumatoid patients with ANAs to double stranded DNA are 
more likely to have severe disease and extra-articular complications.
Anti collagen antibodies have been detected in both rheumatoid 
serum and rheumatoid synovial fluid and collagenase activity has 
been shown to be present in rheumatoid synovial membranes and 
synovial fluid (Steffen, 1980).
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Cell Mediated Immunity
Cytotoxicity measurements, antigen and mitogen responsiveness 
and suppressor activity will be discussed later in Section II with 
respect to discrete lymphocyte populations.
The human leucocyte migration inhibition test (LffT) has been 
used widely to assay cellular responses to antigen (Bendixen et 
al, 1976). Patients with RA respond abnormally to autologous IgG 
(Weisbart, Bluestone and Goldberg, 1975). The abnormal response is 
more marked if the IgG is altered in some way, for example by com- 
plexing to antigen or by heat aggregation (Eibl and Sitko, 1975;
Hall, 1978). Circular dichroism studies have been used to show that 
rheumatoid IgG has an altered structure (Johnson, Watkins, Scopes 
and Tracey, 1974) and it was postulated that this alteration in 
structure may cause autoantibody production resulting in immune 
complex formation (Johnson, Watkins and Holborow, 1975). This 
remains unproven.
Aetiology
The search for a primary antigen in RA has so far proved fruit­
less. It was originally thought that rheumatoid factor was the 
cause of RA but the discovery of high titres in other diseases dis­
pelled the assumption (Zvaifler, 1973; Johnson and Faulk, 1976;
Carson et al, 1978). Using the LMT, scxne workers have demonstrated 
a specific response by rheumatoid pateints to synovial eluates 
(Bacon et al, 1973; Robinson and Muirden, 1980). Other investigators, 
using very large numbers of patients, have shown this effect to be 
non-specific (Morgan et al, 1980).
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An infectious agent has been implicated as the instigator of 
RA since many immunopathological features resembling those of 
connective tissue diseases are associated with infectious diseases.
It is known that arthritis complicates many bacterial and virus 
infections, such as Rubella, although it is nearly always short­
lived and non-erosive. Also, a wide variety of autoantibodies are 
produced in some infectious diseases such as subacute bacterial 
endocarditis (SEE) or leprosy; anti-IgG can neutralise infectious 
complexes of antigen bound to viruses such as Herpes simplex virus 
(HSV). Thirdly, virus infection has been implicated in seme 
degenerative diseases of the central nervous system (i.e. 'slow 
virus' infections) and influenza virus has been shown to precede 
Goodpasture's syndrome, an antibody induced glomerulonephritis 
in which antibodies to glomerular basement membrane are produced; 
there is commonly an immune complex nenhritis in infections including 
SEE and leprosy. This subject is reviewed by Denman (1975) and 
Denman and colleagues (1977); these authors favour a viral aetiology 
for RA but this is not proven.
Following many viral infections, viral antigens are expressed 
on the surface of infected cells and the viral gencme may become 
integrated into host DNA, thus persisting in the host cell. Norval 
and Smith (1979) found no evidence of viral genomes in the DNA and 
RNA of synovial fibroblasts, synovial membranes and peripheral blood 
lymphocytes of patients with RA and other joint conditions. Appleford 
and Denman (1979 a) isolated lymphocytes from the peripheral blood 
and synovial fluid of rheumatoid patients and showed that only 
peripheral blood lymphocytes supported the growth of Herpes simplex 
virus (HSV). The same workers showed that T lymphocytes isolated
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fran synovial fluid could support the growth of HSV but the re­
addition of non-T lymphocytes again caused non-permissiveness. 
However, if synovial fluid non-T lymphocytes were added to auto­
logous peripheral blood T cells, no such effect was noted and the 
virus grew normally. Removal of glass adherent cells from non-T 
synovial fluid lymphocytes did not remove inhibition. The authors 
suggest that synovial non-T cells may be producing anti viral 
factors (Appleford and Denman, 1979 b).
Other investigators suggesting a viral aetiology for RA des­
cribed the presence of a serum antibody in rheumatoid oatients which 
is reactive with a soluble nuclear antigen extracted from human 
lymphoblastoid lines infected with Epstein Barr Virus (EBV) but 
not those infected with other Herpes type viruses. This RA 
associated nuclear antigen (RANA) appears to be distinct frcan 
Epstein Barr nuclear antigen or EBNA (Alspaugh et al, 1978). A 
high frequency of anti-RANA antibody was shown to occur in both 
seropositive and seronegative RA. Normal controls and patients with 
other arthritides had low levels of the antibody (Ng et al, 1980). 
Catalano and co-workers (1980) studied healthy individuals and showed 
that those having antibodies to viral capsid antigen (VGA), which 
is expressed during EBV infection, also had anti-RANA antibodies 
while anti-VGA negative individuals were anti-RANA negative. They 
concluded, therefore, that anti-RANA antibodies are produced only 
after EBV infection. Ferrell and co-workers (1981) confirmed the 
high incidence of anti-RANA antibodies in rheumatoid patients and 
the distinction from anti-EBNA. Other EBV-associated antibodies 
were detected; thus rheumatoid patients had elevated levels of 
anti-VGA and antibody to early antigen, another EBV related antigen, 
was present.
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Anti-Rubella antibody secreting cells have been demonstrated 
in the peripheral blood of patients with RA (H. Chattopadhyay et 
al, 1979 a). Later work showed that although the antibody response 
to viral antigens was increased, rheumatoid patients were hypo- 
responsive to those antigens when tested in the LMT (H. Chattopadhyay,
C. Chattopadhyay and Natvig, 1979 b).
Genetic Factors
Rheumatoid arthritis is a disease of relatively recent origin 
(Bywaters, 1975). It has been suggested that environmental factors 
may effect genetically predisposed individuals to develop the disease.
A D locus related antigen DRw4 was detected in 70% of 
Caucasian rheumatoid patients in comparison with 28% of normal con­
trols (Stastny, 1978). Panayi and Wooley (1977) screened 116 sera 
from multiparous women made specific for HLA-D antigens. One serum 
gave results analogous to those of Stastny (1978). In contrast 
the antigens HLA-DRw7 and HLA-DRw8 were increased in children with 
JCA while HLA-DRw4 occurred significantly less frequently than in 
normal controls (Stastny and Fink, 1979).
The antigen DRwI appears to map RA in Indian patients (Nichol 
and Woodrow, 1981).
It thus appears that much is known of the pathological changes 
occurring in RA but little is known of the aetiology; the causative 
agent may be a combination of two or more of the factors described 
above (Vaughan, 1979).
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(ii) Lymphocyte Subpopulations in Rheumatoid Arthritis
Rheumatoid lymphocyte subpopulations have been enumerated using 
surface markers, responses to mitogen or antigen and functional 
characteristics. The lymphocyte populations present in peripheral 
blood, synovial fluid and synovial tissue will be presented separately 
Each group will be divided into T and non-T cells to avoid the 
confusion described in Section I concerning si g positive and null 
Fc receotor bearing cells. Antibody-dependent and spontaneous 
cell mediated cytotoxicity will be included in the non-T section.
Peripheral Blood Lymphocyte Subpopulations in Rheumatoid Arthritis
(a) T Lymphocytes 
Cell Numbers
Most workers agree that neripheral blood T cells in RA are 
present in normal numbers (Micheli and Bron, 1974; Sheldon,
Papamichail and Holborow, 1974; Winchester et al, 1974; Brenner, 
Scheinberg and CathCart, 1975; Scherak et al, 1976; Horwitz and 
Juul-Neilsen, 1977; Meijer et al, 1980 a; Slavin and Strober, 1981) 
although Burmester and colleagues (1978) have reported reduced 
numbers while other workers found increased numbers (Fr^land, Natvig 
and Husby, 1973; Fr^land, Natvig and Wisl^ff, 1975). Roux and co­
workers (1977) showed that rheumatoid patients had either normal or 
decreased T cell numbers. All patients with low T cell numbers in 
this study were lymphopaenic but this was not correlated with 
disease activity or drug therapy.
Normal levels of the Ty subset have been reported in RA
\
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(Meijer et al, 1980 a; Pfreundschuh et al, 1980; Dobloug et al,
1981) although Dobloug and associates (1981) noted reduced in 
JCA. Levels of cells have been reported as normal (Doubloug et 
al, 1981), Increased (Pfreundschuh et al, 1980) or decreased per­
centages (Meijer et al, 1980 a). The latter authors found some 
correlation between low Tyw. cell numbers and disease activity.
Increased la positive T lymphocytes have been reported in 
rheumatoid patients and these were present in both the Ty and 
non-Ty subsets of T cells. It was noted that these la positive 
T cells were small lymphocytes; in vitro stimulated la positive 
cells are blasts (Yu et al, 1980).
Mitogen Responsiveness
The ability of rheumatoid peripheral blood lymphocytes (PEL) 
to respond to plant mitogens has been widely studied and diverse 
results have been obtained. Lockshln and co-workers (1975) des­
cribed a decreased response of rheumatoid PEL to P H A , Con A and PWM 
in comparison with healthy controls. They were unable to correlate 
this lack of response with E rosette positive lymphocytes. In the 
control group, normal responses could be obtained with as few as 
10% T cells; this low proportion of T cells is not seen in RA.
Eurmester and associates (1978) found a decreased response of 
rheumatoid PEL to PHA and Con A but this decrease was not significantly 
different from control values. The responses to PPD and PWM were 
also similar to those of control lymphocytes. Froebel and colleagues 
(1979) showed reduced responses to PHA which were just significant 
at low doses. The responses to Con A and PWM were also slightly
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diminished but these were not significantly different from control 
values. Other workers have also shown that rheumatoid peripheral 
blood lymphocyte responses to phytomitogens are not significantly 
different from those of healthy individuals (Panayi, 1973; Sheldon, 
Papamichail and Holborow, 1974; Meijer et al, 1980 b ) .
Slavin and Strober (1981) found a decreased PHA responsiveness 
of PEL in active RA but isolated rheumatoid T lymphocytes showed no 
such decrease in PHA responsiveness. The addition of rheumatoid 
sera frcm patients with active disease inhibited the PHA trans- 
fomation of both normal PEL and rheumatoid T lymphocytes. A defect 
in Con-A induced suppression was noted by Sany and colleagues 
(1979) while Dobloug and associates (1981) reported a slightly 
reduced suppressor activity in RA but this was not significantly 
different from control values. Normal suppressor activity was seen 
in JCA patients. Other workers have demonstrated a reduced Con-A 
suppressor T cell function in early active rheumatoid patients 
( 4 3  months). Inactive and late active (> 6 months) rheumatoid 
patients showed no suppressor cell abnormalities. The early active 
patients, when tested 11-23 months later, showed normal suppressor 
activity. An anti-suppressor cell antibody was detected in the 
plasma of early active patients (Abdou et al, 1981). Meijer and 
co-workers (1980 a) found no antibodies to Ty in rheumatoid sera 
and ant i - ^  was present only in active disease. These studies 
demonstrate the necessity of well-defined patient groups.
Mitogen-induced Cellular Cytotoxicity
Fewer studies have been performed on the ability of PHA to
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induce cytotoxicity. Corrigall and Panayi (1978) showed no sig­
nificant differences in PHA-induced cytotoxicity in rheumatoid 
patients when compared with patients with other inflammatory 
joint diseases, Rosenberg and Currey (1979) found no significant 
differences in the PHA-induced cytotoxicity of rheumatoid and 
healthy PBL.
(b) Non-T Lymphocytes 
Cell Numbers
sig positive lymphocytes
There is one report of increased sIg positive cells in rheumatoid 
peripheral blood (Papamichail, Brown and Holborow, 1971) but the 
majority of workers agree that these cells are present in normal 
numbers in PBL (Mellbye et al, 1972; Fr^land, Natvig and Husby,
1973; Micheli and Bron, 1974; Sheldon, Papamichail and Holborow,
1974; Brenner, Scheinberg and Cathcart, 1975; Fr^land, Natvig and 
Wisl^ff, 1975; Horwitz and Juul-Nielsen, 1977; Burmester et al, 1978; 
Meijer et al, 1980 a; Slavin and Strober, 1981). Froebel and 
colleagues (1979) reported significantly raised numbers of sig 
positive cells in rheumatoid patients in remission.
C3R Positive Lymphocytes
Mellbye and colleagues (1972) found significantly reduced 
numbers of C3R positive PBL in adult RA whereas patients with JCA 
had normal numbers. Other workers described normal levels of C3R 
positive cells in RA (Brenner, Scheinberg and Cathcart, 1975;
Burmester et al, 1978).
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Fc Receptor Bearing Lymphocytes
The "rheumatoid rosette" was described by Bach, Delrieu and 
Delbarre (1970). Peripheral blood lymphocytes from both seropositive 
and seronegative patients bound antibody sensitised 0 rhesus negative 
erythrocytes. Increased numbers were detected in RA, particularly 
in early disease. No correlation with IgM rheumatoid factor was 
found. Rheumatoid rosettes were also elevated in patients with 
gout. Sany, Clot, Massip, Charmasson and Serre (1975) showed that 
rheumatoid rosette forming lymphocytes were neither T nor B cells 
since E rosette depletion and nylon filtration increased the propor­
tion of rosette forming cells detected. Other workers have confirmed 
increased EA rosette formation in RA (Scherak et al, 1976;
Sharpin and Wilson, 1977 a). Sharpin and Wilson (1977 b) used 
whole serum for erythrocyte sensitisation but demonstrated that the 
EA rosettes formed were due to FcyRs only. Durance, Micheli and 
Fallet (1974) were unable to find a significant difference in 
rheumatoid rosettes between rheumatoid and gout patients and controls. 
Two other groups of workers also demonstrated normal EA rosette 
numbers in RA (Burmester et al, 1978; Froebel et al, 1979).
Wooley and Panayi (1978) showed increased binding of radio­
labelled heat aggregated IgG by rheumatoid cells compared with 
controls. The authors concluded that the observed increase may 
be due to increased numbers of FcRs per cell or increased avidity 
of FcR on rheumatoid cells.
Third population cells, detected by Ripley sensitised ery­
throcytes, have been found in normal numbers in rheumatoid peripheral
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blood (Fr^land, Natvig and Wisl^ff, 1975; Dobloug et al, 1981).
This null population appears to have memtrane characteristics 
which differ from controls since lower numbers are detected 
following nylon fibre filtration (Fr^land, Natvig and Wisl^ff,
1975). L cells are present in normal percentages but their abso­
lute numbers are depressed (Horwitz and Juul-Nielsen, 1977).
Antibody Dependent Cellular Cytotoxicity (ADCC)
Several groups of workers have found ADCC activity to be 
unaltered in RA. A variety of targets have been used including 
chicken erythrocytes (Fr^land, Natvig and Wisl^ff, 1975; Cooke,
Hay and Perumal, 1979; Rosenberg and Currey, 1979), Chang liver 
cells (Panayi and Corrigall, 1977; Penschow and Mackay, 1980) and 
a human melanoma cell line, IGR^ (Burmester et al, 1978).
McGill and Twinn (1977), using chicken erythrocytes as targets, 
related disease activity to cytotoxic activity; active seropositive 
rheumatoids had reduced ADCC activity while the seronegative patients 
showed normal activity. Froebel and associates (1979) showed reduced 
peripheral blood ADCC against Chang liver cells in active RA.
Patients with early RA ( 4  1 yr) and chronic rheumatoid patients in 
remission had normal activity. EA rosette formation correlated 
with ADCC activity.
Rheumatoid rosette forming cells were found to be active in 
ADCC (Sany et al, 1976). Removal of rheumatoid rosette forming 
cells abolished ADCC and removed EA rosette forming cells. Removal 
of EA rosette forming cells removed rheumatoid rosette forming cells
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and also abolished ADCC. In contrast to other reports ADCC 
activity against chicken erythrocytes was found to be increased in 
rheumatoid patients.
Panayi (1976) described the presence in 31% of rheumatoid 
sera of an IgG antibody which induces healthy PBL to kill Chang 
target cells. Anti-Chang activity was detected in only 4% of 
control subjects and similar results were obtained with other 
connective tissue diseases. In contrast, Cooke, Hay and Perumal 
(1979), using smaller patient groups and chicken erythrocytes as 
target cells, found no significant difference in normal ADCC 
activity when rheumatoid sera were included in the assay but the 
activity was significantly inhibited by sera from patients with 
other connective tissue diseases in comparison to normal human serum.
Spontaneous Cell Mediated Cytotoxicity (SCMC)
Using Chang cell targets, Penschow and Mackay (1980) found 
normal SCMC in the PBL of RA patients. Highton and Panayi (1980) 
examined the spontaneous cytotoxicity of RA and normal PBL against 
four lymphoblastoid cell lines including one T cell line and 3 
B cell lines. Two of the B cell lines were positive for EBV genome.
No significant differences in killing were seen in the PBL of 
rheumatoid or normal individuals; there was no preferential recog­
nition of EBV-associated antigens. High SCMC was mediated against 
the T cell line.
Burmester and co-workers (1978), using a human melanoma cell 
line, described decreased SCMC by rheumatoid peripheral blood at
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high lymphocyte/target ratios (100:1); effector/target ratios below 
this showed no significant decrease.
Synovial Fluid Lymphocyte Subpopulations in Rheumatoid Arthritis
Synovial fluid cells are usually compared with peripheral 
blood lymphocytes of rheumatoids or controls.
(a) T Lymphocytes 
Cell Numbers
Rheumatoid synovial fluid lymphocytes (SFL) are predominantly 
T cells and are present in significantly higher numbers than in the 
peripheral blood of either RA or normal individuals. (Fr^land, 
Natvig and Husby, 1973; Vernon-Roberts, Currey and Perrin, 1974; 
Winchester et al, 1974; Sheldon, Papamichail and Holborow, 1974; 
Fr^land, Wisl^ff and Michaelsen, 1975; Brenner, Scheinberg and 
Cathcart, 1975; Van de Putte et al, 1976).
One group of workers reported similar numbers of T cells in 
PBL and SFL (Burmester et al, 1978) and decreased numbers of T cells 
were found in JCA (Brenner, Scheinberg and Cathcart, 1975). High 
synovial fluid T cell numbers have been described in a wide variety 
of other arthritides (Van de Putte et al, 1976).
Mitogen Responsiveness
Synovial fluid lymphocytes from patients with RA were sig­
nificantly less reactive than autologous PBL in their response to
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PHA, Con A and PWM (Stratton and Peter, 1978). It is generally 
accepted that synovial fluid lymphocytes respond poorly to PHA 
(Panayi, 1973 ; Sheldon, Papamichail and Holborow, 1974; Abrahamsen, 
Fr^land and Natvig, 1978; Burmester et al 1978; Corrigall, Panayi 
and Laurent, 1979). The poor response is not due to blocking 
agents adsorbed on the lymphocyte surface since incubation at 
37°C or enzyme treatment does not enhance lymphocyte responsiveness 
(Corrigall, Panayi and Laurent, 1979). Decreased PHA responses 
have also been reported in synovial fluid of JCA patients 
(Abrahamsen, Fr^land and Natvig, 1978).
Synovial fluid lymphocytes have a high background DNA synthesis 
before mitogen stimulation and it has been postulated that SFL are 
a pre-committed "activated" population.
Con A responses of SFL have been described as decreased 
(Burmester et al, 1978) or normal (Corrigall, Panayi and Laurent,
1979). Similarly, PWM responses were reported as reduced (Abrahamsen. 
Frj)land and Natvig, 1978) or normal (Burmester et al, 1978;
Corrigall, Panayi and Laurent, 1979).
Responses to PPD and Candida albicans antigen have been des­
cribed in RA and JCA. Rheumatoid synovial fluid lymphocytes stimulate^ 
with PPD showed significantly higher responses than autologous PBL 
whereas responses of JCA patients were normal (Abrahamsen, Fr^land 
and Natvig, 1978). Other workers found no significant differences 
in the responses of SFL or PBL from rheumatoid patients to PPD 
(Burmester et al, 1978). Both RA and JCA patients showed normal 
responses to Candida antigen when PBL and SFL responses were compared 
(Abrahamsen, Fr^land and Natvig, 1978).
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Mitogen-induced Cellular Cytotoxicity
No significant differences in mitogen-induced cytotoxicity 
were observed in SFL of RA patients when compared to PBL of RA 
and the SFL and PBL of patients with other inflammatory joint 
diseases (Corrigall and Panayi, 1978).
(b) Non-T Lymphocytes 
Cell Numbers 
sig positive cells
An early study by Mellbye and associates (1972) reported sig­
nificantly higher sig positive cells in rheumatoid joint fluid when 
compared to peripheral blood but this was based on raised sig 
bearing cells which are probably mainly L cells. Some workers have 
reported no significant differences in numbers when compared to PBL 
(Vernoh-Roberts, Currey and Perrin, 1974; Brenner, Scheinberg and 
Cathcart, 1975; Burmester et al, 1978) while other groups found 
decreased numbers of sig positive cells; in some cases this depression 
is very marked (Fr^land, Natvig and Husbuy, 1973; Sheldon,
Papamichail and Holborow, 1974; Winchester et al, 1974; Fr^»land, 
Natvig and Wisl^ff, 1975; Van dè Putte et al, 1976). Vernoh-Roberts, 
Currey and Perrin (1974) detected significantly raised IgA positive 
cells in rheumatoid synovial fluid.
C3 positive Lymphocytes
Synovial fluid C3 positive lymphocytes have been described as 
normal (Mellbye et al, 1972) or reduced (Brenner, Scheinberg and 
Cathcart, 1975; Burmester et al, 1978).
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Fc-receptor Positive Lymphocytes
EA rosettes were found in similar numbers in PBL and SFL of 
rheumatoid patients (Burmester et al, 1978). Third population 
cells are present in rheumatoid synovial fluid (Fr^land, Natvig 
and Wisl^ff, 1975) and also in the fluid of JCA patients; the 
levels are not significantly different from those of peripheral 
blood (Abrahamsen, 1981).
Null cells in synovial fluid have been calculated by negative 
inference (i.e. 100 - (%T + %B)). Brenner, Scheinberg and Cathcart 
(1975) found high levels of null cells in synovial fluid from JCA 
patients. Rheumatoid fluids showed very low or normal to high 
levels of null cells; however this bimodal distribution yielded 
a normal mean value. Vernon-Roberts, Currey and Perrin (1974) 
found significantly reduced null cell values in rheumatoid synovial 
fluid. Winchester and co-workers (1974) demonstrated high levels 
of null cells in rheumatoid synovial fluid detected by binding of 
aggregated IgG.
Antibody-Dependent Cellular Cytotoxicity
Several groups of workers have detected reduced ADCC in synovial 
fluid in comparison with peripheral blood and a number of target cells 
were employed, including chicken erythrocytes (McGill and Twinn,
1977; Cooke, Hay and Perumal, 1979), Chang cells (Corrigall and 
Panayi, 1978) and human melanoma cells (Burmester et al, 1978). 
Abrahamsen (1981) using chicken erythrocytes as targets, found no 
significant differences between peripheral blood and synovial fluid
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lymphocytes of patients with RA or JCA. Effector cells were incu­
bated overnight prior to assay.
Corrigall and Panayi (1978), using Chang cell targets, found 
no increase in cytotoxicity with overnight incubation at 37°C or 
with neuraminidase or trypsin treatment and demonstrated reduced 
ADCC in the synovial fluid of other inflammatory joint diseases; 
the effect is not confined to RA. Panayi (1976) demonstrated 
anti-Chang activity in some rheumatoid synovial fluids. Cooke,
Hay and Perumal (1979) using chicken erythrocytes, described 
inhibition of normal cytotoxicity by rheumatoid synovial fluid and 
fluids from patients with other connective tissue diseases. Com­
parisons were made with normal human serum.
Spontaneous Cell Mediated Cytotoxicity
Most workers found spontaneous cytotoxicity to be raised in 
RA synovial fluid in comnarison to RA and normal peripheral blood 
(Panayi and Corrigall, 1977; Burmester et al, 1978).
Synovial Tissue Lymphocyte Subpopulations in Rheumatoid Arthritis
Synovial tissue lymphocytes are usually prepared as follows. 
Synovial tissue is minced, treated with enzymes (collagenase;
DNase) and the cell suspension eluted. Lymphocyte populations are 
usually compared with peripheral blood normal or rheumatoid lymphocytes
(a) T Lymphocytes 
Cell Numbers
Using immunofluorescent staining of synovial tissue sections.
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Bankhurst, Husby and Williams (1976) concluded that 75-90% of 
lymphocytes in rheumatoid tissue are T cells. The same workers 
eluted cells and this suspension contained 20-30% lymphocytes which 
were predoninantly T cells (78-85%). High T cell numbers were also 
reported by Abrahamsen and co-workers (1975). Wangel and Klockars
(1977) found significantly lower T cell numbers in synovial tissue 
than in rheumatoid synovial fluid and peripheral blood. However, 
following trypsin treatment and overnight culture, the E positive 
cells increased to values similar to those of SFL and PBL. Simi­
larly treated peripheral blood lymphocytes showed no such increase. 
It was suggested that many eluted synovial cells were T cells with 
blocked receptors.
Mitogen Responsiveness
Synovial tissue lymphocytes have been reported to show low 
responses to PHA, Con A and PWÎ in comparison with PBL, (Abrahamsen, 
Fr^land, Natvig and Pahle, 1976; 1977 a; Meijer et al, 1980 b ) . 
Meijer and colleagues (1980 b) also found low respones to Varidase 
(Streptokinase/Streptodomase) and PPD while Abrahamsen, Fr^land, 
Natvig and Pahle (1976) demonstrated negligible responses to 
Candida antigen but the response to PPD was remarkably high, showing 
stimulation indices comparable to those of PHA stimulated synovial 
tissue lymphocytes.
C. Chattopadhyay and co-workers (1979 a) demonstrated a lack 
of suppressor cell activity in rheumatoid synovial lymphocytes. 
Synovial tissue lymphocytes produce high levels of immunoglobulin 
(Ig) which, following stimulation with PWM, shows a small increase.
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In contrast, normal PBL show a significant increase in Ig production 
when stimulated. At high T/B cell ratios, suppression of Ig 
production occurs. Synovial tissue T cells were able to help 
allogeneic normal B cells to respond to PWM but were unable to 
curtail Ig production at high T/B cell ratios. Further work demon­
strated the lack of a con A-activated suppressor activity (c . Chatto­




Wangel and Klockars (1977) detected low numbers of sig positive 
synovial tissue lymphocytes. Similar results were obtained by 
other workers (Abrahamsen, Fr^land, Natvig and Pahle, 1976;
Meijer et al, 1980 b ) .
Fc receptor positive Lymphocytes
Third population cells have been detected in low numbers in 
rheumatoid synovial tissue (Abrahamsen, Fr^land, Natvig and Pahle,
1976). Wangel and Klockars (1977) found no significant differences 
in the FcR positive cells of RA peripheral blood, synovial fluid 
or synovial tissue detected by binding of heat aggregated IgG.
Antibody Dependent Cellular Cytotoxicity
Both RA and JCA synovial tissue lymphocytes effect ADCC but 
activity is lower than that of normal PBL. To determine whether the 
elution procedure was responsible for this reduction, normal PBL
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were similarly treated; no change in ADCC was noted. Nylon 
column filtration resulted in a percentage increase in lympho­
cytes and decrease in third population cells but cytotoxic activity 
either increased, decreased or remained the same. Depletion of 
third population cells gave similarly conflicting activities of 
ADCC (Abrahamsen, Frjiland, Natvig and Pahle, 1977 b).
(iii) Caveat
The analysis of lymphocyte subpopulations and their relative 
functions in disease is beset by problems. Rheumatoid arthritis 
is suffered by individuals of all ages and thus age related changes 
may be mistaken for disease effects. Also, drug treatment may 
radically alter cell numbers or functions. A brief account of 
some of these is given below.
Ageing
It is known from experiments using mice that there is a loss 
of immune function with age. Thus Callard, Hasten and Blanden 
(1979) have related this loss to an abnormality in lymphocyte mem­
branes while other workers suggest that this loss of immune com­
petence is due to impaired regulation of autoantibody production 
(Szewczuk and Campbell, 1980).
Gupta and Good (1979) examined human PBL in young and ageing 
individuals using a number of surface markers. No significant 
difference was observed in absolute lymphocyte counts or in the 
percentages of T, B or third population lymphocytes. The Ty
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population was significantly increased and this increase was most 
noticeable in aged females. A concomitant decrease in was ob­
served. Clot, Charmasson and Brochier (1978) showed that T cells 
increased from infants (3 months) to adults (20-50 years) and 
then decreased with ageing (75-97 years). Both Clot and colleagues 
(1978) and Brohee and associates (1980) demonstrated increased 
active E rosettes in aged individuals. Mellbye and co-workers 
(1972) found no significant difference in sig positive cells between 
ageing humans and children while Clot, Charmasson and Brochier
(1978) showed that sig positive cells were low in adults and returned 
to the original levels with ageing; C3R positive cells decreased 
from the new born to aged individuals (Clot, Charmasson and Brochier,
1978).
Lymphocytes frcan aged individuals show normal responses to 
the non-specific mitogens PHA, Con A and PWM. However a lack of 
Con A-inducible suppressor cells was demonstrated (Abe et al, 1981).
NK but not K cell activity was shown to be grater in males than 
females and greater in young individuals when compared to aged 
individuals (Penschow and MacKay, 1980).
Drug Treatment
It is not possible to present a comprehensive account of drug- 
induced effects on lymphocytes in this short section but a few 
examples relevant to the numbers and possible functions of Fc- 
receptor bearing cells are given below.
The majority of drug-induced changes in lymphocyte populations
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have been noted with ’second-line' treatment (e.g. gold, penicil­
lamine, immunosuppressive or steroidal drugs) and many of these 
effects have been shown in vitro. Thus D-penicillamine and copper 
salts can inhibit helper T cell function (Lipsky and Ziff, 1978;
1980), gold treatment can suppress lymphocyte transformation but not 
ADCC (Davis, Percy and Russell, 1979) and methyl prednisolone can 
affect suppressor cell function (Hirschberg et al, 1980). B cells 
have been shown to be highly sensitive to azathioprine and cyclo­
phosphamide and these immunosuppressive drugs may also effect sub­
populations of T cells (Dimitriu and Fauci, 1978; Hurme, 1979).
Some studies have been done whereby surface markers were 
employed. Thus dexamethasone treatment of a progranulocytic cell 
line, HL-60 reduced the number of Fc receptors per cell by 35-50% 
(Crabtree et al, 1979). Levamisole, administered in a single oral 
dose to healthy individuals, induced suppressor activity in the 
non-T^ subset of T lymphocytes (Moriya et al, 1979). Low mitogen 
responses in patients with RA were restored by in vivo levamisole 
treatment; similarly treated adults showed no significant increase 
in responsiveness (Scheinberg et al, 1978).
Because of the effects of 'second-line' drugs and ageing on 
lymphocyte numbers and functions, the majority of patients studied 
and described in this thesis were receiving non-steroidal anti­
inflammatory drugs (NSAIDs) unless otherwise stated and were age 
and sex-matched with controls. Nevertheless some non-steroidal 
therapy has been shown to affect lymphocyte functions. In vitro 
indoraethacin can enhance the PHA response of rheumatoid peripheral 
blood but not synovial fluid lymphocytes (Panayi and Corrigall, 1979).
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It is obvious that any comparisons made with respect to 
differences in function or numbers of rheumatoid lymphcoyte sub­
populations are subject to error. However by restricting com­
parisons to patients taking NSAIDs alone, the problems are slightly 
alleviated. In this study normal healthy individuals and patients 




Osteoarthrosis is a disease in which joint cartilage is progres­
sively destroyed and replaced by new bone. This new bone appears 
beneath the worn cartilage and as outgrowths or osteophytes. 
Osteoarthrosis is a common condition; the frequency increases with 
age and is found predominantly in women over the age of 55. Osteo­
arthrosis can result from joint trauma, congenital or metabolic 
disorders (e.g. congenital dislocation of the hip or alkaptonuria) 
or as a secondary condition in diseases like rheumatoid arthritis 
and gout (Swinson and Swinburn, 1980).
The term osteoarthrosis is synonymous with degenerative joint
disease (DJD) and suggests a purely mechanical ’wear and tear’ 
condition devoid of inflammation. However there is morphological 
evidence to suggest that cartilage changes in DJD differ from those
of the ageing process (Sokoloff, 1980) and many patients with DJD
suffer episodes of joint inflammation. Originally these inflammatory 
osteoarthritides were described as disease variants but the high
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incidence of inflamination in patients with DJD argues the use of 
the term osteoarthritis (OA) (Huskisson et al, 1979). Both pyro­
phosphate (McCarty, 1975) and hydroxyapatite crystals were detected 
in OA joint fluids and may be the cause of inflammation (Dieppe 
et al, 1976).
Since OA is not considered to be an auto-immune disease, 
patients with OA are often used as control subjects in studies using 
RA patients.
Aetiological Considerations
As previously stated, OA is considered to result primarily from 
joint injury. No synovial antigen was detected in a synovial mem­
brane homogenate of three patients with OA but OA peripheral blood 
lymphocytes responded significantly to rheumatoid synovial antigen. 
The healthy control group showed no response. This reaction may 
reflect the inflammatory component of OA (Bacon et al, 1973).
In contrast to RA, the anti-RANA antibody titre was within normal 
limits (Ferrell et al, 1981).
(ii) Cellular Aspects of Osteoarthritis
Synovial Membrane, Synovial Fluid and Peripheral Blood Cells
Scanning electron microscopy revealed that arthrosic synovial 
membranes (removed during total hip replacement) were infiltrated 
by numerous cells of small size. In contrast to the normal synovial 
membrane which presented a smooth, regular surface, arthrosic
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membranes were covered with short flattened appendices (Gaucher 
et al, 1976).
Synovial fluid of osteoarthritic and rheumatoid joints were 
compared. Much lower numbers of leucocytes were detected in OA 
fluids and these were predominantly mononuclear cells; hydroxyapatite 
crystals were also found. In contrast, RA fluids contained no 
crystals and the predominant cell was the polymorphonuclear leucocyte.
Peripheral blood lymphocyte investigations have shown normal 
numbers of rheumatoid rosettes (Durance, Micheli and Fallet, 1974) 
and of la positive T cells (Yu et al, 1980).
Cellular Function
Cell mediated immunity is considered to be normal in that only 
one of six OA patients responded to native or heat aggregated IgG 
(Weisbart, Bluestone and Goldberg, 1975).
McGill and Twinn (1977) showed normal peripheral blood ADCC 
in a group consisting of 15 healthy and 15 OA subjects and Abdou 
and co-workers (1981) demonstrated normal suppressor activity in a 
group of 11 OA patients. Peripheral blood lymphocytes from OA 
patients suppressed healthy B cell Ig synthesis or secretion and 
the anti-suppressor cell antibody found in the serum of early RA 
patients was not detectable in OA sera.
Normal peripheral blood ADCC was inhibited by synovial fluids 
from 4 OA patients but the inhibition was less than that observed
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using either rheumatoid fluid or fluids from patients with 'other 
connective tissue diseases'. The results were compared with inhibition 
by normal human serum and thus the increased inhibition by OA fluids 
may be an artefact of the method. Normal synovial fluid was not 
available (Cooke, Hay and Perumal, 1979).
Ankylosing Spondylitis
(i) General Introduction
Ankylosing spondylitis is a member of the seronegative spond- 
arthritides, a group which also includes psoriatic arthritis, Reiter's 
disease and enteropathic arthritis.
The disease is characterised by sacroiliitis and spondylitis 
which eventually results in bone fusion (ankylosis). Ankylosing 
spondylitis occurs more commonly in males than females. In women, 
the age of onset is higher and cervical spine involvement less common.
The hip joints are more usually affected in men. Features of anky­
losing snondylitis are, in order of decreasing frequency of occurrence, 
peripheral joint involvement, iritis, urethritis, cardiac complications 
and pulmonary fibrosis (Gow, 1978; Swinson and Swinbum, 1980).
The aetiology of ankylosing spondylitis is unknown although 
Klebsiella has been cited as a possible infectious agent in sus­
ceptible individuals (Ebringer et al, 1977). The strong correlation 
of ankylosing spondylitis with the HLA-B27 antigen is well documented 
(Brewerton et al, 1973; Woodrow and Eastmond, 1978).
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(il) Lymphocyte Aberrations in Ankylosing Spondylitis
The majority of workers investigating lymphocytes in ankylosing 
spondylitis (AS) have studied peripheral blood lymphocytes. McDevitt 
and Bodmer (1974) questioned the relation of specific HLA antigens 
to disease and postulated that the association may be with abnormal 
immune responses. Nikbin and co-workers (1976) demonstrated a 
relationship between HLA-B27 and a diminished mixed lymphocyte 
response (MLR). Asymptomatic controls positive for HLA-B27 and 
AS patients showed similar MLRs which were significantly reduced 
in comparison with HLA-B27 negative controls. Weisbart and 
colleagues (1976) showed that peripheral blood leucocytes from 
patients with AS and their first degree relatives (24 or 36 individ­
uals) reacted in vitro to autologous IgG. However some HLA-B27 
positive individuals did not react and some individuals who showed 
the response were HLA-B27 negative. In this study, there was no 
relation between immune reactivity and the HLA-B27 marker.
Immunological reactivity in AS was demonstrated by Eghtedari, 
Davis and Bacon (1976); raised numbers of circulating immunoblasts 
(activated cells) were detected in some AS patients (11 of 39 cases). 
The plasma viscosity measurement, used as a parameter of inflammatory 
activity, was raised in all patients with increased levels of cir­
culating immunoblasts.
T Lymphocytes
Reduced T cell numbers have been reported in AS peripheral 
blood in comparison with healthy individuals. This low T cell
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population was independent of HLA-B27; both B-27 positive and 
negative AS patients had low numbers of T cells (Fan et al, 1977). 
Rosenthal and Muller (1975) and Nilsson and Biberfeld (1980), using 
neuraminidase treated sheep erythrocytes, found no difference in 
T cell numbers between AS and healthy individuals. Nilsson and 
Biberfeld (1980) suggested that the discrepancy with Fan's group 
may be a result of the enzyme treatment. However Froebel and 
associates (1979) found normal numbers of T cells when measured 
with neuraminidase treated and untreated sheep erythrocytes. In 
AS, raised levels of Ty and normal numbers of were detected 
(Nilsson and Biberfeld, 1980).
Mitogen responses of PBL from patients with AS were normal 
when stimulated with optimal PHA doses (Fan et al, 1977; Nilsson 
and Biberfeld, 1980) or with a range of concentrations of PHA,
Con A and PWM (Froebel et al, 1979).
Non-T Lymphocytes
Fan and associates (1977) detected normal numbers of C3R and 
FcR positive cells in the PBL of AS patients. In another study, 
both EA rosettes and sig positive lymphocytes were reduced but 
this was not significantly different from normal (Froebel et al, 
1979). Rosenthal and Muller (1975) also detected normal numbers 
of B and null cells in patients with AS. Wooley and Panayi (1978) 
measured the uptake of radiolabelled heat aggregated IgG by 
peripheral blood lymphocytes in a group of 14 patients of which 11 
had AS. The remaining 3 patients exhibited symptoms of JCA. The 
group showed no differences in Fc binding from healthy controls.
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Antibody-dependent cellular cytotoxicity to Chang cell targets 
was shown to be significantly reduced in the PBL of AS patients 
(Froebel et al, 1979). Panayi (1976) detected normal low levels 
of anti-Chang antibody in AS.
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S E C T I O N  I I I  
Fc Receptors (FcRs)
The presence of a receptor for the Fc region of immunoglobulin 
on lymphoid cells has been described in previous sections. However 
such receptors are detected on a wide range of cell types for all 
classes of immunoglobulins. In this section FcR positive human 
cell types will be described, FcR heterogeneity and specificity of 
human lymphocytes outlined and the possible functions of FcR 
positive cells presented. Table 1.3 summarises the data given in 
this section concerning the class and IgG subclass specificity of 
human peripheral blood leucocyte FcRs and their susceptibility to 
proteolysis. Table 1.4 shows the various functions ascribed to 
human leucocytes.
(i) FcR Positive Human Cells
Lymphocytes
Human FcR positive T and non-T lymphocytes have been described 
in Section I and therefore this section will briefly outline the 
class and subclass specificity for immunoglobulin and omit the 
functional aspects of FcyR and F ^ R  positive lymphocytes previously 
described. Peripheral blood human lymphocytes selectively bind 
human monomeric IgGl and IgG3 myeloma proteins. However, when 
aggregated, all subclasses of IgG are cytophilic for lymphocytes 
(Lawrence, Weigle and Spiegelberg, 1975).
Table 1.3






P R 0 T E 0 L Y S I S
TRYPSIN PRONASE
h G 1,3 sensitive sensitive
y M sensitive sensitive
B G , D 1,3 sensitive sensitive
NULL G 1.3 résistant sensitive
K G 1,3 sensitive * resistant *
NK G 1,3 resistant *
MACROPHAGE)J G 1,3 resistant
MONOCYTE )
NEUTROPHIL G,A 1,3,4 resistant
* cytotoxic ability measured rather than IgG binding 
The NK cell does not require FcRs for activity
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As reported in Section I, human peripheral blood T lymphocytes 
express F ^ R s  or FcyRs or neither receptor. Receptors specific for 
IgD (Sj^berg, 1980) and IgA have also been detected (Lum, Beneviste 
and Blaese, 1980). The F c „ (  receptor positive cells showed a lower 
MLC response than Ty or and were less effective as helpers in 
the response to PWM. Yodoi and Ishizaka (1980) have demonstrated 
induction of Fc*R in vitro by IgE in mixed lymphocyte culture.
Hoover and colleagues (1981) showed specific FcR expression in myeloma 
patients; patients with IgG myeloma showed increased T y  cells while 
IgA myeloma patients had high levels of . Both sets of patients 
had normal levels of non-T Fc^R and Fc*R.
The Tjj Fc receptor has been isolated; the molecular weight, 
measured using sodium dodecyl sulphate polyacrylamide gel electro­
phoresis under non-reducing conditions, was found to be 120,000 
daltons (Cunningham-Rundles et al, 1980).
Non-T Lymphocytes
Receptors for IgG have been reported on B and null cells (see 
Section I) but are lacking on blast transformed B cells (Jondal,
1974). The FCyR of B cells has been extracted frcm the cells of 
a patient with chronic lymphocytic leukaemia. This had a molecular 
weight of 35,000 daltons and expressed phospholipase A2 activity 
(Suzuki et al, 1980; Suzuki, 1981). Receptors for IgD (Fc^R) are 
also present on non-T cells (Sj^berg, 1980).
Null cells, isolated using anti-rhesus antibodies, were found 
to bind only IgG and not IgA, M, D or E. Of the IgG subclasses 
IgGl and 3 bound with equal affinity while IgG2 and 4 showed very
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weak binding (Fr^land et al, 1974). Natvig and Fr^land (1976) 
screened three anti-rhesus antibodies and showed that all three 
detected third population cells. The workers suggest that the 
suitability of anti-rhesus antibodies for the detection of this 
population may be related to the fact that they are primarily 
IgGl and 3 subclass proteins, the two IgG subclasses that react 
most strongly with the FcyR of third population cells.
Neutrophils
The FcRs of human peripheral blood neutrophils have been shown 
to be specific for IgG and IgA and do not bind IgM, D or E (Henson,
1977). Lawrence, Weigle and Spiegelberg (1975) demonstrated binding 
by all subclasses of aggregated IgG and IgA. However, in unaggregated 
form, binding was achieved with IgGl, 3 and 4, IgAl and 2 and 
secretory IgA. The authors suggest that Fc^R and FCp<R are distinct 
on neutrophil membranes.
Alexander, Titus and Segal (1979) measured the FcyR density 
of human peripheral blood leucocytes; neutrophils exhibited a high 
receptor density. Henson (1977) reported neutrophil FcRs to be 
trypsin and neuraminidase resistant.
Monocytes and Macrophages
Human monocytes and macrophages specifically bind IgG 
(Dorrington, 1977) and show subclass preference for unaggregated 
IgGl and 3 (MacLennan, 1972; Lawrence, Weigle and Spiegelberg, 1975 ;
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Dorrington, 1977). No Fc%R have been reported (Hellstr^m and 
Spiegelberg, 1979) and IgA subclasses demonstrated insignificant 
binding (Lawrence, Weigle and Spiegelberg, 1975). In other mam­
malian species the binding is not IgG specific; there are reports 
of IgE binding by rat macrophages and monomeric IgM binding by 
guinea pig cells (Dorrington, 1977).
Platelets
The FcyR is present on human platelets and may be responsible 
for platelet injury induced by staphylococcal infection (Hawiger et 
al, 1979). It has also been suggested that the platelet FcyR is 
closely associated with the site for von Willebrand factor, which 
causes agglutination of platelets, since agglutination can be 
inhibited 'in vitro' by the addition of Fc or heat aggregated IgG 
but not by monomeric IgG, F (ab')^ , Fab or pFc (Moore, Ross and 
Nachman, 1978).
Basophils and Mast Cells
These cells have beeh shown to have receptors for IgE (Dickler, 1976
(b); Dorrington, 1977). Basophils bind IgGl and 3 also (MacLennan, 
1972).
Virus-Induced FcR Positive Cells
Cytomegalovirus and Herpes viruses can induce FcR expression 
on infected cells ( B u m s  and Allison, 1977). The FcR induced by
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Herpes Simplex Virus has been most studied and found to be trypsin 
sensitive while neuraminidase enhances IgG binding; receptor syn­
thesis is inhibited by 2-deoxy-D-glucose and it is suggested that 
the receptor is possibly a glycoprotein. Anti-y^imicroglobulin did 
not inhibit IgG binding (McTaggart et al, 1978).
Robinson and co-workers (1977) evaluated lymphocyte surface 
receptors before and after transformation with Epstein Barr Virus 
(EBV). Initially, the distribution of cells with characteristics 
of B lymphocytes was similar in human umbilical cord blood and in 
the peripheral blood of cotton-top marmosets and woolly monkeys. 
However, after EBV infection, the transformed cells showed different 
surface markers; human cord lymphocytes expressed the complement 
receptor but not the FcR, woolly monkey cells were complement and 
Fc receptor positive and marmoset cells exhibit neither marker.
Thus, transformation may increase or negate Fc receptor expression.
Cell Lines
Cell lines are usually derived by virus transformation or by 
'in vitro' cell cloning or from patients with immunodeficiencies. 
Receptors for IgG and IgM have been reported (Preud'homme et al,
1979) and Hellstr^m and Spiegelberg (1979) described high Fc^R 
positive cells in a patient with chronic lymphocytic leukaemia.
Huber and colleagues (1976) tested a variety of cell lines 
for several membrane markers including FcR expression. Lymphoid 
cell lines demonstrated a B cell marker pattern, having sIg, C3
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receptors (C3R) and low FcR density. The Burkitt's Lymphoma (BL) 
cell lines (i.e. EBV genome positive) demonstrated sig, C3R and 
FcR while the non-BL cell lines showed varying degrees of expression 
of the three markers, two lines expressing sig only. Myeloma cell 
lines were C3R and FcR negative while leukaemia cell lines were 
sig negative but displayed C3R and FcR in variable concentrations. 
All FcR positive lines showed preferential binding of IgG 1 and 3.
Epithelial Cells
The placental plasma membrane bears FcyRs and again binding 
of IgG 1 and 3 is more effective than 2 and 4 (van der Muelen et 
al, 1980).
Tonsil lymphocytes have been shown to bear receptors for IgM 
(Pichler and Knapp, 1978), IgG (Pichler and Broder, 1978) and IgE 
(Hellstr^m and Spiegelberg, 1979). Adenoid and spleen lymphocytes 
were also shown to bear Fc^R. The majority of FcjR positive lympho­
cytes are sIgM and sIgD positive (Hellstrom and Spiegelberg, 1979),
In contrast, Alexander, Titus and Segal (1979), using radio­
labelled affinity cross-linked trimers of rabbit IgG, found no 
significant detectable FcyR on tonsil or thymus leucocytes. Most 
of the Fc receptors of splenocytes were on myeloid cells and mono­
cytes. The discrepancies may be directly related to the different 
methods of detection.
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(ii) Heterogeneity of FcyReceptors on Human Lymphocytes
A number of different techniques have been employed to demon­
strate FcR heterogeneity. Surface markers are either used alone 
or in conjunction with proteolysis or temperature changes.
Enzyme Treatment
Lobo and Horwitz (1976) examined the ability of B and L lympho­
cytes to bind aggregated IgG (agg G) or IgG complexed to erythrocytes 
(Ripley EA rosettes; EA^^). L lymphocytes bound both human and 
guinea pig agg G, formed Ripley rosettes and possessed trypsin 
resistant Fc receptors. B lymphocytes did not form Ripley rosettes 
and agg G binding was variable; trypsin treatment of B lymphocytes 
abolished the binding capacity.
Gormus, Woodson and Kaplan (1978a) measured the FcR expression
of human mononuclear cells by Ripley rosettes, sensitised chicken
erythrocyte rosettes (EA^^) or human agg G binding. Receptors for
sheep erythrocytes (E rosettes) and C3 were also evaluated and sig
positive lymphocytes assessed. Measurements were made before and
immediately after enzyme stripping and again following overnight
culture. Pronase increased EA and EA , halved the number of ERi Cn
rosettes and almost abolished aggregate binding. No rosettes were 
noted before or after stripping when unsensitised or F(ab')g sensi­
tised chicken erythrocytes were used. Following culture, similar 
results were seen irrespective of which enzyme was used for proteo­
lysis; normal percentages of EA were detected but there was noRi
significant regeneration of agg G receptors. These workers suggest
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that heterogeneity exists among lymphocyte FcRs since they differ 
in susceptibility to proteolysis and re-expression and that lympho­
cytes may have unexpressed receptors which are exposed by pronase. 
Horwitz and Lobo (1975) also showed receptors for agg G to be 
pronase labile but reported regeneration of receptors following 
culture; these workers used lower pronase concentrations.
Three types of FcR positive cells were characterised by immuho-
fluorescent studies using rabbit allotype/anti allotype complexes
(Winfield, Lobo and Hamilton, 1977). Pronase sensitive, trypsin
resistant cells formed 10-15% of peripheral blood lymphocytes and
were identical to EA„. forming cells. Cells with low density FcRK1
comprised 50% of the sIgM positive cells and /v/10% of T cells while 
the very low density FcR positive cells comprised ̂ 15% of peripheral 
blood T and B cells. All T and B cells were pronase and trypsin 
sensitive. Pichler and Knapp (1978) have shown tonsil B lymphocytes 
to be trypsin and pronase sensitive also.
Winchester and associates (1979) used six different immune 
complex test systems for the detection of FcRs. No one system was 
optimal for FcRs on all types of lymphocytes. Thus IgG/anti-IgG 
complexes and agg G gave highest binding of non-T cells while Ty 
cells reacted better with ovalbumin/anti-Ovalbumin and Keyhole Limpet 
haemocyanin (KLH)/anti-KLH complexes. Digestion with graded con­
centrations of pronase revealed that FcRsdemonstrable by sensitised 
ox erythrocytes and KLH/anti-KLH complexes were more susceptible 
to digestion than those detected by IgG/anti-IgG complexes. The 
authors suggest that FcRson T and null cells differ from those on 
B cells. Clements and Levy (1978) used four methods of FcR detection
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and concluded that B lymphocytes require higher concentrations of 
IgG for detection.
It is apparent that some confusion exists in the literature 
although most workers agree that B and null lymphocyte FcyRs 
differ both in their ease of detection and their susceptibility to 
proteolysis.
Another enzyme which is often used in the separation of T and 
B cells by E rosette depletion is neuraminidase. Increasing con­
centrations of this enzyme have been shown to selectively deplete 
IgMFcR and increase IgGFcR. The F ^ R  is re-expressed after incubation; 
this re-expression is a result of active synthesis since it is 
prevented by cycloheximide. Neuraminidase treated lymphocytes
can express FcyR (Schulof et al, 1980).
Other Methods Demonstrating FcR Heterogeneity
Human lymphocyte Fc heterogeneity with ^a. microglobulin (^^)  
has been demonstrated. Partial inhibition of agg G binding by anti- 
^ ^ m  occurred on human tonsil and peripheral blood lymphocytes (Grey 
et al, 1975). Other workers have demonstrated EA rosette inhibition 
by a n t i - ^ m  (Sarmay, Sanderson and Ivanyi, 1979). Enhanced EA 
rosette formation was achieved by the addition of and this en­
hanced binding was attributed to Tŷ  cells. Addition of anti-^a^r*\ 
abrogated the response (Birch, Fanger and Bernier, 1979).
Temperature shift exper I ments have distinguished two types 
of FcjjR on peripheral blood mononuclear cells. Type FcRI is shed
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following a temperature shift from 4°C t<> 37 C and is located on 
FcR positive cells with a low cellular avidity to EA while FcRII 
is not shed following temperature shift. Tbe shed FcRs interact 
with IgG but not IgM (Sandor et al, 1 9 7 8 ;1^79).
(iii) Functional Capacity of FcR Positive Cell*_ In
The most easily demonstrable and thus the most extensively 
studied function of FcR positive cells is that of antibody dependent 
cellular cytotoxicity (ADCC). Macrophages, monocytes and K lympho­
cytes are all capable of lysing antibody coated target cells and 
all bear FcRs. Monocytes active in ADCC have been shown to be of 
large size (Norris et al, 1979). Kurlander (1980) demonstrated that 
IgG can inhibit the in vitro monocyte mediated lysis of IgG coated 
erythrocytes but monocyte function is restored following washing. 
There is cross-reactivity between IgG from different species that 
induce K cell activity; for example, guinea pig IgG can induce ADCC 
by human K cells (Perlmann et al, 1975).
It has been suggested that ADCC is sn in vitro phenomenon. 
MacLennan and co-workers (1973) showed that fresh human serum did 
not inhibit K cell activity against Chang Cell targets; however, 
monomeric IgG isolated by salt precipitation and DEAE chromato­
graphy blocked ADCC, and heat aggregation only slightly increased 
the blocking capacity. All four subclasses of human IgG inhibited 
K cell lysis of Chang liver cells; similar results were obtained 
using chicken erythrocytes although IgG 2 and 4 were found to be 
less effective inhibitors than IgG 1 and .'I (Spiegelberg, Perlmann 
and Perlmann, 1976). No inhibition was noted with human F(ab )g
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(Larsson, Perlmann and Natvig, 1973). MacLennan, Connell and Gotch
(1974) showed that K cells specifically bound the CH3 region of IgG 
since anti-Chang Facb but not anti-HSA Facb inhibited K cell activity 
to Chang cell targets. Ziegler and Henney ( 1 9 7 7 ) in contrast to 
MacLennan and associates (1974) found that, using (Zhang cell targets, 
aggregates were much more effective inhibitors of ADCC than mono­
meric IgG; incubation of lymphocytes with aggregated IgG followed 
by washing still produced marked inhibition. The order of effective­
ness was as follows: cell associated immunoglobulin (Ig) >  immobilised 
immune complexes (i.e.) >  insoluble i.e. >  soluble i.e. > heat 
aggregated IgG (agg G) ^  monomeric Ig.
Gormus, Woodson and Kaplan (1978b) showed that incubating 
lymphocytes with pronase or papain produced no significant inhibition 
of ADCC against chicken erythrocytes whereas agg G almost totally 
abolished the ADCC of untreated lymphocytes and diminished the 
ADCC of enzyme treated cells. These authors concluded that peri­
pheral blood lymphocytes active in ADCC have agg G and EA receptors 
and that K cells deficient in a functional agg G FcR (enzyme treated) 
can induce normal ADCC. As previously reported, Schulof and 
colleagues (1980) demonstrated selective depletion of F ^ R  and en­
hanced expression of Fc^R following neuraminidase treatment of human 
lymphocytes; however, this modulation of FcR phenotypes had no 
effect on ADCC against K562 target cells.
Spontaneous cell mediated cytotoxicity (SCMC) is effected by 
natural killer (NK) cells which also bear FcyRs (Santoli et A * *
1978; Gupta et al, 1978; Kay and Horwitz, 1980). However, tt'O 
FcRs on NK cells are not required for cytotoxic activity sin»”  ̂̂
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has been shown that treatment with trypsin or the addition of 
protein A will block ADCC but not SCMC (Kay, Bonnard, West and 
Herberman , 1977); interaction of lymphocytes with immune com­
plexes (modulation) also abolishes ADCC but not S C W C  (Pape,
Moretta, Troye and Perlmann, 1979). Murine NK cells express a 
Ly5 phenotype and it has been postulated that interferon, produced 
by Ly5 positive cells, acts on Ly5 negative precursor cells to 
induce their differentiation into functional NK cells (Minato et 
al, 1980). Similar conclusions have been drawn following experi­
mentation with human lymphocytes (Saksela, Timonen and Cantell, 1979) 
Supernatants of human lymphocyte/target cell co-cultures augmented 
the NK activity of virgin lymphocyte populations. Interferon was 
detectable in the supernatants and was found to induce natural cyto- 
toxocity in a subpopulation of lymphocytes devoid of 'mature' NK 
cells.
FcRs have been implicated in the regulation of immune responses. 
Using murine spleen cells, Ryan and others (1975) showed that lipo- 
polysaccharide (LPS) could not stimulate mitogenesis in the presence 
of immobilised IgG-IgG complexes. No similar inhibition was 
noted with immobilised IgG-F(ab')g complexes, soluble complexes 
or soluble IgG. A direct competition with FcR did not occur since 
pre-incubation with mitogen did not inhibit binding of agg G . These 
workers suggest that complex binding may produce an alteration of 
the cell membrane so that LPS cannot bind or may cause unresponsive­
ness. Oberbarnscheidt and K^lsch (1978) demonstrated that the anti­
sheep red blood cell response of murine spleen cells could be 
suppressed by the addition of specific antigen/antibody complexes; 
a lack of suppression was shown when the F(ab')g fraction of anti-
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body was used. The suppressive effect was shown to be T-cell 
independent indicating that the B cell FcR can influence B cell 
IgM antibody production.
In contrast to their suppressive effects, FcRs also appear to 
have accessory function. Carvalho, Davis and Horwitz (1980) noted 
a requirement for FcRs in the enhanced blastogénie response to KLH- 
anti KLH complexes by sensitised human lymphocytes and postulated 
the presence of an FcR bearing accessory cell. Lobo (1981) showed 
that positive or negative influences can be mediated by the same 
cell depending on the state of Fc-receptor stimulation; L cells 
modulated by immune complexes had suppressor effect while unmodulated 
cells enhanced immunoglobulin synthesis. Thus FcR bearing cells 
appear to be important regulators of Ig synthesis.
Phagocytosis by both neutrophils and monocytes appears to be 
mediated, at least in part, by FcRs. Monocyte phagocytosis is 
inhibited by heat aggregated IgG, IgGl and IgG3 while F (ab ' ) 2  
fragments and IgG2 and 4 have no effect (Larsson, Perlmann and 
Natvig, 1973). The FcR involved in this inhibition is not species 
specific; guinea pig IgGl and 2 can induce human monocyte phago­
cytosis in monomeric form and inhibit phagocytosis when complexed.
This may be ^elated to receptor heterogeneity (^hlander, Larsson 
and Perlmann, 1978). Neutrophil phagocytosis can be blocked by 
monomeric IgGl and 3 (Henson, 1977). In aggregated form IgGl,
2 and 3 will inhibit phagocytosis; aggregates of intermediate size 
eluted from a Sepharose 6B column were found to be the most efficient 
in blocking neutrophil phagocytosis (MacLennan et al, 1973).
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The data provided in this and previous sections is summarised 
in table 1.4.
(iv) Characterisation of Fc Receptors and Immunoglobulin Binding
Owing to the heterogeneity of Fc receptors, previously described, 
it is not surprising that characterisation of the receptors has 
yielded inconsistent results. The receptor has been described as 
glycoprotein or lipoprotein in nature and molecular weights ranging 
from 15,000 to 130,000 daltons have been quoted. Controversy has 
also arisen concerning the site of attachment of the immunoglobulin 
molecule itself; different cells appear to bind different immuno­
globulin domains. A few examples of FcR characterisation and FcR 
binding will be given in this section.
Wilkinson (1977) incubated several cell types with sphingo­
myelinase C and other lipid-specific agents; the binding of antibody 
coated chicken erythrocytes to human lymphocytes and monocytes and 
the binding of neuraminidase treated EA to human neutrophils was 
inhibited. It is apparent that membrane lipids are important con­
stituents of the binding sites for Fc fragments on human leucocytes 
and sphingomyelin may play an important role in binding. Yagawa,
Onoue and Aida (1979) isolated guinea pig peritoneal macrophage FcRs 
and found that phospholipase C (PLC) inhibited the activity of 
isolated receptors; these workers suggest that phospholipids may 
be required as structural supports for FcR activity. Suzuki (1981) 
has shown that the human B cell FcR has bound phospholipid and 
exhibits phospholipase A^ activity.
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Anderson and Grey (1977) investigated the FcRs of guinea pig 
and mouse macrophages, various mouse cell lines and mouse thymocytes 
and splenocytes. Detergent cell lysates were assayed for FcR 
activity and a strict correlation was found between the lysates 
and intact cells in terms of agg G binding. Enzymes which inhibited 
IgG uptake (PLC, papain, trypsin) also inhibited soluble FcR 
activity. In all cell lysates except those of mouse macrophages, 
isolated soluble FcR density was similar to that of serum high 
density lipoproteins. Phospholipase D and A did not alter soluble 
FcR activity. The authors postulate a lipoprotein nature for FcRs 
rather than steric hindrance by lipid associated membrane components.
The use of enzymes has led to the discovery of multiple FcRs 
on single cell types. Thus mouse macrophage cell lines have been 
shown to express a trypsin sensitive FcR and a trypsin resistant 
FcR which binds complexed rabbit IgG; monomeric rabbit IgG did not 
bind to the trypsin resistant receptor while the trypsin sensitive 
receptor bound both monomeric and complexed murine IgG 2a (Unkeless, 
1977). More recently, a third FcR has been identified on mouse 
macrophages; this is specific for mouse IgG 3 and is also trypsin 
resistant (Diamond and Yelton, 1981).
The Fc region of immunoglobulin is composed of two domains,
Cjj2 and Cjj3 (Fig. 3.1). It is generally accepted that the C ^ 2  
domain is the site of complement fixation (Connell and Porter, 1971) 
but it has also been suggested that this domain may be involved in 
binding to FcRs.
Klein and colleagues (1977), using activated murine T cells
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as the source of FcR, showed that the major site of binding on the 
IgG was localised to the Cy3 domain. However IgG and purified Cy3 • 
and Cy2 fragments all bound but FCab*)^ fragments did not. It 
was concluded that there may be a co-operative inter-domain site 
produced through quartemary binding. Other workers, using guinea 
pig lung macrophages, showed that IgG and Facb sensitised erythro­
cytes were equally effective in forming rosettes and papain 
derived Cy3 fragments did not inhibit the binding of IgG sensitised 
erythrocytes. Two possibilities were suggested, either both 
domains contribute contact residues or one domain stabilises the 
binding site of the other (Ovary, Saluk, Quijada and Lamm, 1976).
Human leucocyte FcR binding sites have been studied. Spiegelberg
(1975) obtained an IgGl myeloma protein with a deletion in the C^3 
domain. This protein formed two half molecules consisting of one 
heavy and one light chain. These half molecules did not bind Clq 
or bind to the FcPs of human lymphocytes, neutrophils or monocytes 
or guinea pig mast cells. However when aggregated, complement 
fixation and binding to lymphocytes, monocytes and neutrophils was 
observed. It was postulated that IgGl may have several (at least 
two) sub-molecular binding sites which are localised on the Cy2 
and Cy3 domains. Proteins with both sites could bind to Clq and 
FcRs in unaggregated form whereas proteins having a site on only 
one domain would need to be aggregated in order to bind. Ciccimara, 
Rosen and Merler (1975) also utilised myeloma proteins with deletions. 
They found that the primary site of attachment of human monocytes 
was in the C ^ 3  domain since myeloma IgGl and 3 proteins with deletions 
in the region showed unimpaired ability to bind. The binding
site was localised to a ten amino acid peptide within the Cy3 domain.
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In contrast, Alexander, Andrews, Leslie and Wood (1978) showed 
that pepsin derived pFc' fragments poorly inhibited either EA 
rosette formation or uptake of labelled human IgG by human
monocytes.
Ripley rosettes were strongly inhibited by Fc and even more 
strongly by the Fch fragments: of IgG3. No inhibition was observed 
when Fab, F(ab ' ) 2 o r  pepsin derived pFc* fragments were added to 
the lymphocytes. Thus it appears that third population lymphocyte 
FcRs bind primarily the Cy2 region (Fr^land et al, 1974). This is 
interesting since, as previously described, third population lympho­
cytes have K cell activity. MacLennan, Connell and Gotch (1974) 
found no inhibition of K cell activity when anti-HSA Facb was added 
suggesting that E cells bind primarily the Cy3 region of IgG. The 
myeloma protein, previously described, weakly inhibited K cell 
activity (Spiegelberg, Perlmann and Perlmann, 1976).
It is obvious from this brief section that the role of Fc receptors 
in immunological mechanisms is unclear. However the presence of 
these receptors on many cell types, their heterogeneity and ease 
of modulation, argues their importance. In rheumatoid arthritis 
there is an abnormal response to IgG and this reactivity has been 
attributed to the C^2 region (Johnson and Faulk 1976; Hall, 1978). 
However it is possible that it is not the IgG which is altered but 
the binding site. In this thesis, abnormal binding of IgG by 
rheumatoid lymphocytes will be reported. Part of this work has 
been published elsewhere (Hall, Winrow and Bacon, 1980).
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C H A P T E R  2
MATERIALS AMD METHODS
9 1
S E C T I O N  1 
M A T E R I A L S
All chemicals were obtained from the British Drug Houses Ltd., Poole, 
unless otherwise stated.
All media reagents were obtained from Gibco Bio-Cult Ltd., Scotland, 
except those listed below.
MATERIALS SUPPLIER
Bio Beads SM2 (20-50 mesh) Bio-Rad Laboratories Ltd., 
Bromley, Kent
Carbonyl Iron Powder (type SF) GAP (G.B.) Ltd., 
Wythenshawe, Manchester
Pokeweed Mitogen (lyophilised; 




Plasmin (human from Cohn fraction I ; 
lyophilised)
Kabi Vitrum Ltd., 
Ealing, London
Concanavalin A (lyophilised; from 
the jack bean Canavalia ensiformis)
Pharmacia (G.B.) Ltd., 
Hounslow, Middlesex
FiCO11-Paque (density 1.077 
- 0.001 g/cm )
Helix Pomatia Lectin-Sepharose 6MB 
Protein A - Sepharose 4B 
DEAE Sephadex A50
Sephadex GlOO (fractionation range 
4,000 - 150,000 daltons)
Sepharos^ CL 6B (fractionation 




(Methyl - H) Thymidine
Specific activity 5 C i /mmol 21 mCi/mg
Radioactive concentration 1 mCi/ml
Sodium Chromate (^^Cr) Solution 
Specific activity 250-500 ^Ci/^g
SUPPLIER
Radiochemical Centre Ltd., 
Amersham, Bucks.
Hyaluronidase (Type II; ovine testes; Sigma Chemical Co. L td.,
lyophilised) Poole, Dorset
Neuraminidase (Type VI; Clostridium 
perfringens; lyophilised)
Phospholipase C (Type I ; Clostridium 
welchii; lyophilised)
Pepsin (hog stomach mucosa; lyophilised)
Papain (Papaya latex; x 2 crystallised; 
suspension in 0.05M sodium acetate pH 4,5)






Calf Blood in Alsevers Solution 
(Animal No. 21)
Sheep Blood in Alsevers Solution
(both obtained fresh fortnightly)
Tissue Culture Services Ltd., 
Slough, Berks.
Hanks Balanced Salt Solution 
(x 10 concentrate)
Phytohaemagglutinin (purified from 
Phaseolus spp.; lyophilised)
Wellcome Reagents Ltd., 
Hither Green, London
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ROUTINE BUFFERS AND MEDIA
10/150
O.IM disodium hydrogen phosphate 
O.IM potassium dihydrogen phosphate
The above solutions were mixed to pH 7.4 and the resulting phos­
phate buffer diluted 1 in 10, incorporating 8.77 g/litre of sodium 
chloride (150mM). The solution was stored at 4°C when not in use.






Potassium dihydrogen phosphate 0.600
Disodium hydrogen phosphate 0.475 pH 7.3
The concentrate was filter-sterilised using a 0.45yUL m filter 
(Millipore) and stored at 4°C, being diluted immediately before 
use. The pH was corrected with IM sodium hydroxide solution if 
necessary.
Phosphate Buffered Saline (PBS)
X 10 concentrate
g/litre
Sodium chloride 80 ; 00
Potassium chloride 2.00




The above concentrate was filter sterilised, stored at 4 C and 
diluted immediately before use incorporating
Calcium Chloride 
Magnesium Chloride
The pH was adjusted if necessary
0.1 g/litre 
0.1 g/litre pH 7.4
Lymphocyte Medium
RPMI 1640 (x 10 concentrate)
200 mM glutamine (GLN)
Penicillin/Streptomycin Solution 
(5,000 I.U./ml of each; P/S)









The medium was prepared using sterile distilled water, adjusted 
to pH 7.3 with sterile IM sodium hydroxide and stored at 4°C.
K562 Medium
RPMI 1640 (x 10 concentrate)
200 mM GLN 
P/S









Sterile distilled water was used in the preparation, the pH 
adjusted with sterile IM sodium hydroxide when necessary and the 
medium stored at 4°C.
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Hanks Balanced Salt Solution (HBSS)
HBSS (x 10 concentrate) was diluted with sterile distilled 
water and brought to pH 7.4 with sodium bicarbonate solution or 4% 
tris hydroxymethyl methylamine (TRIS) solution.
Scintillation Fluid
To 2.5 litres of toluene was added :-
12.50 g 2,5 - Diphenyloxazole (PPG)
0.75 g 1,4 - Di-2-(4-methyl-5-phenyloxazolyl)
benzene (POPOP)
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S E C T I O N  I I  
M E T H O D S
(i) PREPARATION, HEAT AGGREGATION AND ENZYMIC DIGESTION
OF IMMUNOGLOBULIN G (IgG)
PREPARATION OF IgG
(a) AFFINITY CHROMATOGRAPHY - Protein A-Sepharose CL-4B (see Fig. 2.1)
Protein A is a protein isolated from the cell wall of 
Staphylococcus aureus and has been demonstrated to be a useful 
immunosorbent for the isolation of IgG (Hjelm, Hjelm and Sjoquist, 
1972). Human IgG subclasses have been studied; only IgG3 is not 
bound by protein A (Kronvall and Williams, 1969). The binding is 
specific for the Fc region of the IgG molecule (Forsgren and 
Sjoquist, 1966; Kronvall and Fromell, 1970), More recently,
Stewart, Varro and Stanworth (1978), using rabbit IgG enzymic 
cleavage products, were unable to demonstrate reactivity of either 
Facb or p F c ' fragments with staphylococcal protein A; this property 
can be exploited in the preparation of Facb (described later in this 
section). Protein A can also interact with subclasses of IgG of 
species other than humans and rabbits (Goudswaard et al, 1978; 
Chalon, Milne and Vaerman, 1979) and may bind other human immuno­
globulins (Brunda, Minden and Grey, 1979).
A commercial preparation of protein A, covalently coupled to 
Sepharose CL-4B by the cyanogen bromide method, was used for the 
majority of IgG preparations. The swollen gel contains 2 mg/ml of 
protein A with a binding capacity for human IgG of approximately 
25 mg IgG/ml gel. A column (0.9 x 15 cm, Pharmacia K 9 ) , containing
Fig. 2.1
PREPARATION OF IMMUNOGLOBULIN G (IgG) AND ITS 
PLASMIN DIGESTION PRODUCTS BY COLUMN CHROMATOGRAPHY
Protein eluted from the columns was measured by absorbance 
at 280 nm. Typical elution profiles are shown opposite.
Legend
f' material from first column applied to second column.
IMMUNOGLOBULIN G (IgG)
Immunoglobulin G was prepared by affinity chromatography on 
protein A-Sepharose 4B (PrA-4B) as described in chapter 2 ,  section 
II (i). The IgG containing fractions (shaded) were pooled, concen­
trated and applied to a Sepharose CL-6B column (6B). Monomeric IgG 
was pooled and concentrated.
PLASMIN
IgG prepared by affinity chromatography (above) was incubated 
with human plasmin (chapter 2, section II (i) and the digest 
fractionated on Sephadex GlOO (GlOO). The protein eluting in the 
void volume comprising Facb fragments and unreacted IgG (shaded) 
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approximately 5 ml of swollen gel was prepared; serum (2-5 ml) was 
applied to the column and eluted with 10/150 to remove contaminating 
serum proteins. The bound IgG was then eluted with IM acetic acid 
and the acid fraction concentrated over an Amicon Diaflo XM50 mem­
brane (nominal exclusion limit 50,000 daltons). All separations 
were carried out at a temperature of 4°C. The acid concentrate was 
then loaded on to a Sepharose CL6B column and eluted with 10/150 
at a flow rate of 8 ml buffer/hour, collecting 4 ml fractions. 
Monomeric IgG fractions (assessed from an trace) were pooled,
concentrated as above and total protein measured using the Folin- 
Ciocalteu method (Lowry et al, 1951).
(b) ION-EXCHANGE CHROMATOGRAPHY - Diethyl aminoethyl (DEAE) Sephadex
Myeloma sera, which may contain large amounts of IgG and so 
swamp the protein A column were separated using DEAE Sephadex by a 
modification of the method of Ishizaka and co-workers (1965).
DEAE Sephadex was swollen in 10 mM phosphate buffer pH 6.5, 
containing 0.01% sodium azide and stored at 4°C until required. A 
small amount of the suspension was filtered on a Buchner funnel and 
washed extensively with 10 mM phosphate buffer pH 6.5 without azide. 
The cake of Sephadex was added to the serum to form a paste and 
stirred for 1 hour at 4°C. Thé suspension was then filtered, using 
a Buchner funnel, and washed with the phosphate buffer. The fil­
trate was concentrated over an Amicon Diaflo membrane, as before, 
and dialysed against 10/150. Protein was assayed by the Folin 
Ciocalteu method.
1 0 0
In all cases, a small volume of the concentrate was applied 
to the Sepharose CL-6B column to check for aggregation. The yield 
was not as good as with the protein A column but, since myeloma 
sera were used, this was not a problem.
HEAT AGGREGATION OF IgG
Heat aggregated IgG (HAGG) was prepared by maintaining an IgG 
solution at 63°C for periods of time varying from 10 to 60 minutes. 
Aggregation times are quoted for individual experiments.
ENZYMIC DIGESTION OF IgG
(a) PREPARATION OF F(ab')_ - PEPSIN (see Fig. 2.2)
Pepsin digestion was carried out according to Nisonoff 
Markus and Wissler (1961).
IgG was prepared on protein A Sepharose 4B (described previously 
in this section), dialysed against O.OIM acetate buffer pH 4.5 for 
4 hours at 4°C and adjusted to 10-30 mg/ml. A solution of 1 mg 
pepsin/ml acetate buffer was prepared, added to the dialysate to 
give an enzyme/substrate ratio of 1:100 and the solution was in­
cubated for 22 hours at 37°C. Pepsin was inactivated by the addition 
of solid Tris (hydroxymethyl) methylamine (TRIS) to a pH of 8.0 and 
the digest was fractionated on a column of GlOO Sephadex, using 
10/150 as eluant. The protein eluting in the void volume was pooled, 
concentrated and applied to the protein A Sepharose 4B; the unbound 
protein fractions (F(ab')^) were pooled, concentrated and assayed 
for protein.
Fig. 2.2
ENZYMIC DIGESTION PRODUCTS OF IMMUNOGLOBULIN 
G (IgG) PREPARED BY COLUMN CHROMATOGRAPHY
Protein eluted from the columns was measured by absorbance at 
280 nm. Typical elution profiles are shown opposite.
Legend
/ y /  material frcan first column applied to second column
material from second column applied to third column
PEPSIN
A pepsin digest of IgG (chapter 2, section II (i)) was applied 
to a Sephadex GlOO (GlOO) column. Unreacted IgG and F(ab ' ) 2 fragments 
(shaded) were separated by affinity chromatography.
PAPAIN
IgG was treated with papain (chapter 2, section II (i)) and 
fractionated on Sephadex GlOO (GlOO). The Fab and Fc fragments, 
being of similar molecular weight, fractionate together (shaded) 
and were therefore pooled and separated by affinity chromatography 
on protein A-Sepharose 4B (PrA-4B),. Any unreacted IgG, which may 
peak with the fragments, will adhere to protein A together with the 
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(b) PREPARATION OF Fab and Fc - PAPAIN (see Fig. 2.2)
Papain digestion was carried out using a slight modification of 
the method described by Porter (1959).
IgG was prepared on protein A-Sepharose 4B. Ethylene diamine tetra 
acetic acid (EDTA) and cysteine were added to the IgG solution, the pH 
corrected to 7.0 with IM sodium hydroxide solution and the volume ad­
justed to give final concentrations of cysteine and EDTA of O.OIM and 
0.002M respectively in 10-30 mg/ml of IgG solution. Papain was added 
to produce an enzyme/substrate ratio of 1:100 and the solution was in­
cubated at 37°C for 16 hours. The enzyme reaction was terminated by 
the addition of iodoacetamide to O.OIM and the digest was applied to a 
GlOO Sephadex column. Protein was eluted with 10/150 at 8 ml/hr and 
4m1 fractions were collected. The Fab and Fc fragments, being of similar 
molecular weight, are excluded from the column in the same fractions and 
must, therefore, be separated using the protein A-Sepharose 4B column, 
thus Fab fragments were eluted in the phosphate (unbound) fraction and 
Fc fragments in the acid (bound) fraction. The acid concentrate was 
further purified on GlOO Sephadex to remove any unreacted IgG, if present.
(c) PREPARATION OF Facb AND pFc' - PLASMIN (see Fig. 2.1)
Facb and pFc* were prepared as described by Stewart, Smith and 
Stanworth (1973).
IgG was prepared by affinity chromatography on protein A-Sepharose 
4B. The concentrated acid fraction was immediately adjusted to pH 2.7 
with IM hydrochloric acid (HCl) and maintained at 37°C for 1 hour.
10 4
After Incubation, the pH was adjusted to 7.0 with IM sodium hydroxide
and human plasmin was added (3 CU/100 mg IgG). The solution was
incubated at 37°C for 4 hours, with shaking, and the digest then
applied to a Sephadex GlOO column and eluted with 6M urea in O.IM
acetate buffer pH 4.6 at a flow rate of 8 ml/hr; fractions of 4 ml 
volumes were collected. The protein eluted in the void volume 
(i.e. Facb and unreacted IgG) was concentrated and dialysed against 
10/150 for 4 hours at 4°C before loading on to the protein A-Sepharose 
4B column. Since Facb does not. bind to protein A (Stewart, Varro 
and Stanworth, 1978), this fragment was eluted in the phosphate 
fraction whilst residual IgG bound to the affinity column. The 
p F c ’ fragments were recovered from the GlOO column and the concen­
trate dialysed against 10/150 before storage and use. Protein was 
assayed using Folin-Ciocalteu's solution.
The purity of the Facb preparation was checked using a standard 
Ouchterlony immunodiffusion method. A commercial donkey anti-rabbit 
whole serum was used and also an antiserum to rabbit pFc', kindly 
donated by Dr. I. M. Hunneyball (Boots Co. Ltd., Nottingham). The 
Facb preparation gave a single precipitin line against the anti­
rabbit serum, but did not react with the anti-pFc’.
(ii) LYMPHOCYTE PREPARATION
(a) WHOLE BLOOD
Lymphocytes were separated by the isopaque ficoll method of 
Boyum (1968; 1976).
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Heparinised venous blood (30 I.U. heparin/ml blood) was mixed 
1:1 with CMFSS and carefully layered on to Ficoll-Paque in unsili- 
conised conical glass centrifuge tubes. Approximately 3 ml Ficoll- 
Paque was used to 6 ml of diluted blood. Diluting the blood helps 
to prevent aggregation of erythrocytes, thus eliminating trapping 
of lymphocytes and producing higher yields. The tubes were then 
centrifuged at 400 g in a temperature controlled MSB Mistral 2L 
centrifuge at 20°C for 30 minutes. During this period, erythrocytes, 
agglutinated by the ficoll, and granulocytes, which became dense 
due to ingestion of sodium diatrizoate, sedimented to the bottom 
of the tube while the lymphocytes, monocytes and platelets remained 
at the interface.
The lymphocyte rich interface layer was removed using a pasteur 
pipette, transferred to a clean centrifuge tube and washed three 
times with CMFSS by careful resuspension and pelleting at 400 g 
for 10 minutes.
(b) SYNOVIAL FLUID
Heparinised synovial fluid (30 I.U./ml fluid) was treated with 
hyaluronidase (0.15 NF Units/ml fluid) for 30 minutes at 37°C prior 
to dilution and separation as described for whole blood.
CARBONYL IRON TREATMENT
In some instances, whole blood was pretreated with carbonyl iron 
to produce a lymphocyte preparation depleted of mononuclear phagocytes 
Carbonyl iron powder was added to whole blood at a concentration of
10 6
20 mg/ml and mixed for 30 minutes at 37°C before diluting 1:1 and 
separating on Ficoll-Paque as previously described. Care was taken 
to transfer as little carbonyl iron as possible to the Ficoll-Paque 
gradient to avoid trapping of lymphocytes. Using the above carbonyl 
iron concentration^ 0.5% monocytes were present in the interface 
lymphocyte preparation judged by esterase staining (Section II (v)) 
of fixed smears (200 cells counted).
CELL COUNTS AND VIABILITIES
Counting fluid comprising 3% acetic acid/0.1% methylene blue 
was used for leucocyte counts. An aliquot of the cell suspension 
was diluted with counting fluid, causing lysis of erythrocytes, and 
cell numbers were enumerated using a Neubauer haemocytometer.
Viabilities were assessed by the trypan blue exclusion method. 
Viable cells exclude the stain but non viable cells are unable to 
do so and thus appear dark blue. The trypan blue technique is not 
a sensitive test of damage to lymphocytes since some non staining 
cells may appear, under phase contrast, to be in an advanced state 
of degeneration (Tennant, 1964).
(iii) ROSETTE TECHNIQUES
SHEEP ERYTHROCYTE (E) ROSETTES
(a) Materials
Sheep blood in Alsevers solution
Absorbed heat inactivated new born calf serum (AHINBCS) 
To 1 ml of washed (x3) packed sheep blood
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was added 9 ml HINBCS. The suspension was 
well mixed and maintained at 4°C for 16 
hours. The serum was then spun at 400 g 
for 10 minutes and the supernatant stored 
in 0.5 ml aliquots at -20°C.
(b) Preparation of Sheep Blood
A small volume (^Iml) of sheep blood was washed three times 
(x3) with phosphate buffered saline (PBS), the final supernatant 
being removed carefully using a pasteur pipette. To 0.5 ml of 
AHINBCS was added 0.025 ml of packed cells and the volume was made 
up to 5 ml with PBS.
(c) Preparation of Neuraminidase Treated Sheep Erythrocytes (SRBC)
In some instances (e.g. rosette depletions), the sheep blood 
was treated with neuraminidase; this forms a more stable rosette.
Sheep blood was washed three times (x3) in PBS as above and 0.05 Units 
of neuraminidase were added to approximately 0.5 ml of packed cells.
The volume was made up to 5 ml with PBS and the solution incubated 
for 30 minutes at 37°C. Following a further three washes with PBS, 
the erythrocytes were prepared as above to produce a 0.5% v/v 
suspension in PBS containing 10% AHINBCS.
(d) Preparation of Rosettes
Washed lymphocytes, prepared by isopycnic centrifugation on 
Ficoll-Paque, were adjusted to 2 x 10^/ml and equal volumes ( . 2 0 0 ^ 1 )  
of lymphocytes and SRBC suspension were mixed in stoppered, plastic
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round-bottomed tubes (LP3-Luckham). Incubation at 37°C for 10 
minutes was followed by centrifugation at 200 g for 3 minutes.
The pelleted tubes were then maintained at 4°C for 2 hours before 
addition of 2 drops of a 0.2% solution of crystal violet in PBS.
The tubes were resuspended for 1 minute using a rotary turntable 
(20 rpm; Baird and Tatlock Ltd.) and placed in a counting chamber 
(Neubauer). Lymphocytes (stained violet) surrounded by 3 or more 
erythrocytes were scored as rosettes and the percentage of rosetting 
cells was calculated from the observation of 200 lymphocytes.
When using neuraminidase treated erythrocytes, only 45 minutes 
incubation at 4°C was required for rosette formation.
COMPLEMENT (C3) ROSETTES
(a) Preparation of C3b coated erythrocytes
A 10% sucrose solution was prepared containing 0.008 g calcium
chloride and 0.0085 g magnesium chloride in 500 ml. To 30 ml of
this solution was added 3 ml of fresh blood from a healthy 0 rhesus
negative donor and the suspension was mixed gently for 10 minutes 
oat 37 C (rocking turntable). Red cells were washed x 3 with copious 
amounts of PBS and a 1% v/v suspension of erythrocytes in PBS was 
prepared (0.1 ml packed cells in 9.9 ml PBS).
The low ionic strength buffer enhances coating of erythrocytes 
with C3b (Stratton and Rawlinson, 1974; Freedman and Mollison, 1976). 
The cells wefe kept on ice when not in use.
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(b) Rosettes
Lymphocytes at a concentration of 2 x 10^/ml CMFSS and the 1% 
red cell suspension were mixed 1:1 in LP3 tubes, sedimented at 200 g 
for 3 minutes, incubated at 4°C for one hour and the rosette 
preparations stained and counted as for E rosettes.
ERYTHROCYTE-ANTIBODY (EA) ROSETTES
(a) Materials
Calf blood in Alsevers solution 
Rabbit anti-calf erythrocyte IgG
Prepared by affinity chromatography 
(Section II (i)) of rabbit anti-calf 
erythrocyte serum (see below).
(b) Preparation of anti-calf erythrocyte (RBC) serum
The antiserum was raised in rabbits by a number of different 
techniques :-
Repeated intravenous injections of washed calf RBC
Repeated intradermal injections of washed calf RBC 
emulsified 1:1 with Freund's incomplete adjuvant
Repeated intradermal injections of washed calf RBC 
with heat killed Mycobacterium tuberculosis
In all cases, the animals were bled after four weeks and the 
serum separated and frozen.
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(c) Preparation of sensitised erythrocytes
Calf blood (0.5 - 1.0 ml) was washed three times with PBS, 
pelleted and the final supernatant removed carefully with a pasteur 
pipette. A 2% v/v suspension of calf erythrocytes was prepared 
(i.e. 0.2 ml packed cells in 10 ml PBS).
Antibody coated (sensitised) calf RBC were prepared by mixing 
equal volumes of the 2% calf RBC suspension and the required dilution of 
antibody solution and incubating at 37°C for 30 minutes. An optimum 
sub-agglutinating concentration was determined for each rabbit anti 
calf RBC IgG preparation and this was used for assessing total EA 
rosette numbers. The sensitised cells were sedimented at 200 g, 
washed three times with PBS and made up to volume with PBS resulting 
in a 1% suspension of antibody coated calf erythrocytes.
(d) Rosettes
Prepared, washed lymphocytes were adjusted to 2 x 10^/ml 
CMFSS and equal volumes (100 - 200yucl) of lymphocytes and 1% 
sensitised calf erythrocytes were mixed in LP3 tubes sedimented 
at 200 g for 3 minutes and maintained at 4°C for one hour.
After incubation, crystal violet solution was added to the 
tubes and the pellets were resuspended and counted as for E rosettes
Facb ROSETTES
Facb rosettes were prepared in the same manner as EA rosettes
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using rabbit Facb anti calf RBC as the sensitising antibody (Hall,
Winrow and Bacon, 1980; Section II (i)).
Sensitised erythrocytes were mixed with lymphocytes in equal 
proportions (100 - 200^1) in the same manner as EA rosettes and 
treated accordingly.
ROSETTE DEPLETION EXPERIMENTS
Mononuclear cells (10 - 20 x 10^) were rosetted in the normal 
manner. After incubation at 4°C for 60 minutes (EA and Facb rosettes) 
or 45 minutes (E rosettes), the pelleted cells were carefully re­
suspended using a pasteur pipette, layered over ficoll/hypaque 
gradients and spun at 400 g for 30 minutes at 20°C. Rosetted cells, 
by nature of their mass, formed a pellet at the base of the tube 
while non-rosetted cells accumulated at the interface. Rosettes were 
set up to analyse depleted and untreated lymphocyte populations.
After E rosette depletion, E rosette positive mononuclear cells 
can be reclaimed from the base of the tube since E rosettes can be 
disrupted by incubation at 37°C. Pelleted cells were incubated 
at 37°C for 20 minutes and then layered to to ficoll/hypaque and 
spun at 400 g for 30 minutes. The centrifuge buckets and tubes 
were warmed to 37°C before use. Interface cells were harvested and
rosettes prepared.
EA and Facb rosetting cells can be reclaimed by lysis of 
erythrocytes with 0.83% ammonium chloride but this may leave pieces
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of erythrocyte membrane on the lymphocyte receptor.
(iv) RECEPTOR STUDIES
ENZYME TREATMENT OF LYMPHOCYTES
(a) Neuraminidase
Isolated, washed mononuclear cells were suspended in 2 ml of 
TRIS buffered Hanks balanced salt solution (TBH) containing 
neuraminidase at a concentration of 5ywg/ml and incubated at 37°C 
for 45 minutes as described by Hammerstrom and associates (1973). 
The cell suspension was then washed twice in PBS containing 0.2% 
human serum albumin and 0.02% sodium azide.
E, EA and Facb rosettes were set up before and after treatment 
with neuraminidase. Cell viabilities were assessed using trypan 
blue (Section II (ii)).
(b) Trypsin
Isolated, washed mononuclear cells at 4 x 10^ cells/ml were
incubated at 37°C for 30 minutes, washed with warm medium (HBSS
containing 20% HINBCS) and subsequently incubated with 0.25%
otrypsin for 30 minutes at 37 C. Cells were then washed in warm medium.
Before setting up E, EA and Facb rosettes, trypsin treated 
and untreated cell populations were washed once in CMFSS and adjusted 
to a concentration of 2 x 10^ cells/ml. Viable cells were enumerated 
using trypan blue. *
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(c) Phospholipase G
Phospholipase C at concentrations 6f 0.1 U/ml, 0.5 U/ml and 
1.0 U/ml was incubated with isolated, washed mononuclear cells 
(4 X 10^/ml) for 30 minutes at 37°C as described by Wilkinson (1977).
Cells were then washed three times in CMFSS, viabilities assessed 
and EA and Facb rosettes were prepared.
Fc RECEPTOR SHEDDING
Mononuclear cell preparations were maintained at 4°C for 30 
minutes and then immediately incubated at 37°C for 30 or 60 minutes 
(Sandor, Fust, Medgyesi and Gergely, 1978). The degree of receptor 
shedding was determined by setting up EA and Facb rosettes on shed 
and untreated populations. Supernatants of shed lymphocytes were 
stored at -20°C.
(v) CELL CHARACTERISATION STUDIES 
BIO BEAD COLUMN CHROMATOGRAPHY
Styrene divynyl benzene beads (Bio Beads SM2) were prepared for 
use as described by Holloway (1973). Briefly, approximately 200 ml 
of methanol was added to 20 g of beads, the mixture stirred for 15 
minutes using a glass rod and the copolymer beads collected on a 
sintered glass funnel (G3; pore size 15 - 4 0 ^ m )  , washed with a 
further 500 ml of methanol and, without drying, washed with one 
litre of distilled water. The moist beads were then slowly washed 
with 500 ml of 10/150 and stored at 4°C in 10/150 containing 0.2%
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sodium azide until required. Immediately before use, the beads 
were washed in azide free 10/150.
The separation procedure used was a modification of the method 
of Pang and Wilson (1978). The washed beads were incubated at room 
temperature with 20% HINBCS in HBSS until the beads became orange 
in colour (approximately 1 hour). A Pharmacia K9 column (15 x 0.9 cm), 
with an SOyum mesh base net, was packed with 8 ml of beads, eluted 
with several volumes of 20% HINBCS/HBSS and allowed to equilibrate 
at 37°C for 30 minutes. Ficoll-Paque prepared lymphocytes (20 x 10^) 
in 2 ml HBSS were applied to the column and incubated for 30 minutes 
at 37°C before eluting with 30 ml HBSS.
E, EA and Facb rosettes were set up using cells before and 
after column separation.
HELIX POMATIA LECTIN - SEPHAROSE 6MB COLUMN CHROMATOGRAPHY
Helix pomatia lectin, prepared from the vineyard snail, binds 
specifically to carbohydrate molecules containing N-acetyl-D- 
galactosamine and has been shown to interact with neuraminidase 
treated human T lymphocytes (Hammarstrom, Hellstrom, Perlmann and 
Dillner, 1973). The property can be exploited to purify peripheral 
blood T lymphocytes using affinity chromatography (Hellstrom et al, 1976).
A commercial preparation of Helix pomatia lectin - Sepharose 
6MB was used in all separations. The swollen beads are of a large 
size (macrobeads) and have a narrow size range (200 - 30(yA_m) to 
ensure minimal trapping of lymphocytes during separation.
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Reagents and Method
(i) PBS - HSA - NaNg
A solution containing 0.2% human serum albumin (HSA) 
and 0.02% sodium azide (NaN^) in PBS
(ii) PBS - HSA - NaNg (as above) + 0 . 1  mg/ml N-acetyl-«t-D-
galactosamine (NADG)
(iii) PBS - HSA - NaN^ (as above) + 1.0 mg/ml NADG
(iv) Tris buffered HBSS (TBH)
(v) Neuraminidase
Approximately 3 ml of gel were transferred to a K9 column, 
fitted with a 80yu.m net, and eluted with 50 ml of PBS - HSA - NaN^ 
buffer at a flow rate of 8 ml/min to remove merthiolate (preservative)
Washed mononuclear cells, prepared from 30 ml peripheral blood, 
were suspended in 2 ml TBH containing neuraminidase at a concen­
tration of 5yvkg/ml. The cell suspension was incubated at 37°C for 
45 minutes to expose lectin receptors, before washing twice with 
PBS - HSA - NaNg.
The lymphocytes were counted, resuspended in 1.0 - 1.5 ml of 
PBS - HSA - NaNg, applied to the column and allowed to penetrate 
the bed. The flow was then stopped and the cell suspension incubated 
on the gel at ambient temperature for 15 minutes. Unbound cells 
were then removed by eluting with 50 ml PBS - HSA - NaN^ (flow rate
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8 ml/min). Weakly and strongly bound cells were eluted using 
PBS - HSA - NaNg buffers containing 0.1 mg/ml and 1.0 mg/ml NÂDG 
respectively. The three populations of cells were washed and counted.
E , EA and Facb rosettes were prepared on unfractionated and column 
fractionated populations.
SURFACE MEMBRANE IMMUNOGLOBULIN (sig)
Immunofluorescence techniques were employed for the enumeration 
of sig-positive mononuclear cells. These were performed by 
Mr. K. Case (Immunology Department, Royal United Hospital, Bath) 
using affinity column-purified fluoresceinated rabbit antibody against 
human Fd ^u) fragment.
Briefly, lymphocytes were isolated on Ficoll-Paque, incubated 
at 37°C for one hour and washed twice in warm (37°C) medium to 
remove surface labile IgG. The mononuclear cells were adjusted to 
4 X 10^/ml and to 1 ml of cells was added 1 drop of the antiserum. 
Following incubation at 4°C for 20 minutes, the cells were washed 
twice at 4°C and resuspended in 95% glycerol/5% PBS. Wet mounts 
were prepared and sIg-positive cells were enumerated using a Nikon 
fluophot microscope fitted with epifluorescence.
ESTERASE STAINING
Monocytes were enumerated using cell smears stained for
*4-naphthyl acetyl (non-specific) esterase (Lake, 1971). These were 
performed by Mr. S. Scott (Haematology Department, Royal United 
Hospital, Bath).
117
(vi) LYMPHOCYTE ACTIVATION BY MITOGENS
Three mitogens were used for lymphocyte transformation in vitro
Concanavalin A (Con A)
Phytohaemagglutinin (PHA)
Pokeweed Mitogen (PWM)
Con A was prepared immediately before use and filter sterilised 
(0.22/wL m filter; Millipore); PHA (400 ymg/ml) was prepared and stored 
in aliquots in a liquid nitrogen refrigerator and PWM was stored in 
aliquots at -20°C.
Isolated, washed mononuclear cells were prepared in CMFSS and 
resuspended in lymphocyte medium (see Section I) to a concentration 
of 5 X 10^/ml. Cell cultures were set up in quadruplicate using 
Nunc round-bottomed tissue culture plates (Gibco Bio Cult Ltd.).
Each well contained :-
20Cy&1 mononuclear cells 
lOywkl medium or mitogen solution 
A range of mitogen concentrations was used and the optimum dosage 
determined. The plates were incubated for 65 - 70 hours in a humidi­
fied atmosphere of 95% air/5% CO^.
Four hours before the cells were harvested (Titertek Cell 
Harvester; Flow Laboratories Ltd.), 0.5^*Ci of tritiated thymidine 
(specific activity 5 Ci/mmol) was added to each well. Radioactivity 
incorporated into trichloroacetic acid (TCA) - precipitable material 
was measured in a Packard Tri-Carb liquid scintillation spectrometer 
(Model 5574) using toluene/PPO/POPOP scintillation fluid.
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The above method was used to assay the effect of Fc receptor 
positive cells on lymphocyte stimulation by mitogens. In these ex­
periments only optimum mitogen concentrations were used. (See 
results Chapter 6).
In other experiments comparing Fc receptor expression before 
and after mitogen stimulation, bulk cultures were set up in sterile, 
plastic, flat bottomed tubes (Brunswick; Z/IO/R). Again only optimum 
mitogen concentrations were used. EA and Facb rosettes were prepared 
on the activated and unstimulated lymphocytes.
(vii) FUNCTIONAL ASSAYS
NATURAL KILLER (NK) CELL ASSAY
A 16 hour assay was used based on the 4 hour assay described 
by Pape and co-workers (1979).
Facb and EA rosette depleted cell populations were prepared 
(Section II (iii)); sham depletions were also performed using un­
sensitised calf erythrocytes. Rosettes were set up on treated and 
untreated populations to confirm depletion and the remaining cells 
were adjusted to a concentration of 6 x 10^/ml in K562 medium.
Chromium labelled (Cr^^) K562 cells were prepared by Dr. P. Bland
(Clinical Investigation Department, Royal United Hospital, Bath)
by incubation with lOOy^Ci ^^CrO^Nag (specific activity 250-500ygwCi^g)
4for 1 hour. The cells were washed x 3, diluted to 2 x 10 /ml and 
the assays were set up in polypropylene screw top vials (Nunc;
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Gibco Bio Cult Ltd.) to give a lymphocyte/target cell ratio of 60:1 :- 
0.50 ml lymphocytes (ie 3 x 10^ cells)
3
0.25 ml K562 (ie 5 x 10 cells)
Controls were prepared containing 0.5 ml medium or 0.5 ml 
unlabelled K562 cells at 6 x 10^/ml in place of the lymphocyte sus­
pension and the screw tops were loosely fitted. Whenever possible, 
assays were set up in quadruplicate, and the tubes maintained at 
37°C in a humidified atmosphere of 95% air/5% CO^ for 16 hours.
After incubation the tops were screwed down and the tubes spun 
at 200 g for 10 minutes. A 0.5 ml aliquot of supernatant was with­
drawn from each vial and expelled into an LP2 tube (Luckham). 
Pelleted cells were resuspended using a pasteur pipette and also 
expelled into an LP2 tube. The LP2 tubes were capped, placed into 
gamma counting vials (Gammavial B ; Koch Light Laboratories Ltd.) 
and radioactivity monitored using the Packard Tri Carb liquid 
scintillation spectrometer.
Depleted and untreated cell populations were assessed in their
ability to lyse K562 cells in the absence of antibody. Cytotoxicity
was calculated as follows :-
Let a = number of counts in 0.5 ml supernatant
b = number of counts in 0.25 ml residue
Then total activity present = a + b
total activity in supernatant = a x 1.5
Therefore, % ^^Cr released = ^ x  100
( a + b )
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If s = % released by lymphocytes + K562
and K = % ^^Cr released by K562 alone 
Then specific % ^^Cr released = S - K
KILLER (K) CELL ASSAY
Facb and EA rosette and sham (unsensitised calf erythrocytes) 
depleted cell populations were prepared and loss of rosetting cells 
confirmed as above.
A K cell assay using Chang liver cells, rabbit anti-Chang 
antiserum and the above prepared cell populations was carried out 
by Dr. P. Bland (Clinical Investigation, Royal United Hospital, Bath) 
according to the method of Panayi and Corrigall (1977).
Briefly, Chang liver cells (10^) were radiolabelled with ^^Cr 
sodium chromate (100yUK.Ci for 1 hour at 37°C) and the washed labelled 
target cells, antiserum or medium and various lymphocyte populations 
were incubated together for 18 hours at 37°C in a total volume of 
400y^l. The assay tubes were then sedimented at 400 g for 10 minutes 
and 20CyuCl of the supernatant was removed. Radioactivity present 
in the supernatants and pellets was determined.
Cultures comprised :-
lOOywLl Chang (target cells)
100yiLl lymphocytes (effector cells) or medium or detergent 
lOOyid rabbit anti-Chang serum (10 ^ or 10 ^ dilution) or medium 
100 medium
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The following cultures were set up (all 400ywL 1 total volume) :-
1. targets + medium (spontaneous release)
2. targets + lOOyw^l detergent + medium (maximum release)
3. targets + effectors + medium (SCMC)
4. targets + effectors + antiserum + medium (ADCC)
Calculation of Results
Let a = number of counts in 2 0 0 ^ 1  supernatant
b = number of counts in 200ywU. residue
Then % ^^Cr released = x 100
(a + b)
If % ^^Cr released by cultures 1, 2 ,  3 and 4 is K, M, S and A 
respectively then
Specific %  ^^Cr released (SCMC) = —--- —
M - K
Specific % ^^Cr released (ADCC) = (A - K) - j
(M - K)
The mean maximum detergent release obtained is 90%
Spontaneous release is variable between 15% and 30%
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C H A P T E R  T H R E E
ENUMERATION OF PERCENTAGE Facb ROSETTE 
FORMING CELLS IN HEALTHY SUBJECTS AND IN PATIENTS 
WITH RHEUMATIC DISEASES
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S E C T I O N  I
(i) INTRODUCTION
It is generally accepted that RÂ has an immune-mediated pathology 
since large numbers of immunocompetent cells are detectable in 
rheumatoid synovia (Zvaifler, 1973) and the removal of lymphocytes 
by thoracic duct drainage leads to significant clinical improvement 
(Paulus et al, 1977). A major feature of RA is the production of 
both IgM and IgG rheumatoid factors (antiglobulins). This may imply 
an abnormal interaction between rheumatoid leucocytes and IgG and 
many authors have demonstrated an abnormal response of rheumatoid 
leucocytes to autologous, heat aggregated and complexed IgG 
(Eibl and Sitko, 1975; Weisbart, Bluestone and Goldberg, 1975;
Hall, 1978). Raised numbers of EA-rosette forming cells in patients 
with RA have been reported (Bach, Delrieu and Delbarre, 1970;
Scherak et al, 1976; Sharpin and Wilson, 1977) and Wooley and Panayi 
(1978) have detected abnormal binding of heat aggregated IgG by 
rheumatoid lymphocytes.
The Fc region of immunoglobulin consists of both the CH2 and 
CH3 domains (Fig. 3.1). Hall (1978) described specific migration 
inhibition of rheumatoid leucocytes by the Facb fragment of rabbit 
IgG. In order to examine possible differential binding by rheumatoid 
leucocytes, a rosette assay was developed using Facb sensitised 
calf erythrocytes (Chapter two, section iii) to measure Fc receptor 
binding by the CH2 region of IgG. Cells which bind the CH2 region 
of immunoglobulin will be termed Facb rosette forming cells. In some 
instances, E rosette and EA rosette forming cells were enumerated 
(Chapter two, section iii).
Fig. 3.1
SCHEMATIC REPRESENTATION OF IMMUNOGLOBULIN G
The basic structure of a molecule is shown opposite. Each loop 
in the heavy or light chain formed by an intrachain disulphide bond 
represents a single domain. There are one variable and three constant 
region domains. The Fc region encompasses both the second and third 
domains of the constant region of the immunoglobulin heavy chain, that 
is the CH2 and CH3 domains.
The heavy chain constant region of human IgG begins at the amino 
acid 118 while kappa light chain constant regions begin at 108 and 
the lambda light chain constant region at 109. These residue numbers 











S E C T I O N  I I  
Fcy-Receptor Bearing Cells in Health and Rheumatic Disease
Rabbit IgG and Facb fragments were prepared from anti-calf 
erythrocyte serum (Chapter two, section i). Calf erythrocytes were 
sensitised with various dilutions of the antibody to determine the 
maximum subagglutinating titre (Chapter two, section iii). Results 
obtained with one particular serum sample are presented in figs. 3.2 
and 3.3. Each new preparation of IgG or Facb was titrated in this 
manner.
Patients with RA used in this study were receiving only analgesic 
or non-steroidal anti-inflammatory drug therapy. Control subjects 
consisted of healthy hospital personnel. Rheumatoid patients showed 
increased percentages of EA rosette forming cells at all the dilutions 
tested (Fig. 3.2). This difference was highly significant at all 
IgG titres between 1/400 and 1/6400. The 1/200 dilution was the 
maximum subagglutinating titre. Although percentage total EA rosettes 
were increased in RA, this increase was not significant at the 1/200 
dilution. Increased percentage Facb rosette formation was also 
seen in RA patients (Fig. 3.3). This difference was highly significant 
at the 1/1:28 dilution (p< 0.001) and percentage rosette numbers 
detected using this dilution did not differ significantly from those 
detected using the 1/64 dilution, that is the maximum subagglutinating 
titre. A «comparison of figures 3.2 and 3.3 shows that the Facb 
rosette forming cells do not account for all the FcyR positive 
cells but sre a smaller population. It was found that there was 
a good correlation (r - 0.784) between percentage Facb rosettes and 
percentage EA rosettes at a dilution of 1/1600 (Fig. 3.4). Cells
Fig. 3.2
EA ROSETTE FORMATION BY RHEUMTOID
AND HEALTHY MONONUCLEAR CELLS
Rosettes were prepared using various dilutions of IgG to sensi­
tise calf erythrocytes. The maximum subagglutinating concentration 
is 1/200 but at this concentration rheumatoid and healthy subjects 
are not significantly different with respect to EA rosette percentages
The columns and bars represent the mean - 1 standard deviation.
The numbers of subjects tested are listed below.
(IgG Titre) ^ M HEALTHY Student's t test
200 8 8 NS
400 10 10 p <  0.02
800 10 10 p <  0.005
1600 34 20 p < 0 . 0 0 1
3200 26 19 p<.0.001
6400 7 7 NS








Facb ROSETTE FORMATION BY RHEUMATOID 
AND HEALTHY MONONUCLEAR CELLS
Rosettes were prepared using various dilutions of Facb to 
sensitise calf erythrocytes. A dilution of 1/128 was chosen as the 
maximum subagglutinating concentration since the difference between 
rheumatoid and healthy subjects is highly significant and the values 
obtained do not differ significantly from the 1/64 dilution.
The columns and bars represent the mean - 1 standard deviation.
The numbers of subjects tested are listed below.
-1(Facb Titre) RA HEALTHY Student’s t test
64 4 4 p < 0 . 0 2
100 6 6 NS
128 27 18 p < 0 . 0 0 1
200 9 6 NS
400 3 2 NS














CORRELATION BETWEEN HIGH AVIDITY EA ROSETTES (%)
AND Facb ROSETTES (%)
Linear regression analysis was performed on the individual rosette 
values obtained for samples of mononuclear cells from healthy and 
rheumatoid donors. These values apply to IgG at 1/1600 and Facb at 
1/128 (see Figs. 3.2 and 3.3).
This data fits the straight line:-
y = 0.789% + 2.345 (r = 0.784)
1 3  2

















forming EA rosettes at suboptimal titres will be referred to, in 
this thesis, as high avidity EA rosette forming cells.
In order to establish whether raised percentage Facb rosetting 
cells are unique to RA, peripheral blood lymphocytes were prepared 
from patients with other rheumatic diseases, namely osteoarthritis 
(OA) and ankylosing spondylitis (AS); percentage numbers of Facb 
rosette forming cells were scored. The results are shown in figure 
3.5. Only patients with RA had significantly raised percentages 
of lymphocytes with Facb receptors compared to healthy controls 
(p<  0.001) although occasional samples with increased percentage 
Facb rosettes were seen in all groups. Absolute counts were not 
performed. It was noted that patients with AS who had raised 
percentage Facb rosettes often had peripheral joint involvement.
This observation prompted attempts to correlate disease activity 
with the incidence of raised percentage Facb rosettes in patients 
with RA. No correlation was found. Sero-positive and sero-negative 
patients had similar percentage numbers of Facb rosettes and both 
groups showed significantly raised percentage Facb rosettes (figure 
3.6; p <.0.001). Neither IgMRF nor IgGRF titres were related to 
percentage Facb rosettes (figure 3.7; IgGRF values were determined 
by Miss C. Allen, Bristol University). Plasma viscosity and 
erythrocyte sedimentation rate (ESR), often used as parameters of 
disease activity, showed no correlation with percentage Facb rosettes 
(figure 3.8). Patients assessed clinically as having active synovitis 
did not have enhanced percentage levels of Facb rosette forming cells 
(figure 3.9b) and synovial inflammation measured by quantitative 
thermography also showed no correlation with raised percentage of 
Facb rosettes (figure 3.10). A mean thermographic index of two or
Fig. 3.5
Facb ROSETTE FORMATION BY PERIPHERAL BLOOD MONONUCLEAR 
CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS (RA),
OSTEOARTHRITIS (OA), ANKYLOSING SPONDYLITIS (AS) 
AND FROM HEALTHY CONTROLS -
SUBJECTS NO. TESTED %  Facb ROSETTES SIGNIFICANCE
(- 1 S.D.) (Student's t test)
Healthy 18 6.6 - 3.5
RA 27 12.2 - 3.4 pwCO.OOl
OA 18 5.9 - 3.5 NS
AS 24 8.7 - 3.8 NS
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Fig. 3.6
Facb ROSETTE FORMATION BY PERIPHERAL BLOOD
MONONUCLEAR CELLS FROM PATIENTS WITH SERONEGATIVE
AND SEROPOSITIVE RHEUMATOID ARTHRITIS (RA)
SUBJECTS NO. TESTED % Facb ROSETTES
( - 1 S.D.)
Seropositive RA 14 1 1 . 6 - 2 . 8
Seronegative RA 10 1 2 . 9 - 4 . 5
Healthy 18 6.6 - 3.5
There is no significant difference between the two patient 
groups (Student's t test). Both seropositive and seronegative 
















COMPARISON OF Facb ROSETTE FORMATION WITH 
ANTIGLOBULIN TITRES IN RHEUMATOID ARTHRITIS
Fig. 3.7 (a) shows IgG rheumatoid factor titres (IgGRF) in 38 
patients with RA. There is no linear correlation with percentage 
Facb rosetting peripheral blood mononuclear cells. Only a small 
number of patients had raised levels of IgGRF while many patients 
had raised Facb rosettes. The IgGRF assay is described elsewhere 
(Allen, EIs o n , Scott, Bacon and Bucknall, 1981).
Fig. 3.7 (b) demonstrates a lack of linear correlation between 
percentage Facb rosettes and the differential agglutination titre in 
patients with RA. Many patients with raised levels of Facb rosettes 
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Fig. 3.8
COMPARISON OF Facb ROSETTE FORMATION WITH
ERYTHROCYTE SEDIMENTATION RATE (ESR) AND
PLASMA VISCOSITY (pV) IN RHEUMATOID ARTHRITIS
Figs. 3.8 (a) and 3.8 (b) demonstrate a lack of linear correlation 






















Facb ROSETTE FORMATION BY RHEUMATOID PERIPHERAL 
BLOOD MONONUCLEAR CELLS. COMPARISON WITH DISEASE 
DURATION AND ACTIVE SYNOVITIS
Fig. 3.9 (a)
Facb rosettes show raised levels irrespective of disease duration, 
However, patients with early RA (i.e. two years' duration) possessed 
very high levels of Facb resetting cells. All patients were receiving 
non-steroidal anti-inflammatory therapy.
SUBJECTS NO. TESTED % Facb ROSETTES
(- 1 S.D.)
Early RA ( ^ 2  yrs) 7 15 - 4
RA ( > 2  yrs) 19 1 1 - 3
The above difference is significant (p<0.02) using 
the Student's t test.
Fig. 3.9 (b)
Patients assessed as having active synovitis did not have sig­
nificantly raised levels of percentage Facb rosettes.
SUBJECTS NO. TESTED %  Facb ROSETTES
(- 1 S.D.)
Active RA 9 13 - 3
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Facb ROSETTE FORMATION IN RHEUMATOID ARTHRITIS 
COMPARISON WITH SYNOVIAL INFLAMMATION MEASURED 
BY QUANTITATIVE THERMOGRAPHY
The mean thermographic index of two or four joints was calculated 
(Table 3.1) and the results plotted against percentage Facb rosettes. 
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four joints was obtained and compared with percentage peripheral 
blood Facb rosettes (Table 3.1). Although no correlation was shown 
to exist between percentage Facb rosettes and disease duration, it 
was noted that patients with early RA (i.e. 2 years or less) had 
significantly increased percentages of Facb rosettes (p 4. 0.02;
Figure 3.9a). One patient (LK) followed over a period of 12 months 
from diagnosis showed a rapid rise in Facb rosette forming cells 
(Table 3.2). No other serial data was compiled during this work 
but such studies are, at present, being investigated. Another in­
dividual (LW) also presented at clinic with a high differential 
agglutination titre (DAT >  1/4000) but no clinical symptoms. He 
also had low percentage Facb rosettes (4%). This individual did 
not develop RA.
A number of rheumatoid patients, members of a long-term study 
in progress at the RNHRD, were tissue typed. These patients were 
receiving a wide variety of drug treatment including steroidal and 
immunosuppressive therapy. Percentage peripheral blood Facb rosettes 
were evaluated. No correlation was found between percentage Facb 
rosettes and DR4 positivity (Figure 3.11). Both DR4 positive and 
DR4 negative rheumatoid patients had higher percentage Facb rosettes 
than controls ( p ^  0.001 and p <,0.05 respectively). However, the 
control group was not tissue typed.
The lack of correlation observed between synovitis, a major 
feature of early RA, and percentage Facb rosette forming cells 
(Figs. 3.9b and 3.10) may reflect the use of peripheral blood 
lymphocytes. The response may be localised to the major site of 
inflammation, that is the synovium. Paired peripheral blood and
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TABLE 3.1
THERMOGRAPHIC INDICES OBTAINED FOR RHEUMATOID
PATIENTS WITH SYNOVITIS
The mean thermographic index (T.I.) of two or four joints was 
calculated. Facb rosettes were prepared using peripheral blood mono­
nuclear cells.
SUBJECT




LEFT KNEE RIGHT KNEE LEFT HAND RIGHT HAND
RA 1 3.58 4.28 - - 3.93 11
RA 2 2.75 2.52 3.72 3.53 3.13 14
RA 3 5.28 5.13 4.52 3.74 4.67 6
RA 4 6.05 5.80 5.69 6.05 5.90 10
RA 5 - - 2.18 2.71 2.45 13
RA 6 5.23 6.14 6.04 5.55 5.74 11
RA 7 4.85 4.69 3.88 4.93 4.59 24
RA 8 5.97 6.33 2.58 3.50 4.60 7
RA 9 6.14 6.21 5.01 5.33 5.67 15
RA 10 5.25 5.89 5.69 5.12 5.48 10
RA 11 3.40 3.73 4.85 4.63 4.16 19
RA 12 3.64 4.77 4.20 3.85 4.12 13
TABLE 3.2
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Facb ROSETTE FORMING PERIPHERAL BLOOD




EA ROSETTES Facb ROSETTES
21/12/78 Minimal symptoms ; DAT 1/1024 22% 4%
25/1/79 Diagnosed as early RA 17% 3%
4/5/79 Widespread peripheral joint 
involvement; treatment DF118 only
32% 22%




Facb ROSETTE FORMATION IN DRw4 POSITIVE AND DRw4 NEGATIVE
RHEUMATOID ARTHRITIS PATIENTS
SUBJECTS NO. TESTED % Facb ROSETTES
(- 1 S.D.)
DRw4 positive RA 34 10 - 4
DRw4 negative RA 6 9 - 3
Healthy (not shown) 16 5 - 4
There is no significant difference in Facb rosette formation in 
DRw4 positive and DRw4 negative RA patients
Both DRw4 positive and DRw4 negative RA patients have significantly 
higher percentages of Facb rosette forming cells (p<0.001 and p <  0.05 
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synovial fluid samples were obtained from rheumatoid patients with 
active synovitis on a variety of anti-inflammatory drugs. The 
results are expressed diagramatically in figure 3.12. Percentage 
total E , EA and Facb rosettes were enumerated. As previously stated, 
the term high avidity EA rosettes has been used to describe those 
cells which form EA rosettes under suboptimal conditions, that is 
with low concentrations of IgG coating thé calf erythrocytes 
(figure 3.2; IgG titre of 1/1600). No strict measurements of receptor 
avidity were made. Mononuclear cells, harvested from a ficoll- 
hypaque gradient, were used for rosette formation but the preparation 
may contain other contaminating cell types of similar density.
The distribution of rosette forming cells within rheumatoid peripheral 
blood and synovial fluid was virtually identical (figure 3.12).
Only the percentage of high avidity EA rosettes was significantly 
different. Synovial fluid was found to contain lower percentage 
numbers (p ^  0.05) of high avidity EA-rosette forming cells; this 
may be due to blocking of receptors by immune complexes in the joint 
fluid, which are not removed by washing. No parallel decrease of 
Facb rosette forming cells was observed. This may reflect differences 
in immune complex binding by Facb and high avidity EA rosette 
forming cells.
Alexander, Titus and Segal (1978) have reported that erroneous 
estimations of FcRs can be made using ficol1-hypaque prepared 
lymphocytes due to binding of cytophilie immunoglobulin induced by 
ficol1-hypaque, and pre-washing of whole blood is recommended. Ex­
periments were carried out to determine whether pre-washing affected 
the relative percentages of Facb rosettes detected. It is possible 
that serum IgG is bound more avidly by control lymphocytes than by
Fig. 3.12
ROSETTE FORMATION BY RHEUMATOID PERIPHERAL
BLOOD AND SYNOVIAL FLUID MONONUCLEAR CELLS
Mononuclear cells were prepared from rheumatoid peripheral blood 
and synovial fluid using ficoll hypaque. Percentage E , EA and Facb 
rosettes were enumerated. The results are expressed as the mean - 
1 S.D. In some instances synovial fluid was obtained from two joints 
and rosettes assessed separately; in all these cases, similar rosette 
numbers were found in the two fluids.
PERIPHERAL SYNOVIAL
BLOOD FLUID
E Rosettes 65 - 17 (n = 4) 58 - 18 (n = 7)
Total EA Rosettes 18 - 6 (n = 10) 17 - 11 (n = 15)
High Avidity EA Rosettes 9 - 6 (n = 10) 4 - 4 (n = 13)
Facb Rosettes 8 - 3 (n=: 10) 8 - 5 (n = 15)
Only high avidity EA rosettes showed significant differences. 
Peripheral blood high avidity EA rosettes were significantly increased 
(p<0.05)
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rheumatoid lymphocytes and the observed differences in percentage 
Facb rosettes may be lost. The results (figure 3.13) show that, 
in all cases, pre-washing of whole blood increased the percentage 
of detectable rosettes, but this washing only served to increase 
the observed differences between patients with RA and healthy 
subjects; only rheumatoid patients showed significantly increased 
percentage values of Facb and high avidity EA rosettes after 
washing. In this experiement, three of the five patients had low 
levels of Facb rosettes while two of the control subjects had very 
high levels resulting in a lack of significance between rheumatoid 
and healthy subjects with respect to percentage Facb rosette forming 
cells. This lack of significance was probably due to the small 
number of estimations compared. It was also noted that lymphocyte 
preparations from pre-washed blood contained increased numbers of 
contaminating polymorphonuclear cells and it may be advisable to 
repeat this experiment using purified lymphocyte populations (i.e. 
following carbonyl iron treatment).
S E C T I O N  I I I
The Significance of Raised Fc*R Bearing Cells
As previously stated, raised percentages of Facb rosettes were 
detectable in occasional samples of all the groups tested (figure 
3.5). The percentage Facb rosettes detected in normal healthy in­
dividuals varied from day to day. Occasional raised values were 
seen; serial results for two female and two male individuals are 
shown in table 3.3. For example, subject VW showed a high value 
of 11% in March 1979; similarly DP had a raised value of 9% in
Fig. 3.13
EFFECT OF PRE-WASHING OF WHOLE BLOOD ON THE DETECTION OF 
LYMPHOCYTE SUBPOPULATIONS BY EA AND Facb ROSETTES
Heparinised venous peripheral blood (approx. 5 ml) was washed 
three times with copious amounts of CMFSS. Both washed and unwashed 
blood from healthy and rheumatoid donors were used for lymphocyte 
isolation. EA and Facb rosettes were prepared. Percentage rosette 
forming cells detected in washed and unwashed preparations were com­
pared. The results are presented numerically and diagramatically. 
Washing significantly increased the number of rosettes detected in 
rheumatoid but not healthy peripheral blood.







(n = 5) Unwashed
34 - 13 
27 - 15
11 - 4 
4 - 2
11 -  2 )
6 - 3 )**
Healthy Washed 
(n = 5) Unwashed
2 6 - 8  
24 - 11
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TABLE 3.3
Facb ROSETTE FORMATION BY PERIPHERAL BLOOD










June 1978 8% May 1979 1%
Aug. 1978 2% Dec. 1979 2%
Sept. 1978 7% June 1980 5%
Nov. 1978 1% Aug. 1980 1%
VW Nov. 1978 3% Sept. 1980 4%
(^ ) Jan. 1979 4% Oct. 1980 1%
4 - 3
Feb. 1979 1% Dec. 1930 2% (%)
Feb. 1979 3% Dec. 1980 6%
March 1979 11% Jan. 1981 8%
May 1979 1% Jan. 1981 6%
May 1979 1%
Aug. 1978 5%
DP Oct. 1978 9%
(?) June 1979 1% 4 - 3
Dec. 1979 3% (%)
Jan. 1981 3%
July 1978 8% May 1979 16%
NH Jan. 1979 3% Oct. 1979 16% 1 1 - 5
(/») March 1979 19% Dec. 1979 6% (%)
April 1979 13% Nov. 1980 8%
Jan. 1979 2%
KB June 1980 7% 5 - 3
June 1980 7% (%)
July 1980 2%
158
October 1978 but this value is still within the normal range.
Subject NH had high percentage levels of Facb rosettes on all 
occasions tested over a period of several months; this high level 
was not associated with one particular preparation of Facb. All 
the values obtained for KB were within the normal range. One in­
dividual, admitted to the RNHRD with orchitis due to mumps virus 
infection, also had a very high percentage of Facb rosette forming 
cells (17%; Table 3.4). The possibility that Facb rosette forming 
cells are raised in response to infection was investigated. Peripheral 
blood lymphocytes from rheumatoid patients with concurrent infections 
were prepared and percentage Facb rosettes enumerated. The values 
were not significantly raised when compared with uninfected rheumatoid 
patients (Table 3.4). A different approach was made. Mononuclear 
cells were prepared from healthy subjects having skin tests prior 
to possible BCG vaccination and from one subject receiving an 
influenza vaccine. The results are shown in Figs. 3.14 and 3.15.
The PPD skin tests produced an increase of percentage Facb rosettes 
in sensitised individuals (Fig. 3.14). Inoculation with 'flu* 
vaccine also produced an increase in percentage Facb rosette forming 
cells (Fig. 3.15).
TABLE 3.4
Facb ROSETTE FORMATION BY PERIPHERAL BLOOD
MONONUCLEAR CELLS. EFFECT OF INFECTION BY
MUMPS VIRUS AND OTHER INFECTIVE AGENTS
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SUBJECT DIAGNOSIS
%  Facb 
ROSETTES
PE mumps/orchitis 17
SA RA + pneumonia 13
PH RA + pneumonia + myeloma 
+ amyloid
14
JO RA + septic severe chronic 
chest infection
10
EAR septic arthritis 6
HAN septic arthritis 7
Mean % Facb 
ROSETTES - 1 S.D. 
10 - 3
Figure 3.14
PERIPHERAL BLOOD Facb ROSETTE FORMING CELLS
EFFECTS OF SKIN TESTING
Three healthy individuals having PPD skin tests prior to possible 
Bacillus Calmette-Guerin (BCG) vaccination were used for study. 
Percentage peripheral blood Facb Rosettes were evaluated before skin 
testing and on days 3 and 5 following testing. The results are shown 
opposite. Two individuals showed positive results to the skin test 
while the third was skin test negative.
SUBJECT DAY 1
% Facb ROSETTES

























PERIPHERAL BLOOD Facb ROSETTE FORMING CELLS
EFFECT OF VACCINATION
Percentage peripheral blood Facb rosette forming cells were 
enumerated prior to and on several days following inoculation of 
one healthy subject with an influenza vaccine.
DAYS FOLLOWING %  Facb ROSETTES
VACCINATION














C H A P T E R  F O U R
Fc^ RECEPTORS DETECTED BY Face ROSETTES: 
BINDING SPECIFICITIES AND SENSITIVITY 
TO ENZYME TREATMENT
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S E C T I O N  I
INTRODUCTION
It was renorted in Chapter 3 that patients with RA had increased 
percentage numbers of FcyR nositive peripheral blood cells, detected 
by Facb rosettes (Fig. 3.5). It was also shown that a correlation 
exists between Facb and high avidity EA rosettes (Fig. 3.4). Receptors 
defined by Facb rosette formation will be termed Facb receptors.
Facb receptor bearing cells were also demonstrated in rheumatoid 
synvoial fluids and those results indicated that there may be some 
differences in immune comnlex binding by Facb receptors although 
that was highly speculative. In this chapter, binding experiments 
will be reported; these were carried out in order to determine if 
high avidity EA and Facb rosettes detected the same receptor.
Preliminary experiments were performed to confirm the relationship 
between EA and Facb rosettes. Depletion of total EA rosettes 
(Chapter 2; Section II (iit)) resulted in a significaht loss of 
percentage Facb rosettes (p ^  0.05). Similarly, Facb rosette depletion 
produced a significant reduction in percentage high avidity EA 
rosettes (p < 0.02); percentage total EA rosettes were lowered but 
the reduction was not significant (Fig. 4.1). It was noted that 
Facb rosettes were difficult to deplete due to their fragility; 
if not handled carefully, particularly during resuspension prior 
to the second Ficoll-Paque separation, the rosettes tended to break 
up resulting in an insignificant depletion of rosettes. Depletions 




Mononuclear cell populations (n = 3) were depleted of total EA 
rosette forming cells (Chapter 2; Section II (iii)). This produced 
a reduction of Facb rosette forming cells. The results are expressed 













p<0 . 0 0 1 p < 0 . 0 5
Fig. 4.1 (b)
Mononuclear cell preparations were depleted of Facb rosette forming 
cells. Percentage total EA rosettes were reduced but the difference 
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1 8 - 8
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NS pwC0.02 p < 0 . 0 5
NS = not significant
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S E C T I O N  I I
Binding Specificity of FcyReceptors Defined by Facb Rosettes 
and High Avidity EA Rosettes
Human and rabbit native IgG and rabbit IgG fragments were pre­
pared as described previously (Chapter 2; Section II (i)) and stored 
in a liquid nitrogen refrigerator until required. Myeloma sera 
of known subclass were used for the preparation of human IgG.
These were obtained either from the Royal United Hospital, Bath 
or as generous gifts from Dr. C. J. Elson (University of Bristol),
Dr. P. M. Johnson (University of Liverpool) and Dr. P. I. Gaarder 
(Statensinstitutt fur Folkehelse, Oslo). The IgG preparations 
were stored in a liquid nitrogen refrigerator until required. Heat 
aggregation was performed immediately before use (63°c; 10 mins).
Rosette inhibition studies were performed by the addition of 
competitor protein as follows. A solution of the test protein 
(lCy*.l. or 2 0 y j X  ) or an equal volume of CMFSS was added to the LP3 
tube prior to addition of the lymphocytes; the tubes were well 
mixed and the sensitised erythrocytes added. Rosettes were enumerated 
as previously described (Chapter 2; Section II (iii)). In early 
experiments using rabbit IgG, a range of protein concentrations was 
tested (10-lOOyA.^/ml). The optimal final concentration was found 
to be 40yuL^/ml and subsequently this concentration was used (lOyiA 
of CMFSS or inhibitor protein at 1.6 mg/ml). In each experiment, 
the percentage rosette formation in the absence of competitor was 
given the value 100 and the effect of competitor related to this.
The mean percentage values of Facb and high avidity EA rosettes
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were similar, 11% and 10% respectively. For these experiments, 
only rheumatoid natients were used since they possessed higher per­
centage rosette numbers. Accurate measurement of differential 
binding is difficult using healthy cells due to the low percentage 
numbers of Facb receptor positive cells; only complete removal of 
Facb rosette forming cells would probably appear significant 
(e.g. 4% to <1%). Therefore, the results in this section relate 
to rheumatoid cells only. For comparative purposes, at least one 
healthy subject was included in each experiment. All rheumatoid 
patients were receiving only analgesic or non-steroidal anti­
inflammatory therapy.
The results of the competition experiments are shown in Fig. 4.2.
The effect of human IgG samples is shown in Fig. 4.2 (a). Both 
high avidity EA and Facb rosette forming cells showed similar binding 
specificity with respect to human IgG. Monomeric IgG, isolated 
from either healthy or rheumatoid sera, did not block either Facb 
or high avidity EA rosettes. The same preparations when heat aggre­
gated, were strongly inhibitory. Receptors detected by both assays 
showed strong subclass specificity for IgGl and IgG3; IgG4 was 
weakly inhibitory and IgG2 showed no inhibition at the concentration 
used. At least two different myeloma sera of each IgG subclass 
were used for these experiments.
Competition experiments carried out using native rabbit IgG 
and its enzymic digestion products show some differences in binding 
by Facb receptors and high avidity EA receptors. Native rabbit 
monomeric IgG and Facb inhibited both rosette assays while Fab 
fragments showed no inhibition of either assay. However, F(ab ' ) 2
Fig. 4.2
COMPETITION EXPERIMENTS WITH HUMAN AND 
RABBIT IgG AND RABBIT IgG FRAGMENTS
Fig. 4.2 (a)
Inhibition of Facb and high avidity EA rosettes by human IgG.
The columns and bars represent the relative mean - 1 standard deviation 
based on a control assay without competitor. The actual percentage 
Facb and high avidity EA rosette numbers were 11% and 10% respectively. 
There were no significant differences in binding by the two assay 
systems.
Fig. 4.2 (b)
Inhibition of Facb and high avidity EA rosettes by rabbit IgG and 
IgG fragments. The columns and bars represent the relative mean - 1 
standard deviation based on a control assay without competitor. The 
actual percentage Facb and high avidity EA rosette numbers were 11% 
and 10% respectively.
Significant Results (Student's t test)
Inhibition of Facb rosettes in comparison 
with high avidity EA rosettes
(i) F (abl)g p ^ O . O l  Facb rosettes only
(ii) Fc p < 0.01 Both assays but high
avidity EA more strongly
(a)
I I Facb Rosettes 1 7  1
















IgGNone F(ab’)Facb Fab Fc pFc'
Addition (40ywLg/ml)
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fragments of rabbit IgG were only inhibitory in the Facb rosette 
assay and this difference in inhibition was significant (p 4 0.01) .
In contrast the pFc* fraction, comprising only CH3 domains of IgG, 
had no effect on Facb rosettes but caused some enhancement of high 
avidity EA rosette formation. Predictably, the Fc fragment inhibited 
both rosette assays but the effect was more marked on high avidity 
EA rosettes (p <  0.01). These results indicate that Facb receptor 
binding may involve the hinge region of IgG. However there is no 
conclusive proof that Facb and high avidity EA receptors are in­
dependent entities.
Carbohydrate binding by Fc^R's was also investigated. It is 
known, from investigations using myeloma proteins, that immuno­
globulin molecules contain oligosaccharide units (Dawson and Clamp,
1968) and such oligosaccharide units have been located in the 
C-terminal region (Fc fragment) of IgG heavy chains (Franklin, 1960). 
Should Facb receptors be specifically inhibited by a certain sugar 
molecule, then it is possible that Facb rosette forming cells could 
be purified by affinity chromatogranhy. Such procedures have been 
used for lectin receptors (Hellstr^m et al, 1976). Competition 
experiments were performed as described for the IgG fragments, using 
a variety of sugars at a final concentration of O.IM. Since glucose 
is a constituent of CMFSS, mononuclear cells were prepared using 
PBS. It was noted that cell yields were much lower when PBS was 
used. Thus, the monosaccharide D-glucose and the disaccharide, 
sucrose were tested as well as two deoxy hexoses and two acetyl 
hexosamines. The absolute and relative percentage rosettes (cal­
culated as described for IgG fragments) are shown in figure 4.3.
In all cases, except that of N-acetyl-D-galactosamine, addition of
Fig. 4.3
COMPETITION EXPERIMENTS : INHIBITION OF
Facb AND HIGH AVIDITY EA ROSETTES BY SUGARS
Rheumatoid peripheral blood mononuclear cell preparations (Chapter 2; 
Section II (ii)) were used for rosette formation incorporating O.IM 
concentrations of six saccharide compounds. The columns and bars rep­
resent the mean - 1 standard deviation. Fig. 4.3 (a) shows the relative 










ROSETTES - 1 S.D. RELATIVE ROSETTES - 1 S.D.
NO, HIGH AVIDITY Facb HIGH AVIDITY Facb
CO. IM) TESTED EA EA
None 3 5 - 2 8 + 2 100 100
(a) 3 4 - 2 10 + 1 83 - 47 133 - 19
(b) 3 9 - 4 13 + 4 217 - 31 163 - 15
(c) 3 3 - 3 9 + 3 83 - 66 123 - 40
(d) 3 2 - 2 8 + 2 46 - 41 106 - 40
(e) 3 3 - 2 10 + 5 113 - 77 143 - 73
(f) 3 4 - 2 9 + 5 108 - 66 113 - 40
There were no significant differences (Student's t test) between 
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sugar molecules to O.IM tended to decrease high avidity EA rosettes 
and increase Facb rosettes. The acetyl hexosamine, N-acetyl-D- 
galactosamine enhanced both Facb and high avidity EA rosettes but 
this increase was not significant. The results are based on only 
three experiments but they suggest that D-glucose has little effect 
on rosette formation at O.IM; the salt solution, CMFSS, contains 
only 1.6 g/litre of glucose ( <  lOmM). None of the sugars tested 
gave complete inhibition of rosette formation.
S E C T I O N  I I I
Fc Receptors Detected by Facb and High Avidity EA Rosettes :
Effect of Enzyme Treatment
Fc receptors have been characterised by their susceptibility 
to proteolysis (Chapter 1; Section IV (ii)). Rheumatoid and healthy 
mononuclear cell preparations were treated with neuraminidase, 
trypsin or phosnholipase C. The experimental details are given in 
Chapter 2, Section II (iv). EA and Facb rosettes were prepared before 
and after enzyme treatment in all cases. E rosettes were set up 
prior to and following neuraminidase and trypsin treatment. Only 
one concentration of each of these enzymes was used. In the case 
of phosnholipase C , three different enzyme concentrations were 
assayed but E rosettes were not set up.
The effect of proteolysis on rosette formation using trypsin 
is shown in figure 4.4. Incubation of rheumatoid cells at 37°c 
produced a drop in all rosette forming cells measured but the differences 
were not significant. Healthy cells, however, showed a significant
Fig. 4.4
EFFECT OF TRYPSIN ON MONONUCLEAR CELLS
E , EA and Facb rosettes were prepared using healthy and rheumatoid mono­
nuclear cells before and after incubation at 37°C and following proteolysis 
with trypsin (Chapter 2; Section II (iv)). The columns and bars represent 





(a) = before 37 C incubation
(b) = after 37°C incubation
(c) = following trypsin treatment
Results
E
RA (a) 6 6 - 9




(b) 57 - 7 J





%  ROSETTES - 1 S.D.
TOTAL EA HIGH AVIDITY EA Facb YIELD
(%)
2 5 - 8 1 3 - 6 9 - 3 -
18 - 6 8 - 2 64 - 20
25 - 6 16 - ej 1 8 - 5 61 - 9
(n=6) (n=5) (n=6)
1 7 - 5 4 - 2 ^ 5 - 3
1 3 - 5 7  -  2 }  * 6 - 2 72 - 9
2 0 - 5 9 - 5 9 - 4 65 - 19
(n=5) (n=5) (n=5)
Significance (Student’s t test) X p ̂  0.05
* p <  0.01 
































(a) (b) (c) (a) (b) (c)
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loss of E rosettes (p <  0.05) and a parallel significant increase 
in high avidity EA rosettes (p <  0.05); these results may reflect 
cell death since only live T cells form E rosettes (WHO report, 1974). 
Trypsin virtually eliminated E rosette formation in both rheumatoid 
and healthy oopulations. Rheumatoid Facb rosettes were significantly 
increased (p < 0.01); although high avidity EA rosettes were also 
increased, the difference was not significant. Healthy trypsinised 
cells showed no significant percentage differences in Facb and 
high avidity EA rosettes. It is possible that the increase observed 
with rheumatoid cells merely reflects removal of immune complexes 
from blocked receptors. Thus E rosette forming cells have trypsin 
sensitive sheep erythrocyte receptors while the F e y  receptor positive 
cells are trypsin resistant.
Neuraminidase cleaves sialic acid residues from glycosylated 
molecules. The effect of neuraminidase on rosette formation is 
shown in figure 4.5. Results from both healthy and rheumatoid sub­
jects are combined since only 2 rheumatoid and 2-3 control subjects 
were used. The results appeared to be very similar. Predictably, 
neuraminidase enhanced E rosettes; this agrees with the findings of 
Hammarstr^m et al (1973). However, the enhancement was not sig­
nificant. All FcyR positive cells measured by the Facb and EA 
rosette assays were significantly increased. Thus Fc^R’s on peripheral 
blood cells are neuraminidase resistant in that neuraminidase does 
not abolish EA or Facb rosette formation.
The effect of phospholinase C on neripheral blood FcyR bearing 
lymphocytes is shown in figure 4.6. Cell viabilities drooped dra­
matically with increasing concentrations of phosnholipase C The
Fig. 4.5
NEURAMINIDASE TREATMENT OF PERIPHERAL BLOOD MONONUCLEAR 
CELLS : EFFECT ON ROSETTE FORMATION
Mononuclear cells prepared on Ficoll Paque (Chapter 2; Section 
II (ii)) were treated with neuraminidase (Chapter 2; Section II (iv). 
Rosettes were set up before and after treatment. The columns and bars 
represent the mean - 1 standard deviation.
%  ROSETTES - 1 S.D.
TOTAL EA HIGH AVIDITY EA Facb
Untreated 
Neuraminidase Treated
64 - 12 
75 - 13
2 0 - 8
3 6 - 7
1 2 - 4
1 8 - 2
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PHOSPHOLIPASE C TREATMENT OF HEALTHY AND 
RHEUMATOID PERIPHERAL BLOOD MONONUCLEAR CELLS 
EFFECT ON FcyR POSITIVE CELLS
Mononuclear cells prepared by isopycnic centrifugation (Chapter 2; 
section II (ii)) were treated with phospholipase C (Chapter 2; Section II 
(iv)). Percentage FcyR positive cells were measured before and after 
treatment. The results are shown opposite. The columns and bars represent 




(b) 0.1 U/ml phospholipase C
(c) 0.5 U/ml phospholipase C




% ROSETTES - 1 S.D. 
TOTAL EA HIGH AVIDITY EA Facb N O .
TESTED
RA (a) 96 + 3 20 + 7 5 + 3 6 + 3 10
(b) 88 + 15 18 + 6 7 + 4 6 + 2 10
(c) 75 + 11 15 + 9 4 + 3 5 + 5 6
(d) 60 + 10 13 + 3 7 + 4 5 + 1 3
Healthy (a) 95 + 1 19 + 5 5 + 4 3 + 1 6
(b) 80 + 8 9 + 3 3 + 3 3 + 1 6
(c) 67 + 23 10 + 4 3 + 1 5 + 2 4
(d) 40 '+ 11 10 + 3 4 + 1 2 + 2 2
Significant Results 
(Student's t test)
Healthy (a) Vs (b) p<,0.01 
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results indicate that both rheumatoid and healthy Facb and high 
avidity EA rosette forming cells have phospholipase C resistant 
FcjjR’s. The effect of phospholipase C on percentage total EA rosettes 
was different in rheumatoid and healthy subjects. Percentage 
rheumatoid EA rosette forming cells fell progressively with increasing 
concentrations of enzyme while percentage healthy total EA rosettes 
were sensitive to low concentrations of enzyme (0.1 U/ml). Higher 
concentrations of phospholipase C produced no further loss of healthy 
EA rosette forming cells. Significance levels measured by the 
Student’s t test are given in figure 4.6. The loss of significance 
at 1.0 Unit/ml using healthy cells probably reflects the low numbers 
(n=2).
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C H A P T E R  F I V E
CHARACTERISATION OF THE Facb 
RECEPTOR POSITIVE CELL
18 5
S E C T I O N  I
INTRODUCTION
In Chapters 3 and 4, it was shown that circulating peripheral 
mononuclear cells bear Fc^R's which recognise the CH2 region of IgG 
and these cells are present in high percentages in rheumatoid 
patients. The receptor appears to have a high avidity for IgG 
and binding is specific for the CH2 region, although some involve­
ment of the hinge region may occur. This receptor is not exclusive 
to rheumatoid patients since raised percentages are occasionally 
detected in normal subjects and also occur after skin testing of 
primed individuals.
In this chapter, attempts to characterise the Facb receptor 
positive cell will be accounted.
S E C T I O N  I I
PHAGOCYTE DEPLETION OF MONONUCLEAR CELL PREPARATIONS : EFFECT ON 
Facb ROSETTE FORMATION
Ficoll-Paque separation of whole blood results in lymphocyte 
populations contaminated with monocytes since the density of mono­
cytes falls within the range of lymphocyte densities; polymorpho­
nuclear leucocytes may also be present in smaller numbers. It is 
possible that the raised percentage numbers of Facb resetting cells 
detected in rheumatoid peripheral blood are due to raised numbers 
of contaminating monocytes or granulocytes since both cell types 
bear FcyR's.
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Phagocytes were removed from mononuclear cell preparations 
either by adherence to plastic tissue culture flasks (Nunc; Gibco 
Bio Cult Ltd.) or by treatment with carbonyl iron. Cell smears 
stained with *-naphthyl-acetyl-(non-specific) esterase show that 
incubation for 30 minutes at 37°C or addition of 20 mg/ml of 
carbonyl iron removed monocytes (Tables 5.1 and 5.2). Table 5.3 
demonstrates that removal of plastic adherent or phagocytic cells 
had no significant effect on Facb rosette formation. However, cells 
obtained after plastic adherence showed much disruption and there­
fore carbonyl iron appears to be a better method of phagocyte 
removal. Using either method, lymphocyte yeilds were low (< 50%).
A purified monocyte population (prepared on Percoll by Miss C. Minty, 
RNHRD) consisting of 88% monocytes was used for Facb rosette for­
mation; only 12% of the cells formed Facb rosettes (Table 5.4).
Thus, a contaminating monocyte population of 20-30% would produce 
only 2-3% Facb rosettes. Similarly, using purified polymorphonuclear 
cell preparations (prepared on Percoll by Miss C. Minty, RNHRD),
Facb rosettes were detected in a mean of only 10% of the cells 
(Table 5.5). One synovial fluid polymorphonuclear cell preparation, 
harvested from the base of a Ficoll-Paque gradient after lymphocyte 
separation, was also measured (Table 5.5); the Facb rosette 
percentage numbers were very low (3%).
The low percentage numbers of Facb rosettes obtained using 
purified phagocyte preparations may have been obtained because 
the sensitising antibody concentrations are not optimal for 
monocyte and granulocyte rosettes. Therefore, it cannot be assumed 
that only low numbers of phagocytes form Facb rosettes. However, 
it can be stated that raised percentages of FacbR positive lymphocytes 
observed in RA in the current study are not due to the effects of 
such cells.
Table 5.1
MONOCYTE DEPLETION FROM MONONUCLEAR




PRE INCUBATION POST INCUBATION
RA 1 11 1
RA 2 12 1
RA 3 1 1
RA 4 10 1
HEALTHY 1 9 2
HEALTHY 2 7 2
Tabe 5.2
MONOCYTE DEPLETION FROM MONONUCLEAR
CELL SUSPENSION BY CARBONYL IRON
% MONOCYTES
SUBJECT CARBONYL IRON CONC, (mg/ml)
0 1 5 20
RA 8 1 < 1 C 1
HEALTHY 23 8 < 1 < 1
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Table 5.3
EFFECT OF MONOCYTE DEPLETION ON
Facb ROSETTE FORMATION BY MONONUCLEAR
CELL SUSPENSIONS
METHOD OF MONOCYTE NUMBER % Facb ROSETTES - 1 S.D.
DEPLETION TESTED
PRE DEPLETION POST DEPLETION
Plastic adherence 16 6 — 3 5 - 3
Carbonyl Iron (20 mg/ml) 24 11 - 6 11 - 6
Table 5.4
















(d H  k  Motf








^  CQH  HM  H + 1Q  HH  W>  CQ 69 69 69 69 69 I 69<  O M CO iH O CM CO in
(6 iH gBÜ  < @M  W SB
+ 1<  CQ CMH  HH 69 69 69 69 69 69J H 0) 0) O ■A Oi 00 I<! H (O CO t> COH  B dO  O 3H  B ®S
g 69 69 69 69 69 69M 0) 0) Oi Oi o> O) 0>B o> 0) 0) 0) 0) Oi 0)BB
H H CM COUM iH N >> >» X >>B B B B <OQ < < +J •P +> P BS3 B B iH iH tH rHCQ (d 00 OO COQ) o 0) 0)B B B B
•o00 •o
iH •HCQ PH iHU iH BB C8B U rHO 0> (0CQ B •HB >
•H 0U d0) >>B CQ
190
S E C T I O N  I I I
CHARACTERISATION OF THE LYMPHOCYTE SUBPOPULATION FORMING Facb 
ROSETTES
As described previously, Fc^R's are present on many cell types 
(Chapter 1, Section IV). Thus subsets of T cells, B cells and 
null cells all bear Fc^Rs and these receptors can also be detected 
on certain virus transformed cells and at various stages during 
cell differentiation. In this section, experiments will be described 
which attempt to characterise the lymphocyte subpopulation bearing 
Facb receptors.
(i) T Cells
T cells are commonly characterised by their ability to form 
rosettes with sheep erythrocytes (E rosettes). Mononuclear cells 
prepared on Ficoll-Paque were depleted of phagocytic cells by 
treatment with carbonyl iron. This lymphocyte population was 
then depleted of E rosette forming cells using neuraminidase 
treated sheep erythrocytes (Chapter 2, Section II (iii)). Both the 
E rosette enriched and E rosette depleted populations were har­
vested and used for rosette formation. The results of two such 
experiments are presented in figure 5.1. E rosette depletion 
increased the percentage of Facb rosette forming cells while en­
richment of E rosette positive cells decreased the percentage 
Facb receptor positive cells. The results show that the majority, 
if not all, of the Facb receptor positive cells do not form E 
rosettes.
Fig. 5.1
E ROSETTE DEPLETION OF MONONUCLEAR CELL
PREPARATIONS : EFFECT ON Facb RECEPTOR
POSITIVE CELLS
Phagocytic cells were removed frcm mononuclear cell preparations 
by plastic adherence. This lymphocyte population was then depleted 
of E rosette positive cells. E , high avidity EA and Facb rosettes 
were set up on the lymphocyte population and on both E rosette 
enriched and depleted cell populations. E rosette depletion produced 
an enrichment of Facb receptor positive cells but this is not sig­
nificant.
% ROSETTES 
E HIGH AVIDITY EA Facb NO.TESTED
56 + 8 10 + 1 9 +
5 + 2 19 + 6 16 +
50 + 17 5 + 1 4 +
Non Adherent Cells 5 - 8  1 0 -  9 - 2  2
2
E-rosetting Cells 5 - 1 7  5 - 1  4 - 1  2
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□ E Rosettes
Y / High Avidity EA Rosettes 


















Helix pomatla lectin Sepharose can be used for the purification 
of T cells (Hellstr^m et al, 1976). Mononuclear cell preparations 
were treated with neuraminidase and applied to a column of Helix 
pom atia lectin Sepharose. The cells were eluted with various 
buffers as described in Chapter 2, Section II (v). Rosettes were 
prepared at each stage of the procedure. The results are shown in 
figure 5.2. A group of four rheumatoid patients and a group of 
four healthy subjects were used in these experiments. Both groups 
behaved identically and thus the results are presented as a whole.
E rosette positive cells were significantly decreased in the unbound 
fraction (p < 0.001) in comparison with untreated cells; the bound 
fraction (fraction 5) showed significantly increased numbers of T 
cells (p <  0.05). In comparison, total EA rosettes were significantly 
enhanced in the unbound fraction (p <  0 .001) and significantly depleted 
in the bound fraction (p < 0.01). Both Facb and high avidity EA 
rosettes followed a similar pattern to total EA rosettes. These 
results also indicate that Facb receptor positive cells are not 
T cells.
(ii) B and Null Cells
The most popular method of B cell identification is by measure­
ment of surface membrane immunoglobulin (sig). Fig. 5.3 shows 
experiments used to correlate Facb receptor positive cells with 
B cells. Calf erythrocytes were chromic chloride conjugated to 
normal sheep IgG or to sheep IgG anti-human light chain (prepared 
by Mr. A. Ahmed, Department of Biochemistry, Bath University).
These erythrocytes were used to deplete immunoglobulin bearing 
cells. Facb rosettes were prepared on untreated and B cell depleted
Fig. 5.2
PURIFICATION OF T CELLS USING HELIX POMATIA LECTIN 
SEPHAROSE : A SEARCH FOR Facb RECEPTORS ON PERIPHERAL
BLOOD T CELLS
The experimental procedure is given in Chapter 2, Section II (v) 
The combined results of four rheumatoid and four healthy subjects 
are presented. Unbound cells were enriched in Facb receptor positive 
cells while the bound fraction contained low percentages of Facb 
receptor positive cells. The effect of neuraminidase treatment has 
been reported in Chapter 4.
Legend
(1) Unfractionated mononuclear cell population
(2) Neuraminidase treated mononuclear cells
(3) Unbound cells
(4) Weakly bound cells
I(5) Bound cells 
RESULTS
%  ROSETTE FORMING CELLS - 1 S.D.
CTION E TOTAL EA HIGH AVIDITY EA Facb
(1) 69^12 (8) 23-9 (8) 14-7 (7) 15-5 (6)
(2) 75-13 (5) 36-7 (5) 18-2 (4) 25-4 (5)
(3) 42-13 (8) 27-17 (8) 36-13 (7) 44- 6 (6)
(4) 72-14 (8) 24-8 (9) 15-7 (7) 17^9 (6)
(5) 82-11 (8) 11-4 (8) 6-4 (7) 6-4 (6)
The numbers in brackets after percentage rosettes refer to the 
number of samples tested.
Significant Results (Student's t test)
G) Vs <5) (p Vs (s)
E Rosettes p < 0.001 p < 0.05
Total EA Rosettes o <  0.001 p < 0 . 0 1
High Avidity EA Rosettes p < 0.01 p < 0.05
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(1) (2) (3) (4) (5)
Fig. 5.3
A SEARCH FOR Facb RECEPTORS ON RHEUMATOID PERIPHERAL
BLOOD B CELLS
Chromic chloride conjugated erythrocytes (Calf RBC) were used 
for the preparation of cell populations depleted of light chain 
positive lymphocytes (Chapter 4, Section III (iii)). Light chain 
and Facb rosettes and sIg were measured before and after depletion 
The results are shown opposite; the columns and bars represent the 
means and standard deviations of the various cell populations.
RESULTS
(1) Calf RBC - Sheep IgG (% rosettes)
(2) Calf RBC - Sheep anti human light chain (% rosettes)
sig % B cells (measured by immunofluorescence; Chapter 2,
Section X v')
SUBJECT Pre Depletion
(2) (2)-(l) sig Facb
RA 1 2 12 10 4 4
RA 2 2 5 3 12 3
RA 3 3 21 18 2 14
RA 4 2 8 6 4 4
mean - 1 S.D. - - 9-6 6-4 6-4
SUBJECT Post Denletion
(1) (2) (2)-(l) sig Facb
RA 1 3 3 0 < 0 . 5 2
RA 2 3 5 2 < 0.5 4
RA 3 3 3 0 <0.5 17
RA 4 3 3 0 <0.5 6
mean - 1 S.D. — _ 1-1 <0.5 7-6
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populations and sig bearing cells were measured as described in 
Chapter 2, Section II (v). Loss of sig bearing cells tended to 
increase Facb receptor positive cells which indicates that the Facb 
receptor is not present on B cells.
The results shown in figure 5.4 indicate that Facb receptor 
bearing cells are also 03 receptor negative. Mononuclear cell 
preparations were depleted of Facb rosettes and EA, Facb and 03 
rosettes were prepared. Complement receptor positive cells were 
increased after Facb rosette depletion.
Styrene beads have been used for the selective depletion of 
B cells (Pang and Wilson, 1978). Columns of styrene beads were used 
for the separation of Ficoll-Paque prepared lymphocytes (Chapter 2, 
Section II (v)> from patients with RA, AS and from healthy subjects.
In all cases total EA rosettes were decreased in the unbound 
fraction in comparison with the unfractionated mononuclear cell 
preparation (Fig. 5.5). Facb rosette forming cells were removed 
only from rheumatoid cells after passage through styrene beads.
(iii) Cell Lines
Many of the experiments described above utilised Facb rosette 
depletions. Facb rosettes seem to be very fragile and break up 
easily during handling. A number of cell lines were tested for 
Facb rosette formation since an Facb receptor positive cell would 
prove ideal for studies of receptor characterisation. Also 
antibody to isolated receptors could be coupled to cyanogen bromide 
activated Senharose to facilitate removal of Facb receptor positive
Fig. 5.4
Facb ROSETTE DEPLETION OF MONONUCLEAR CELL 
PREPARATIONS ; EFFECT ON COMPLEMENT 
RECEPTOR (C3R) POSITIVE CELLS
Mononuclear cell preparations (n = 4) were depleted of Facb 
resetting cells. EA, Facb and C3 rosettes were prepared before 
and after depletion. A decrease in Facb rosette forming cells 
produced an increase in C3R positive cells. The increase did 
not reach significance but these results indicate that Facb 
rosette forming cells do not possess complement receptors. EA 
rosettes were significantly decreased.





%  ROSETTES - 1 S.D.










Significance p < 0 . 0 1
(Student's t test)
NS NS NS
NS = not significant
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EFFECT OF STYRENE BEAD COLUMN CHROMATOGRAPHY ON
LYMPHOCYTE SUBPOPULATIONS FROM PATIENTS WITH
RHEUMATOID ARTHRITIS (RA) AND ANKYLOSING
SPONDYLITIS (AS) AND HEALTHY INDIVIDUALS
The methodology is described in Chapter 2, Section II (v) 
Legend .
RESULTS






























Significant Results (Student’s t test) ** p < 0.01
* p < 0 . 0 5
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cells. The myeloid leukaemia cell line K562 is known to possess 
a high density of FcyRs (Kldin et al, 1976). However, this and all 
the others tested proved to be Facb receptor negative (Table 5.6).
In contrast, the F(ab')^ fragment of an IgG antibody raised against 
isolated K562 Fc receptors (a gift from Dr. D. Hough, Biochemistry 
Department, University of Bath) inhibited both total EA and Facb 
rosettes prepared using rheumatoid peripheral blood mononuclear 
cells. Normal rabbit F (ab')^ showed some inhibition but, in these 
experiments, did not reach significance (Fig. 5.6). A human FcR 
preparation, obtained by temperature shift experiments (Chapter 2, 
Section II (iv)) showed no significant inhibition of either high 
avidity EA or Facb rosettes in the five rheumatoid patients tested 
(Table 5.7); total EA rosettes were not tested. The supernatant 
containing shed receptors was not concentrated prior to use as a 
competitor.
Cell lines are often derived from leukaemic cells. During 
the course of these investigations on Facb receptors, two patients 
with leukaemias were tested. One individual with RA and mono­
cytic leukaemia showed high percentage Facb rosettes (17%) while 
the second individual with OA of the hip and chronic lymphocytic 
leukaemia (CLL) possessed low percentages of peripheral blood 
Facb rosette forming cells (< 1%).
(iv) Effect of Culture and Mitogenic Stimulation on the Expression of the 
Facb Recentor
FcR expression can be associated with cell activation. Peripheral 
blood mononuclear cells prepared from rheumatoid and healthy subjects 
were incubated overnight and with or without mitogens over a period
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Table 5.6
Facb ROSETTE FORMATION BY VARIOUS CELL LINES
% Facb ROSETTES
CELL LINE SOURCE
(Mean - 1 S.D.)
COMMENTS
K562 Human 6—2 one line tested five times
Raji Human 3-2 one line tested five times
Leukaemia (L 1210) Murine 1 one line tested once
EBV Transformed * HumanHealthy 3^1
twelve lines 
tested once
EBV Transformed * HumanRheumatoid 3±1
six lines 
tested once
♦Provided by Dr. A, B. Rickinson, Department of Pathology, 
University of Bristol
Table 5.7
INHIBITION OF RHEUMATOID PERIPHERAL BLOOD LYMPHOCYTE
HIGH AVIDITY EA and Facb RECEPTORS BY A HUMAN Fc
RECEPTOR PREPARATION OBTAINED BY TEMPERATURE SHIFT
Facb
Facb + 4 0 supernatant 
High Avidity EA (EA^^)














SPECIFICITY OF K562 Fc RECEPTOR ANTIBODY FOR Facb
RECEPTORS ON RHElPiATOID PERIPHERAL BLOOD
MONONUCLEAR CELLS
The F ( a b * f r a g m e n t  of a rabbit IgG antibody raised against 
purified K562 Fc receptors was used as a competitor in the EA and 
Facb rosette assays at a concentration of 40yucg/ml. The F (ab ' ) g 
fragment of normal rabbit IgG was also used at the same concentration
Legend
(a) Total percentage rosettes (no competitor)
(b) F(ab')g fragment of rabbit anti K562 FcR added as competitor
(c) F(ab')g fragment of normal rdbbit IgG added as competitor
RESULTS
ROSETTES (Mean - 1 S.D.) 
ADDITION TOTAL EA Facb
(40^ g / m l )
None (a) 18-3 (n=4) l 4-3 (n=6)1
-4 (n=4)J 1-1 (n=6)JF(ab')g anti K562 FcR (b) 
normal rabbit F(ab')„ (c) 13-5 (n=4) 4-3 (n=4)2
n = number of subjects tested
Significant results (Student's t test)
** p < 0.01
♦ p < 0 . 0 5
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of 60-70 hours (Chapter 2, Section II (vi)). EA and Facb rosettes 
were prepared on all samples. The results are shown in figures 
5.7 and 5.8. Incubation overnight did not significantly affect 
Facb receptor expression. However, longer incubations caused a 
decrease in percentage detectable Fc receptors using both rosette 
assays irrespective of whether cells were subjected to mitogenic 
stimulation or merely cultured without mitogen. Only concanavalin 
A stimulated healthy cells showed an insignificant percentage 
decrease of Facb receptor positive cells with respect to freshly 
prepared cells.
Fig. 5.7
EFFECT OF INCUBATION ON Facb RECEPTOR POSITIVE
PERIPHERAL BLOOD CELLS
Peripheral blood mononuclear cells were incubated overnight 
(16 hours). Rosettes were prepared before and after incubation.
SUBJECTS NO-
TESTED
% ROSETTES (Mean - 1 S . D .) 
TOTAL EA Facb












Significant Results (Student’s t test) * p < 0 . 0 5
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EFFECT OF MITOGENIC STIMULATION ON Facb RECEPTOR 
EXPRESSION BY PERIPHERAL BLOOD CELLS
Peripheral blood mononuclear cells were incubated with or without 
mitogens for 60-70 hours. Percentage EA and Facb rosettes were 
enumerated before and after incubation.
Legend
(a) Pre incubation (mononuclear cell preparation)
(b) Post incubation (no mitogen)
(c) Post incubation with 1yuLg/ml phytohaemagglutinin
(d) Post incubation with 50y*g/ml concanavalin A





































Significant Results (Student's t test)
** p <0.01 
* p < 0.02














FUNCTIONAL ASPECTS OF F a c b  
RECEPTOR POSITIVE LYMPHOCYTES
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S E C T I O N  I
INTRODUCTION
The results given in Chapters 4 and 5 have provided evidence 
for the specificity of the Facb receptor and the type of peripheral 
blood cell on which such receptors are detected. In Chapter 3, it 
was shown that Facb receptor positive peripheral blood cells are 
present in all individuals and that raised percentages occur in 
patients with RA and occasionally in healthy persons; skin testing 
of sensitised individuals also resulted in raised percentages of 
Facb rosette forming cells. This suggests that these cells may be 
important in the immune response to antigen. Functional aspects 
of FcR positive cells were reviewed in Chapter 1, Sections II and 
IV (iii). In this chapter, preliminary experiments will be described 
which attempt to ascribe a function to Facb receptor positive cells.
S E C T I O N  I I
CYTOTOXICITY ASSAYS
Natural killer (NK) and killer (K) cells both bear Fc^R. Mono­
nuclear cell populations were depleted of Fc receptor bearing cells 
and assessed for their ability to lyse chromium labelled (^^Cr)
K563 target cells in the presence and absence of antibody.
(i) NK Cell Assay
The methodology is given in Chapter 2, Section II (vii). Some 
problems were experienced using the 4 hour assay described by Pope,
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Moretta, Troy and Perlmann (1979) since the values obtained for spe­
cific release were very low ( <  10%). The time taken to deplete 
rosettes and the fact that the cells undergo two passages through 
Ficoll-Paque may explain the low specific releases obtained. Mono­
nuclear cells were prepared and an NK cell assay was set up at 
hourly intervals for three hours (Table 6.1; Assays I, II, III).
The cell preparations were maintained at ambient temperature for 
the three hours. A fourth assay (Table 6.1; Assay IV) was set up 
at the same time as the final 4 hour assay (Table 6.1; Assay III) 
and incubated overnight. All of the 4 hour assays gave low specific 
releases and varied little with time. The 16 hour assay showed 
higher specific releases and was thus favoured for routine use.
Table 6.2 shows the results obtained for 5 rheumatoid and 3 healthy 
individuals using the 16 hour assay. There was no significant 
difference between isolated peripheral blood rheumatoid and healthy 
lymphocytes in their ability to lyse K562 target cells in the absence 
of antibody.
The results obtained for NK cell activity following depletion 
of FcyR bearing cells are given in Table 6.3. All depletions were 
checked by re-rosetting. Sham depletions had no effect on natural 
killer cell activity. Therefore either undepleted or sham depleted 
populations were ascribed 100% NK activity and depleted populations 
were related to this figure. The results are presented diagram- 
matically in Figure 6.1. Although the numbers tested were small, 
it can be seen that total EA rosette depletion reduced natural killer 
cell activity indicating that Fc%R positive cells are important in 
natural cytotoxicity. Depletion of either Facb receptor positive 
cells or high avidity EA rosette forming cells showed little effect
Table 6.1
NATURAL KILLER CELL ASSAY
COMPARISON OF TWO INCUBATION PERIODS
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ASSAY NO. INCUBATION TIME (hrs)
SPECIFIC Cr RELEASE (%)
RA 1 RA 2 RA 3 HEALTHY
I 4 0.1 3,8 5.9 6.6
II 4 2.5 4.3 6.8 9.8
III 4 3.7 7.4 10.9 8,1
IV . 16 18.4 9,6 24.8 24.3
Table 6.2
NATURAL KILLER CELL ASSAY
SUBJECT INCUBATION SPECIFIC Cr RELEASE (%)
MEAN SPECIFIC 
Cr RELEASE (%)TIME (hrs)
RA 1 16 18.4
RA 2 16 9,6
RA 3 16 24.8 20.0 - 7.6
RA 4 16 29,9
RA 5 16 12,3
HEALTHY 1 16 24.3






NATURAL KILLER CELL ASSAY
EFFECT OF REMOVAL OF FcyR BEARING CELLS
SPECIFIC ^^Cr RELEASE (%)
MONONUCLEAR LYMPHOCYTE
CELL TO TARGET RA HEALTHY
PREPARATION CELL RATIO
1 2 3 1 2 3
Pre Depletion 60:1 * - 29,9 12.2 - 42,7 18,8
Sham Depleted 10:1 12.0 8.8
60:1 * * — 18,5 13,1 — 67,4 19,4
Total EA Rosette 
Depleted 60:1 - 9,9 8,9 - 44,6 16,2
High Avidity EA 
Rosette Depleted 10:1 9,2 - - 8.8 - -
Facb Rosette 10:1 11,6 12.2
Depleted 60:1 - 36.8 7.1 - 63,6 29,8
* Mean specific ^^Cr release (%) = 25,9 - 11,6 (n=4) 
** Mean specific ^^Cr release (%) = 29,6 - 22,0 (n=4)
There is no significant difference between the two samples
Fig. 6.1
NATURAL KILLER CELL ASSAY
EFFECT OF DEPLETION OF FcyR BEARING CELLS
The cytotoxicity assay was carried out as described in Chapter 
2 ,  Section II (vii). Mononuclear cell preparations were depleted 
of various Fc^R positive subpopulations. The percentage cytotoxicity 
and Facb rosettes were calculated relative to the untreated or 
sham depleted population. The results are shown opposite. The 
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on NK cell activity. No differences in activity between rheumatoid 
or healthy individuals was apparent. Some enhancement of NK cell 
activity occurred following Facb rosette depletion indicating 
possible enrichment of NK cells. Thus, Facb receptor positive cells 
do not appear to mediate spontaneous cell mediated cytotoxicity.
(ii) K Cell Assay
The effects of depletion of Fc^R bearing cells on K cell activity 
are shown in Table 6.4 and Fig. 6.2. The results in Fig. 6.2 are 
expressed relative to undepleted or sham depleted populations as 
described for the NK cell assay. Owing to the low cell yields 
obtained following Facb rosette depletion, low lymphocyte to target 
cell ratios were used in some instances. Depleted populations 
were checked by re-rosetting. Total EA rosette depletion drastically 
reduced K cell activity demonstrating a requirement for FcyR positive 
cells in antibody dependent cytotoxicity. However depletion of both 
Facb receotor positive cells and high avidity EA rosette forming 
cells produced an enhancement of K cell activity. Thus K cells do 
not appear to possess Facb receptors.
S E C T I O N  I I I
LYMPHOCYTE ACTIVATION BY MITOGENS ; EFFECT OF REMOVAL OF Fc^R 
POSITIVE CELLS
FcR positive cells have been implicated in the response to 
mitogenic stimulation (Chapter 1, Section II and IV (iii)). Depletion 
experiments were carried out and the untreated and depleted populations 
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30:1 31.9 36.7 36,0
Sham Depleted 5:1 12.3 12,0 13.9 12.0
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EFFECT OF DEPLETION OF FcyR BEARING CELLS
Antibody dependent cytotoxicity was assayed as described in 
Chapter 2 ,  Section II (vii). Mononuclear cell preparations were 
depleted of various FcyR positive subpopulations. The percentage 
cytotoxicity and Facb rosettes were calculated relative to the 
untreated or sham depleted population. The results are shown 
opposite. The columns and bars represent the mean cytotoxicity 
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(b) Total EA Rosette Depleted
(c) High Avidity EA Rosette Depleted











Section II (vi). The results are presented in Table 6.5. In many 
instances, sham depletions affected mitogen responses and little 
difference occurred between FcyR positive cell depleted and sham 
depleted populations. Occasional samples showed increased or 
decreased stimulation but no simple pattern of effects is apparent.
Table 6.5
LYMPHOCYTE ACTIVATION BY MITOGENS









1 2 3 4 1 2 3 4
PHA 82 12 6 2 1 1 2 31
Pre Depletion Con A 21 10 5 19 1 1 1 8
PWM 24 8 6 8 2 1 2 8
PHA 8 20 4 1 1 2 7
Sham Depleted Con A 5 12 - 4 5 1 16 2
pm 4 6 — 7 2 1 3 2
PHA 7 9 18
Total EA
Rosette Depleted Con A 2 7 — — — 4
pm 8 3 9
PHA 9 28 2 5 1 1 5 12
Facb Rosette
Depleted Con A 2 13 1 12 2 1 3 4
PWM 3 6 2 5 1 2 3 4
STIMULATION INDEX =
mean cpm of stimulated cells 
mean cpm of unstimulated cells
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C H A P T E R  7
DISCUSSION
226
Facb Receptor Positive Cells
(i) Surface Characterisation and Relationship to Null Lymphocytes
Receptors for the Fc portion of immunoglobulin (FcRs) are 
present on some subsets of all human peripheral blood leucocytes 
(Chapter 1, Section III (i)) . In this thesis, a rosette assay has 
been described which detects an FcyR binding the C^2 region of IgG 
(Facb receptors). The characterisation of the lymphocyte bearing 
Facb receptors was described in Chapter 5. Such cells were shown 
to lack receptors for Helix pomatia lectin, sheep erythrocytes and 
complement (C3) and were surface Ig negative. Thus the Facb 
receptor (FacbR) positive lymphocyte is a C3 receptor negative null 
lymphocyte. Null lymphocytes have been described as third population 
cells (Fr^land, Wisl^ff and Michaelsen, 1974), LQ^XTs (Horwitz and 
Lobo, 1975) and UL cells (Dickler, 1976 b ) . Pang and Wilson (1978) 
showed that null cells formed EA rosettes at low concentrations of 
sensitising antibody. Similar results were obtained for FacbR 
positive lymphocytes (Fig. 3.4 and Fig. 4.1). Cells forming EA 
rosettes at low antibody concentrations will be termed high avidity 
EA rosettes.
L lymphocytes are C3 receptor negative non-T non-B lymphocytes; 
these cells have been shown to react with anti-myeloid sera (Horwitz, 
Niaudet, Greaves, Dorling and Deteix, 1978). This is an interesting 
observation since a high percentage of Facb rosettes (17%) was 
detected in a subject with monocytic leukaemia (Chapter 5, Section III
(iii)) but this patient also had RA. The myeloid leukaemia cell 
line K562 did not bind Facb sensitised erythrocytes although a rabbit 
IgG antibody raised against isolated K562 FcRs inhibited Facb and
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total EA rosette formation (Chapter 5, Section III (iii)). The 
meaning of these conflicting results is unclear. It is possible 
that the rabbit antiglobulin is raised against a FcR componenet 
which is normally inaccessible on the intact cell but is exposed 
following receptor isolation; it is known that enzymes (e.g. 
neuraminidase) can effect receptor expression (Hammarstr^m et al,
1973). However if the component is normally hidden it would seem 
unlikely that the antibody could block EA rosette formation.
FacbR bearing lymphocytes do not appear to be myeloid since 
removal of cells staining with non-specific esterase did not decrease 
the percentage of detectable Facb rosettes (Table 5.3). However,
Kay and Horwitz (1980) have shown reactivity of the monoclonal 
antibody OKMlywhich is thought to detect myeloid/monocytic cells, 
with L lymphocytes; a previous report had shown L lymphocytes to be 
non phagocytic and esterase negative (Niaudet, Greaves and Horwitz,
1979). The recent production of the monoclonal antibodies has 
further complicated the detection of lymphocyte subpopulations since 
OKMl positive cells are found not only in the null cell fraction 
but also in the Ty population (Reinherz et al, 1980), and some Ty 
cells have been shown to contain non-specific esterase (Manconi et 
al, 1979). It is possible that the use of neuraminidase treated 
sheep erythrocytes (SRBC) in the isolation of Ty cells may lead to 
a loss of specificity for T cells. FacbR bearing cells did not 
seem to react with neuraminidase treated SRBC since E rosette 
depletion enhanced the percentage detectable Facb rosettes (Fig. 5.1).
It was thought that the FacbR positive lymphocyte might be an 
immature cell but incubation of isolated peripheral blood mono-
2;: 8
nuclear cell populations for periods up to 70 hrs resulted in a 
loss of FcRs, and mitogenic stimulation did not enhance FacbR 
expression (Figs. 5.7 and 5.8). Immature cells show increased 
FcR expression with maturation (Yang et al, 1978) while blast 
transformed cells lack FcRs (Jondal, 1974).
Ripley rosettes have been shown by some workers to detect 
cells other than third population cells (Doblougeet a l , 1979;
Andersson and Svennevig, 1980). Likewise, Facb rosettes were shown 
to detect FacbRs on some polymorphonuclear leucocytes and monocytes 
(Table 5.4 and 5.5). None of the cell lines tested expressed high 
percentages of Facb receptors (Table 5.6). As previously stated, 
the sensitising antibody was not titrated for detection of poly­
morphonuclear leucocyte or monocyte FcRs and therefore, the percen­
tage total number of FcyR and FacbR positive cells may be higher.
It thus appears that FacbR positive lymphocytes show characteristics 
of null lymphocytes and may be analogous to the L cell population
or form a subset of L cells.
(ii) Binding Specificity of the Facb Receptor
Third population cells have been shown to preferentially bind
IgGl and IgG3 (Fr^land et al, 1974) and L cells have been shown to 
form Ripley rosettes (Horwitz, 1977). Similarly, FacbR positive 
C3R negative null cells showed strong subclass specificity for
IgGl and IgG3 although IgG4 showed some binding (Fig. 4.2(a)).
Monocytes also show subclass preference for IgGl and IgG3
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(MacLennaQ, 1972'; Lawrence, Welgle and Spiegelberg, 1975; Dorrington,
1977) while neutrophils bind IgGs 1, 3 and 4 (Lawrence, Weigle 
and Spiegelberg, 1975). It is apparent that all FcyRs seem to 
exhibit Gl, 3 specificity and this may partly explain why the Facb 
rosette assay detects some receptors on monocytes and neutrophils.
High avidity EA rosette forming cells and FacbR positive cells 
showed identical human IgG subclass specificity (Fig. 4.2 (a)).
However fragments of rabbit IgG showed differential binding between 
the two cell populations. FacbR positive cells did not bind the 
Cg3 domain (pFc' fragment) of rabbit IgG but showed some binding 
of F(ab'). fragments while high avidity EA rosettes were not inhibited 
by the addition of F(a b * ) 2  fragments (Fig. 4.2 b ) . This implies 
that the hinge region is possibly involved in FacbR binding. It 
has been showed that Ripley rosette formation is not inhibited by 
pFc', which agrees with the finding for FacbR positive cells; however, 
using Ripley rosettes, F(ab ' ) 2  showed no inhibition of binding and 
the Fc fragment was strongly inhibitory (Fr^land et al, 1974).
Both Facb and high avidity EA rosettes were inhibited by Fc fragments 
in this study, but the inhibition was less marked using Facb 
rosettes. Fr01and and co-workers (1974) concluded that third popu­
lation lymphocyte FcyRs bind primarily the C^2 region of IgG. This 
is in agreement with the results using FacbR positive cells although, 
in this case, binding may also involve the hinge region. Other 
workers have suggested stabilisation of one binding site (0^2) by a 
second (C„3) (Ovary, Saluk, Quijada and Lamm, 1976) or co-operative 
binding through quarternary structure (Spiegelberg^# al, 1975- 
Ovary et al, 1976). Binding to FacbRs may involve some interaction
230
at the hinge region, possibly an altered structure due to antigen 
binding, and immune complex formation.
Some monocytes express FacbRs (Table 5.5); Ciccimara, Rosen
and Merler (1975) showed that the primary site of attachment of
IgG to monocyte FcRs was in the C„3 domain. Perhaps the altered
hinge, after immune complex formation for example* exposes another
binding site on the C„2 region of the immunoglobulin molecule.- n
However, a more likely explanation is that a few monocytes have a 
higher Fc receptor density and are therefore able to bind Facb.
Another possibility is that the observed monocyte binding is merely 
due to contaminating lymphocytes or neutrophils. If the FacbR 
is an immune complex receptor, one might expect to find high per­
centages of FacbR positive neutrophils; this is not the case (Table 5,4).
Receptors shed as a result of a temperature shift from 4°C 
to 3 7 did not inhibit Facb or high avidity EA rosettes (Table 5.7). 
Inhibition of total EA rosettes was not assayed. It has also been 
shown that Facb receptors are not shed as a result of temperature 
shift experiments (L.J.Eales - unpublished observations).
The competition results suggest that the FacbR positive cell 
and the high avidity EA rosette forming cell show some heterogeneity 
in their FcyRs, although there is no clear evidence to support the 
existence of two different cells or two different receptors on the 
same cell.
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(iii) FacbRs —  Susceptibility to Enzyme Treatment
Third population cells and L lymphocytes have been shown to 
possess trypsin resistant, pronase sensitive FcyRs while B cells 
have trypsin sensitive FcyRs (Lobo and Horwitz, 1976; Winfield,
Lobo and Hamilton, 1977). Healthy FacbR positive cells were also 
found to be trypsin resistant (Fig. 4.4) which further strengthens 
the argument that these cells are not B cells but belong to the 
null cell population. Neuraminidase enhanced FacbR expression 
(Fig. 4.5); this is probably a surface charge related phenomenon.
The increased percentage E rosettes observed using neuraminidase 
treated sheep erythrocytes is due to loss of negative surface charge 
by removal of sialic acid residues (Bentwich, Douglas, Skutelsky 
and Eunkel, 1973); a similar effect may occur with Facb rosettes. 
Competition experiments using saccharide molecules showed that most 
of the sugars used increased Facb rosette formation and decreased 
high avidity EA rosette formation. The acetyl hexosamine, N-acetyl- 
D-galactosamine (NADG), enhanced rosette formation in both assays 
(Fig. 4.3) but none of the results reached significance. One could 
speculate that this sugar may be a constituent of the binding site 
itself. The addition of NADG may cause membrane changes resulting 
in increased FacbR expression or a change in surface charge or may 
increase accessibility of FacbR; it is known that NADG has membrane 
effects since it inhibits the early phospholipid response to PHA 
in that there is a decreased incorporation of phosphatidyl choline 
(Fisher and Mueller, 1969).
Phospholipase C had no effect on the expression of FacbRs by 
healthy cells; however percentage total EA rosettes were sensitive
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to low concentrations of this enzyme and the percentage of detectable 
cells fell to the level of percentage FacbR positive cells. Higher 
concentrations of phospholipase C produce no further decrease in 
detectable total EA rosette forming cells (Fig. 4.6). This is in­
teresting since it has been shown that the FcyR is isolated from 
B lymphoblastold cells has bound phospholipid and exhibits phos­
pholipase Ag activity (Suzuki, 1981). The FacbR appears not to 
have bound phospholipid but a proportion of the total EA rosette 
forming cell population was sensitive to phospholipase C .
The results obtained for total EA rosette agree with those 
described by Wilkinson (1977). The Facb receptor thus appears to 
be trypsin, phospholipase C and neuraminidase resistant. Phospholipase 
C hydrolyses only the polar head groups of several phospholipids 
including phosphatidylcholine and sphingomyelin. Wilkinson (1977) 
showed almost complete inhibition of EA rosette formation and leuco­
cyte chemotaxis by the addition of sphingomyelinase C; this enzyme 
has a specificity for sphingomyelin only. Wilkinson (1977) suggests 
that the tail region of sphingomyelin may be important for cell 
interactions with extrinsic molecules. It is therefore possible 
that FacbRs have membrane associated sphingomyelin but no direct 
experiments have been performed.
(iv) Functional Aspects of FacbR Positive Lymphocytes
Both null and Ty cells have been shown to exhibit K cell 
activity (Wisl^ff, Fr^land and Michaelsen, 1973; Horwitz and Garrett,
1977; Gupta, Fernandes, Nair and Good, 1978). Kay and Horwitz (1980)
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showed that all null and Ty cells which effected ADCC reacted with 
the monoclonal antibody OKMl and thus may be of myeloid origin.
FacbR positive lymphocytes, however, showed no K cell activity; 
removal of Facb rosette forming cells increased K cell activity 
(Fig. 6.2). Null and Ty OKMl positive cells have also been shown 
to exhibit NK cell activity (Horwitz and Garrett, 1977; Gupta,
Fernandes, Nair and Good, 1978; Kay and Horwitz, 1980). Facb rosette 
depleted mononuclear cell populations had normal or increased SCMC 
activity (Fig. 6.1). Removal of total EA rosette forming cells sig­
nificantly reduced both ADCC and SCMC confirming the requirement 
for FcyR positive cells. However removal of cells with high avidity 
FcyRs, defined by the criteria described in Chapter 3, Section ii, 
failed to remove cytotoxic activity in all cases except one (Fig. 6.1). 
Further studies are necessary to verify this result. It is generally 
accepted that cytotoxic cdllsT(K and NK) bear high avidity FcyRs.
The effect of depletion of populations of FcyR bearing cells on 
mitogenic stimulation is presented in Table 6.5. The resùlts are 
inconclusive in that no pattern of reactivity is apparent. Sham 
depletions using unsensitised calf cells affected mitogenic stimulation. 
Stimulation indices dropped, rose or remained unchanged. It is 
possible that the introduction of foreign antigen (calf erythrocytes) 
activates the lymphocytes thereby lowering the observed stimulation 
index. However this is unlikely as the unstimulated cells did not 
show high background tritiated thymidine incorporation. It is more 
likely that the second passage through Ficoll-Paque removed most
of the monocytes which may be important in this system. It is 
possible that the use of pre-détermined optimal mitogen concentrations
\
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affected the results. However, owing to the low yields obtained 
following rosette formation and two passages thorough Ficoll-Paque, 
it was only possible to use one concentration for each mitogen and 
to test for rosette depletion by re-rosetting.
Although the numbers of individuals used in the cytotoxicity 
assays are low, it is apparent that FacbR positive cells do not 
have cytotoxic potential. In contrast, L cells and third population 
cells have been shown to lyse antibody coated target cells (Horwitz 
and Garrett, 1977; Wisl^ff, Fr^land and Michaelsen, 1974). It is 
possible that FacbR positive cells form a subset of L cells which 
do not have cytotoxic potential. The mitogen experiments provided 
no clue to their possible helper or suppressor function.
(v) Facb Receptor Positive Lymphocytes in Rheumatoid Arthritis
A clear difference observed between rheumatoid and healthy 
mononuclear cells was the significantly raised percentage numbers 
of FcyR and FacbR positive cells (Figs. 3.2 and 3.3). The raised 
percentage of EA rosettes is in agreement with the findings of 
other workers (Bach, Delrieu and Delbarre, 1970; Sharpin and Wilson,
1977 a; Wooley and Panayi, 1978). Evidence provided in this thesis 
concerning FacbR positive cells describes them as non-B non-T 
lymphocytes. However both third population and L lymphocytes have 
been reported in normal percentages in rheumatoid peripheral blood 
(Fr^land, Natvig and Wisl0ff, 1975; Horwitz and Juul-Nielsen, 1977) 
although Horwitz and Juul-Nielsen (1977) found that absolute numbers 
of L cells were depressed. FacbR positive cells are present in
- \
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very low percentages in healthy peripheral blood (Fig. 3.5) while 
percentage L or third population cells are much higher (10-30%
Fr01and, Natvig and Wisl^ff, 1975; Horwitz and Juul-Nielsen, 1977;
Lobo, 1981). It is possible that FacbR positive cells constitute 
a subpopulation of null (L) cells, or alternatively that the FacbR 
is only expressed following molecular or cellular interaction.
However incubation or mitogenic stimulation of mononuclear cells 
failed to increase the percentage number of detectable FacbR 
bearing cells (Figs. 5.7 and 5.8). The increased binding of Facb 
sensitised erythrocytes by rheumatoid lymphocytes could possibly 
be artefactual since Alexander, Titus and Segal (1978) have described 
binding of serum IgG to ficoll/hypaque prepared lymphocytes. Pre­
washing of whole blood only served to increase the percentages of 
detectable FacbR bearing cells in rheumatoid peripheral blood (Fig. 3.13). 
Trypsin also significantly increased the percentage of detectable 
Facb rosettes in rheumatoid peripheral blood (Fig. 4.4). Both these 
observations probably reflect the removal of immune complexes or 
IgG from previously blocked receptors. Binding studies have suggested 
possible immune complex binding by FacbRs (discussed previously in 
this chapter). Synovial fluid and peripheral blood contained similar 
percentage numbers of FacbR positive lymphocytes. This is in 
agreement with Abrahamsen (1981) \dio showed similar percentages of 
third population lymphocytes in rheumatoid peripheral blood and 
synovial fluid.
Rheumatoid lymphocyte cell membranes appear to have different 
properties than those of healthy lymphocytes. Phospholipase C 




decrease of total EA rosettes (Fig, 4.6). This may reflect an 
increased or altered lipid content of rheumatoid membranes.
Rheumatoid Facb rosette forming cells were phospholipase C 
resistant as shown by healthy cells. FacbR positive rheumatoid 
lymphocytes differed from those of healthy subjects and patients 
with ankylosing spondylitis in their affinity for styrene beads.
Only rheumatoid FacbR bearing lymphocytes adhered to columns of 
styrene beads; this implies that the cells are more "sticky" and 
this may explain why Horwitz and Juul-Neilsen (1977) found no 
differences between rheumatoids and controls in terms of cell 
numbers since these authors employ an adherence step to deplete mono­
cytes. Fr01and, Natvig and Wisl^ff (1975) observed depletion of 
third population rheumatoid cells following nylon fibre filtration.
As previously stated, phospholipase C hydrolyses only the polar head 
groups of phospholipids while Wilkinson (1977) has suggested that 
the tail région of membrane Sphingomyelin may be important in extra­
cellular interactions. Rheumatoid EA rosette forming cells which 
do not bear FacbRs appear to have an altered membrane lipid content; 
it is tempting to speculate that the FacbR bearing cell also has 
membrane lipid differences which are not detected by phospholipase C.
Attempts to correlate raised percentages of FacbR positive 
cells with disease activity in a cross-sectional study proved fruitless. 
No correlation was found between percentage Facb rosettes and plasma 
viscosity, ESR (Fig. 3.8) or thermographic index (Fig. 3.10).
Patients with osteoarthritis and ankylosing spondylitis had normal 
percentage levels of Facb rosettes (Fig. 3.5); this observation 
could lead to the supposition that it is the auto-immune aspect of
237
RA rather than the inflammatory component which is responsible 
for the increased percentages of these cells. However percentage 
Facb rosettes also showed no correlation with the presence of 
either IgM or IgG antiglobulins (Figs. 3.6 and 3,7). It was noted, 
however, that Facb rosettes were increased particularly in early 
disease ( <  2 years).
The lack of relationship between percentage Facb rosettes 
and the expression of the DRw4 antigen (Fig. 3.11) is perhaps 
not surprising. Early work, using L lymphocytes, described a DR 
positive, C3 receptor negative sub-group (Horwitz et a l , 1978).
It is now accepted that the majority ( >90%) of non-cultured L cells 
lack a DR antigen (Lobo, 1981). The results obtained in this thesis 
(Fig. 3.11) indicate that there is no correlation between DRw4 
positivity and FacbR expression implying that there is no membrane 
interaction between these molecules.
Rheumatoid FacbR positive lymphocytes, like those of healthy 
individuals, did not exhibit K or NK cell activity. Rheumatoid 
patients have been shown to exhibit normal or subnormal ADCC 
(Fr^land, Natvig and Wisl^ff, 1975; McGill and Twinn, 1977; Panayi 
and Corrigall, 1977; Froebel et a l , 1979; Penschow and MacKay, 1980).
If FacbR positive cells w e r e  responsible for K cell activity, one 
might expect increased ADCC in rheumatoid peripheral blood. Similarly 
rheumatoid peripheral blood SCMC activity has also been described 
as normal (Penschow and MacKay, 1980; Panayi and Highton, 1980) or 
decreased (Burmester et a l , 1978).
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(vi) General Discussion
This discussion has so far been restricted to a discussion of 
the results obtained with FacbR positive cells and thmyr possible 
relationship to L or third population lymphocytes. FacbR positive 
lymphocytes are a subpopulation of cells lacking conventional B 
and T cell surface markers but possessing h i ^  avidity FcyRs and 
thus resemble L cells. Perhaps the most surprising finding is that 
FacbR positive lymphocytes are present in low percentage numbers 
in healthy individuals and do not exhibit ADCC or 8(ZMC; both of 
these observations oppose the published results for L and third 
population cells. It is therefore probable that L cells and FacbR 
positive lymphocytes are overlapping but notidentical populations, 
the latter possibly being a subset of L cells which are not cytotoxic.
This short section will be assigned to an attempt to define 
a possible role for FacbR positive lymphocytes. Since the majority 
of work in this thesis is confined to surface receptor expression, 
cell characterisation and immunoglobulin binding specificity and not 
to the immune responsiveness of FacbR positive cells, this discussion 
will rely on published work using L lymphocytes.
Until very recently, little was known of the role of L lympho­
cytes in immune responses. In 1977, Horwitz presented evidence for 
cytotoxicity by L lymphocytes and postulated that these cells may 
have inducer/suppressor potential. Experimental evidence for the 
L lymphocyte as an accessory cell was provided by Carvahlo, Davis 
and Horwitz (1980). L cells could not replace monocytes in helping
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B cells respond but they enhanced the blastogénie response of sensi­
tised human lymphocytes to KLH-anti KLH complexes. Lobo (1981) 
has confirmed the accessory effect of L lymphocytes and shown that 
these cells also have suppressor activity. L lymphocytes, when 
added to peripheral blood mononuclear cells, are always stimulatory; 
this differs from the findings for T lymphocytes which can exert 
positive or negative responses depending bn the ratio of T suppressor 
to T helper cells. Lobo (1981) also showed that culturing L 
lymphocytes for 48 hours or modulation with EA immune complexes 
induced potent suppressor activity. Addition of Con-A did not aug­
ment the observed suppression. Other workers have shown that nylon 
non-adherent cells (enriched for null and T cells) develop suppressor 
activity following incubation (Fr01and and Natvig, 1973; Horwitz 
and Lobo, 1975). The existence of T^ suppressor cells is well docu­
mented (Moretta, Webb, Grossi, Lydyard and Cooper, 1977) and the 
possible overlap of Ty and L cells with respect to OKMl positivity 
has been discussed previously (Reinherz et al, 1980; Kay and Horwitz,
1980). Hayward and colleagues (1978) have described the existence 
of a Ty-derived suppressor population which is activated by Con-A 
and transition of Ty to Ty has been described (Pichler, Lum and 
Broder, 1978); however Con^A activated '^-derived suppressor cells 
are radioresistant (Hayward et al, 1978) while L suppressor and 
accessory functions are radiosensitive (Lobo, 1981). Lobo (1981) 
suggests that Ty-derived suppressor cells may be necessary during 
the primary response while L lymphocytes may provide feedback control 
of the secondary immune response.
Percentage FacbR positive cells are raised following immunisation 
of sensitised individuals (Fig. 3.14). This observation may parallel
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the findings of Carvahlo, Davis and Horwitz (1980). The increased 
percentages of FacbR positive cells may indicate recruitment of L 
accessory cells. Following B cell antibody production, immune 
complex modulation may induce L suppressor activity as described 
by Lobo (1981). By day 5, healthy immunised individuals show 
normal percentage levels of FacbRs; this may indicate that the FacbR 
is expressed or detectable only on accessory L lymphocytes and may 
also help to explain the lower numbers of FacbR cells measured in 
comparison with L or third population lymphocytes and the residual 
cytotoxic activity in Facb depleted mononuclear cell preparations 
(Figs. 6.1 and 6.2).
No skin testing was performed on rheumatoid individuals. If 
FacbRs are expressed only on L accessory cells and percentage 
FacbR positive cells are high in rheumatoid patients, it is possible 
that rheumatoid FacbR positive cells lack the capacity to suppress 
following immune complex modulation. This may be specific for 
Ig/Ig complexes. Alternatively the FacbR may be modified on 
rheumatoid cells such that the necessary interaction between the 
receptor and the immune complex does not occur. A schematic diagram 
is shown in figure 7.1. The idea that Facb expression is specific 
to accessroy function is further strengthened by the observations 
on cultured and mitogen stimulated mononuclear cells; FacbR 
expression decreased irrespective of whether mitogens were present 
(Figs. 5.7 and 5.8). Lobo (1981) described increased L suppressor 
activity following culture.
Raised percentages of FacbR positive lymphocytes are detected 
in patients with rheumatoid arthritis and appear to be particularly
FIGURE 7.1
(a) POSSIBLE EXPLANATION OF OBSERVED CHANGES IN FacbR POSITIVE CELLS
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high in early RA ( < 2  years; Fig. 3.9 a). Abdou and co-workers 
(1981) described a reduced Con-A suppressor T cell activity in 
early active (<,3 months) rheumatoid patients and the presence of 
an anti-suppressor cell antibody in early RA. This may reflect 
the change from the primary response (Ty-derived suppressor) to the 
secondary response (Ty or L suppressor) as speculated by Lobo 
(1981) and may account for the very high percentage of FacbR 
positive cells observed in some patients with early disease. Meijer 
and associates (1980 a) have described the presence of an anti- 
Ty antibody in active disease. No correlation was found between 
percentage Facb rosettes and disease activity (Figs. 3.8, 3.9b 
and 3.10). However no serial studies were performed and this may 
be necessary to detect individual changes.
Unlike T cells, L lymphocytes did not show differences in 
response dependent on the ratio of inducer/suppressor cells.
The high levels of FacbR positive accessory cells in RA is 
difficult to interpret. The presence of immune complexes in 
rheumatoid sera would be expected to activate the L suppressor 
cell. It is possible that the immune complexes are of the wrong 
size or composition and are thus unavailable for binding.
Binding characteristics of rheumatoid FacbR positive lymphocytes 
differed slightly from those of high avidity EA rosette forming 
cells (Fig. 4.2). No binding experiments were carried out on 
healthy cells due to practical difficulties. Perhaps a modification 
within the Fc binding site prevents the generation of suppressor 
activity following immune complex binding. However, both pre­
washing of whole blood and trypsin treatment of rheumatoid mononuclear 
cells enhanced percentage Facb rosettes; this implies removal of
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immune complexes or IgG from receptor sites. Also rheumatoid 
lymphocytes behave in a similar manner to healthy cells when 
cultured in that they lose FacbRs (Figs. 5.7 and 5.8). It would 
be interesting to know whether cultured rheumatoid FacbR positive 
cells exerted suppressor activity. The mitogen results (Table 6.5) 
provide very few clues. In the one rheumatoid lymphocyte population 
which was depleted of total EA rosettes (RA4), the PWM response 
was enhanced when compared with the sham depleted population; this 
enhancement was also seen in the Facb depleted population but to 
a lesser degree. This might suggest the removal of FacbR positive 
suppressor cells. Similar results were seen with one healthy 
individual (Healthy 1; Table 6.5). However the data is insufficient 
for further analysis.
From the data available it is tempting to speculate on the 
presence of a C3R negative accessory cell which can form rosettes 
with Facb sensitised erythrocytes. The presence of high percentages 
of these cells in rheumatoid patients is consistent with the con­
tinued production of IgM rheumatoid factor; however it is unclear 
from this data why immune complex modulation does not induce the 
loss of FacbRs and thereby possibly suppressor activity.
(vii) Suggestions for Further Studies
The low percentage numbers of FacbR positive cells in healthy 
individuals make studies Of these cells difficult. It is obvious 
that a better purification technique is necessary since the time 
interval in isolation may affect the final result when using 
functional assays. The most useful method of purification would
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be the development of an anti-FacbR antibody. Since high percentage 
numbers of Facb rosettes were detected in one rheumatoid patient 
with myeloid leukaemia, it may be useful to test other CML patients 
without RA for the presence of FacbRs. In the absence of a specific 
FacbR antibody, a FcyR antibody could be used to enrich for FacbR 
positive cells although this would still require a second Ficoll- 
Paque separation to deplete FacbR bearing cells.
Owing to the difficulties encountered using purified human 
lymphocytes, it may be beneficial to search for FacbR positive cells 
in other mammals. The presence of these cells during primary or 
secondary immune responses could be ascertained. This may give a 
clearer picture of the situation in man.
Direct measurements still need to be carried out on human cells.
Thus it would be interesting to know whether FacbR positive cells 
form Ripley rosettes and are OKMl positive. Also the speculation 
concerning the loss of FacbR with transition to suppressor activity 
needs to be investigated although this is not necessarily indicative 
of the in vivo situation.
The whole field of lymphocyte characterisation remains confused 
at present owing to the lack of specificity of the available markers. 
Since Facb rosette forming cells have many characteristics of null 
lymphocytes but do not have cytotoxic potential, it is possible 
that this technique defines a specific population. The function
of that small population may be difficult to investigate.
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